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Abstract 
The project focused on the Ultra Scale-Down (USD) modelling of harvest and early 
purification for viral vaccine and vector production processes.  USD models seek to 
mimic the commercial scale process environment using only millilitres of material.  
Many commercial processes include a disc-stack centrifuge, micro-filtration, 
tangential flow ultrafiltration and density gradient ultracentrifugation steps, which are 
investigated in this work.  
A key parameter of USD, in particular for centrifugation, has been shown to be 
shear, which may cause significant damage to biological products and increase the 
difficulty of subsequent processing steps. To quantify shear rate therefore the PSC-5 
disk-stack centrifuge and PKII density gradient ultra-centrifuge have been modelled 
using Comsol Multiphysics®.  
This EngD project extended existing Computational Fluid Dynamic (CFD) analysis by 
treating the centrifuge as a 3 dimensional system, drawing comparison to the 
rotating disc shear device based on a simple population balance analysis 
(accounting for different shear rate levels and time of exposure), and identifying the 
nature of the shear (simple versus extensional).  This modified approach produced a 
good prediction of shear rate as validated against experimental results, as well as 
intuitively representing a closer match to the physically important points of 
comparison between the two systems. 
In order to overcoming the challenge of experimentally validating CFD predictions in 
downstream process units a novel approach was adopted: use of synthetic particles 
that mimic mammalian cells.  Adju-Phos was applied successfully for the prediction 
of shear rate in a number of pilot scale centrifuges of both tubular bowl and disk-
stack design, by correlating changes in the particle size distribution against that seen 
in the USD shear device. The significant advantages of using Adju-Phos include 
reduced cost, pre-work and time.  
   
Page 5 of 308 
 
For the PKII density gradient ultracentrifuge, a smaller virus shear mimic, consisting 
of an off-the-shelf polystyrene nanobead coated with streptavidin, was used for 
experimental validation of CFD.  This work also represents the first steps in 
developing an USD model for the continuous feed industrial ultracentrifuge, 
consisting of the rotating disc shear device and laboratory ultracentrifuge matched to 
the large scale on the basis or 2t and head at the product layer.  The fact that these 
nanobeads showed an impact from hydrodynamic forces despite their small size, 
raised the possibility that viruses, which had been thought to be too small for 
damage by hydrodynamic or other forms of shear, might also be susceptible. 
There is limited if any literature on the impact of shear rate on cells used to produce 
viral products, or on the viral products themselves.  The existing USD tool was used 
to provide some insight into the performance of the harvest step for influenza and 
adenovirus production processes in continuous cell-lines.   
The results indicated that virus infected cells do not actually show any increase in 
sensitivity to shear forces, and may indeed become less shear sensitive, in a similar 
manner to that previously observed in old or dead cell cultures.  Clarification may be 
most significantly dependent on the virus release mechanism, with the budding 
influenza virus producing a much greater decrease in clarification than the lytic, non-
enveloped adenovirus. A good match was also demonstrated to the industrial scale 
performance in terms of clarification, protein release and impurity profile. 
The impact on the influenza and adenoviruses themselves was measured using 
infectivity assays, TEM and particle size distribution and protein contents of post 
shear purified viral particles.  Whilst no impact was recorded based on the infectivity 
assays or TEM, a small but significant change in particle size distribution was shown 
for adenovirus, and is indicated for influenza.  The influenza virus also showed a 
possible change in protein make-up of purified viral particles, indicating possibly a 
loss of those proteins from the virus structure. The significance of these 
morphological changes, if any, remains to be confirmed.   
Key words: Scale-down, centrifugation, viral vaccine, shear, gene-therapy 
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Impact Statement 
Traditional regulatory approaches involve testing representative batches to confirm 
that a range of quality and safety criteria are met.  This approach is changing, with 
the emphasis, for new processes, shifting to understanding the impact of varying 
process conditions on the quality of the final product.  This new approach is known 
as Quality by Design (QbD). The aim is to use QbD approaches to improve the 
robustness and reduce the risks associated with pharmaceutical processes.  This 
has the potential to improve the success rate of production processes and allow 
pharmaceutical producers greater flexibility, both reducing the final product cost. 
The use of qualified scale-down models is an essential component of the QbD 
process; allowing characterisation of the design space for a new product/process 
economically and rapidly, producing sufficiently comprehensive quantities of data for 
confidence and to generate knowledge of the product-process interactions and to 
test design space boundaries in a manner which is not feasible at large/pilot scale 
(Garcia et al., 2012, McCreath and Shivhare, 2011, Chhatre et al., 2011).  This is of 
particular use for low-volume, high-cost products (Garcia et al., 2012), which 
describes viral vaccines, particularly during early stage process development.  The 
shift from animal/tissue based (e.g. ova) production to cell based manufacturing in 
the vaccines industry (Whitford and Fairbank, 2011) also implies that Ultra-Scale 
Down (USD) models for vaccine purification steps may have considerable utility 
going forwards.  In this work an existing USD methodology for the centrifugal harvest 
step is used to characterise, for the first time, a viral vaccine production process.   
To address cost and safety concerns, the first stage of the project was to develop 
and characterise synthetic shear tracer particles which can be used as a mimic for 
various biological products (cells and viruses).  The focus on shear is based on 
previous work (Maybury et al., 2000, Boychyn et al., 2004) in scaling down 
continuous centrifugation which showed shear rate to be the key scaling parameter.  
The shear mimics may also be useful tools in characterising shear rate in large-scale 
equipment and reducing the cost of USD development.
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Nomenclature 
 
Symbol Description Page # Eqn # 
Q1, Q2   the flow rate through centrifuge 1 and 2   
46  
 
1 Σ1, Σ2   the settling area or sigma for centrifuge 1 and 2 
Z0 
the number of revolutions per second following 
acceleration to full speed 
  
  
  
  
  
46  2 
x the fraction of run time spent accelerating 
y the fraction of run time spent decelerating 
V the volume of material being centrifuged 
R2 the radius to the base of the centrifuge tube 
R1  
the radius to the surface of the liquid in the 
centrifuge tube 
N the number of active discs 
  
  
  
  
  
  
46  3 
Z the number of revolutions per second 
R0 the outer disc radius 
Ri the inner disc radius 
θ the half disc cone angle 
fl 
a correction factor accounting for the flow area 
occupied by the strips which hold the discs 
apart  
 the solution density 
  
  
  
  
 48 4 
ΔP the pressure drop along the pipe 
D the pipe diameter 
L the pipe length 
μ the solution viscosity 
λ the Kolmogorov scale   
  
 55 5 
 the kinematic viscosity 
EDR the local energy dissipation rate 
μ the dynamic viscosity   
  
 55 6 
U the velocity vector 
∇U  the velocity gradient vector 
A a constant, typically 1 
  
  
 55 7 
V' 
the fluctuating velocity, typically using root 
mean square fluctuating velocity 
L  
a characteristic length, typically larger than 
turbulent eddies 
u, v and w  
 the fluid velocities in the x, y and z directions 
respectively 
  
74  8 
subscript of x, y or 
z denotes differentiation in the indicated direction 
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Symbol Description Page # Eqn # 
Q the volumetric pumping rate 
  
  
  
  
74  9 / 10 
vr the velocity at a given distance (r) from the disc 
A the flow area 
N 
the number of passes over the time (t) (typically 
20seconds) 
V 
the volume of liquid in the chamber of the 
rotating disc device (typically 15ml) 
b breakage kernel / rate 
  
  
  
  
78  11 
C4, β, α and γ  constant parameters  
EDR the energy dissipation rate 
kvis 
the kinematic viscosity (assumed to be that of 
water) 
DP the particle diameter 
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1. Introduction 
1.1. Thesis overview 
The project aim is to produce laboratory scale mimics for the purification steps in a 
vaccine manufacturing process.  A number of technologies can be used in the 
downstream purification processes, however, in this project the focus was on disk-
stack centrifugation, ultrafiltration clarification and density gradient 
ultracentrifugation, of which the first and last were successfully explored in some 
detail.  Within industrial centrifugation shear and related phenomena have previously 
been identified as a key scaling parameter.  This remained to be confirmed for viral 
vaccine production processes. It was envisioned that this work be made as generic 
as possible, first involving the identification and use of a synthetic shear tracer 
particle.   
This review will therefore briefly introduce downstream separation and the above 
technologies in particular, with reference to trends in vaccines, vaccine types and 
production technology and the implications of these for downstream separation 
processes; the role of ultra-scale down in bioprocess development and optimisation; 
the nature of shear; the impact of hydrodynamic shear forces within bio-processing 
and particularly its impact on downstream purification and subsequent product 
efficacy. 
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1.1.1. Vaccines 
Vaccines are a diverse group of biological products, coming in various forms. 
Traditionally including attenuated viruses, inactivated bacteria and toxoids 
(Josefsberg and Buckland, 2012), novel product types including molecule subunit 
antigens, virus-like particles, combination vaccines and gene-therapy therapeutic 
vaccines have been developed since the 1980s. A broader range of product types 
and applications have been developed in recent decades thanks to factors such as 
greater systematisation of product testing, through well plates and automated 
methods, and unlocking of the human and pathogen genomes, potentially allowing 
more logical direction of research efforts (Yarmush, 2003). 
The earliest products were derived by extraction from infected animals or humans, 
through to ova based culture and have evolved through greater understanding of 
how to manipulate existing organisms and cell culture based technologies 
(Josefsberg and Buckland, 2012).  Cell culture in better defined cells, using 
processes such as recombinant DNA technology or virus infection are the current 
standard and better understood and controlled.  By contrast, the use of human and 
animal blood serum is less acceptable for the risk of transmission of adventitious 
agents.  Ova based culture techniques are still used for legacy and cost reasons, 
especially in influenza vaccine manufacture (Yarmush, 2003). 
Differences between viruses include size, shape, chemical composition and surface 
structure, including charge distribution and density, hydrophobicity or hydrophobic 
components, addition of poly or oligosaccharides to surface proteins (Wolff and 
Reichl, 2011).  Protein size ranges from 0.005x106Da to 0.08x106Da.  Viruses are 
much larger, generally larger than 5x106 Da with virus particles as big as 100s of nm. 
During this EngD project two separate virus production processes have been 
explored, which represent enveloped virus (influenza) and non-enveloped virus 
(adenovirus) processing. The work aims to draw lessons from work done at UCL and 
apply this to work done in collaboration with GSK.  This has the added advantage 
potentially of broadening the processes examined, and by comparing and 
contrasting, drawing some indication of how general the results obtained might be. 
Adenovirus was grown at UCL in an adherent culture of the continuous HEK 293 
cell-line, in stationary T-flasks.  The latter is not expected to be representative of a 
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large scale culture.  The influenza viral vaccine was produced, using a continuous 
EB66 cell-line, in a stirred tank reactor at a scale of 50Litres.  The section below 
details some of the existing literature on these two viral products and their production 
processes.  Section 1.1.2.4 discusses the impact of shear forces on viruses in more 
detail. 
1.1.1.1. Influenza 
Historic flu pandemics have had a devastating toll, with tens of millions of deaths 
around the world, and concerns for the possibility of another such pandemic remain 
high (Kamps et al. (2006),Osterhaus et al. (2011)).  Seasonal flu alone causes 
millions of cases of severe illness and hundreds of thousands of deaths annually 
(WHO, 2014).  Prevention by vaccination has been the most widely used and 
successful strategy for combating influenza (Hedlund et al. (2010), Salomon and 
Webster (2009), Muennig and Khan (2001)). 
Historically influenza vaccine production has used a live egg-based system.  This 
traditional production process has numerous limitations including the imperfect and 
fragile supply of appropriately sourced eggs, the risk of contamination, cost and 
allergenic nature of some egg constituents (Feng et al., 2011).  There is a need for 
more efficient and cost-effective processes to meet the demand for a rapid response 
capacity, and billions of doses of stock piles, which are required to deal with 
emergent pandemic strains, alongside the ongoing annual seasonal flu vaccine 
production (Chua and Chen (2010), Osterhaus et al. (2011)).  The degree of 
investment and support from public and commercial projects, and the number of 
continuous cell-line based candidates and processes in development, are witness to 
the importance placed on improving production (Genzel and Reichl, 2009).  For 
example the continuous cell lines currently under investigation for production of 
influenza vaccine include Vero, MDCK, CEFs, PER.C6, AGE1.CR, EB66, PBS-1, 
QOR/2E11, SogE and MFF-8C1 (Genzel, 2015).  For development and a smooth 
transition to production these new processes must be well characterised. 
The seasonal nature of influenza, and the evolution of different strains, means that 
each year process development, troubleshooting and clinical safety trial must be 
complete all within very tight timeframes.  This is also likely to limit the amount of 
material, expert personnel and resources available for any new or alternative 
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process developments which may be occurring in parallel with annual production 
(Proctor, 2012).  Moving on from legacy processes also requires meeting modern 
regulatory expectations, including QbD, and a full understanding of process-product 
interaction (Rathore and Winkle, 2009).  The complex nature of the product, virus-
cell and immune-virus interactions in the context of products mechanisms of action, 
and of the virus-cell interaction, in the context of production, make viral vaccine 
production a particularly difficult process to characterise.   
Influenza virus is a member of the orthomyxoviridae family. It is enveloped, 
pleomorphic and varies in size between 80 and 120nm. In its core are segmented 
negative-sense, single RNA strands. It has 9 viral proteins forming a capsid layer, 
composed largely of a single matrix (M1) protein, and embedded in the viral 
envelope, of which haemagglutinin (HA) and neuraminidase (NA) are identified as of 
chief importance in the viral vaccine for their role in stimulating the immune response 
(Dimitrov (2004), Chang et al. (2015), Shaw et al. (2008), Osterhaus et al. (2011)). 
Figure 1.1-1 and Table 1.1-1 gives a summary of the proteins in influenza virus for 
later reference.
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Figure 1.1-1. Schematic summary of influenza virus proteins and structure (The Rapid Reference to 
Influenza Resource Center Team. Adapted from Wilschut (2006), (Gürtler, 2006), (Lamb et al., 1994), 
(UniProt, 2016a), (Guu et al., 2008), (SinoBiologicalInc), (Pflug et al., 2014), Chang et al. (2015)).
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Protein ID MW 
(kDa) 
Prevalence/Copy 
Number per virion 
 Dimer of PA, P2 
subcomplex I 
400  
 PA, PB1 & PB2 
heterotrimer 
250  
 HA trimer 228 167* 
 NA tetramer 220 25* 
 PA, P2 subcomplex I 200  
PB2 Polymerase basic protein 
2 
91 30-60 
PB1 Polymerase basic protein 
1 
87.8 30-60 
PA Polymerase acidic 
Protein 
83 30-60 
HA0 Haemagglutinin 76 500 
 M2 tetramer 60 5-15* 
NP Nucleoprotein 56.6 1000 
HA1 Haemogglutinin (post 
cleavage) 
55 500 
NA Neuraminidase 55 100 
Nucleoprotein post cleavage 53 1000 
 Dimer of NS1 52  
 PA trypsinised 51 30-60* 
 45 30-60* 
 30 30-60* 
M1 Matrix protein M1 28 3000 
NS1 Non-structural proteins 26  
HA2 Haemogglutinin (post 
cleavage) 
25 500 
M2 Matrix protein M2 15 20-60 
NS2 Non-structural proteins 11 130-200 
Table 1.1-1. Summary of protein molecular weight and prevalence in influenza virus (The Rapid 
Reference to Influenza Resource Center Team. Adapted from Wilschut, 2006, Guu et al., 2008), (Zhirnov et 
al., 2002).  *Assumed values 
It might be speculated that the mechanical properties of the cell and thus its 
response to process conditions would be most greatly affected by the entry and 
release stages of the viral life cycle.  
The entry route of influenza is by endocytosis, via attachment of the HA to siallic acid 
receptors on the host cell surface (Dimitrov (2004), Gürtler (2006)).  Influenza 
crosses the cell membrane very rapidly and with high efficacy, i.e. the majority of 
viruses which attach to a cell go on to enter that cell.  Dimitrov (2004) shows the 
stages of influenza viral entry in to the cell, following attachment, as internalisation in 
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an endosome, conformational changes in the attachment protein leading to fusion of 
the viral and endosomal membrane, leading in turn to the release of the viral 
genome into the cell cytoplasm. 
Influenza buds from the cytoplasmic membrane, which is first modified to create lipid 
rafts, the characteristics of which include concentration of viral membrane proteins, 
and a different cholesterol/lipid compositions from that of the standard cell 
membrane.  These lipid rafts may be isolated, or may coalesce to form large lipid raft 
zones from which multiple viruses bud.  The capsid and core are assembled at the 
membrane where it buds, and the receptors for HA are destroyed prior to budding in 
order to allow the virus to leave the cell unencumbered, and presumably to minimize 
self-aggregation of virus.  The local membrane properties, chemical and physical, 
are also modified to allow it to bend, forming an envelope around the virus, and 
eventually separate from the host cell membrane. Virus release from the cell is 
associated predominantly with the action of NA (Handel et al., 2014).   
Enveloped viruses in particular may contain host encoded protein, which it is 
presumed is due to host cell proteins which are ‘caught up’ in the viral membrane 
during budding.  In addition, as with therapeutic proteins, processes such as 
glycosylation may vary from one host cell type to another.  The properties of the 
viruses themselves may therefore vary as a function of the type of cell line used to 
produce them (Shaw et al. (2008), Schaap et al. (2012), Shigematsu et al. (2014)). 
The above gives some sense of the complexity of the virus life cycle and structure 
for influenza.  To some extent its historic usage, under circumstances where full 
evaluation of that structure was impossible, set a precedent for use of this killed virus 
product in humans without the same kind of quality assurance / quality control 
(QA/QC) burden which might apply to future such attenuated or killed viral vaccine.  
The European Medicines Agency (EMA) Vaccines Working Party (VWP (2013)) 
provide guidelines for measuring flu vaccine quality, including HA antigen 
identification against calibration strain by immunodiffusion, HA physicochemical 
properties, NA antigen identification, ratio of NA to HA, purity, aggregate size etc.   
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1.1.1.2. Adenovirus 
Gene therapy has great potential in healthcare and therapeutics, particularly for 
unmet medical needs (Carr and Bradshaw, 2016).  Adenovirus is one of the leading 
candidates currently being studied for use as a vector in gene therapy (Silva et al. 
(2010), Waehler et al. (2007), Zhang and Godbey (2006)), with particular potential in 
oncology, and immunotherapies / vaccines (Kotterman et al., 2015). 526 reported 
trials are currently ongoing (Edelstein, 2016) and licenced products include 
Gendicine in China for head and neck cancer (Kotterman et al. (2015), Kasala et al. 
(2016)).    
As with influenza there is considerable interest in scaling up production as gene 
therapy treatments move through clinical trial, towards production phases.  This 
scale-up is set to pose a number of challenges, including the shift from existing 
adherent culture at laboratory scale to large scale bioreactors.  This project focuses 
on shear rate, as a particularly challenging factor, associated with downstream 
processing, which is likely to be significantly different between laboratory and 
production scales (Pettitt et al., 2016).  One of the many significant differences 
between influenza and adenovirus for gene therapy is the relative stage of 
development in view of regulation:  gene therapy is at a much earlier stage in terms 
of its applications as a therapeutic, and therefore likely to be subject to considerably 
more stringent demands with respect to understanding of its structure, mechanism of 
action and critical quality attributes (CQA) (Scherman, 2014).   
Adenovirus is part of the Adenoviridae family, unenveloped, icosahedral in structure, 
with a double strand of Deoxyribonucleic acid (DNA) at its core, a diameter of 70-
100nm, a large number of serotypes (>=52), with serotype 5 being used for this 
project, and c. 13 structural proteins (Waehler et al. (2007), Harrison (2010), Russell 
(2009)).  The structural proteins include a trimerised hexon which constitutes the 
majority of the outer capsid, and which are arranged systematically around a penton 
base with fibre proteins attached (Lynch et al., 2011).  These fibres give adenovirus 
its distinct pattern of spikes, and are responsible for initial cell attachment (Vellinga 
et al., 2005). 
Figure 1.1-2 and Table 1.1-2 gives a summary of the proteins in adenovirus for later 
reference. 
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Figure 1.1-2. Schematic summary of Adenovirus proteins and structure ((Liu et al., 2010), (Vellinga et 
al., 2005), (Perez-Berna et al., 2009), (Moyer and Nemerow, 2012), (Haruki et al., 2003), (UniProt, 2016b), 
(UniProt, 2015), (MyBioSource.com, 2016)) 
   
Page 32 of 308 
 
Protein ID MW 
(kDa) 
Prevalence/Copy 
Number per virion 
References 
(Wisniewski et al., 
2014) 
Hexon Trimer 240 240 (Vellinga et al., 
2005) 
Hexon 108 720 (Vellinga et al., 
2005, Silvestry et al., 
2009) 
pTP Preterminal protein 76 2 (Perez-Berna et al., 
2009) 
pIIIa Pre-Hexon Linking 65 60 (Perez-Berna et al., 
2009) 
PIIIa Hexon Linking 63.5 (60)  
Penton Protein 63.2 60 (Christensen et al., 
2008, Silvestry et al., 
2009) 
Fiber Protein 61.6 12,  
 
36 
(Henning et al., 
2006) 
(Campos and Barry, 
2006, Silvestry et al., 
2009) 
TP Terminal Protein  55 (2)  
Protein VI Dimer 54 (360/2)  
Protein V 39.4 170 (Silvestry et al., 
2009) 
Pre-protein VI 27 360, 
 
369 
(Perez-Berna et al., 
2009) 
(Silvestry et al., 
2009) 
pVIII Pre-hexon-linking protein 24.7 120 (Perez-Berna et al., 
2009, Silvestry et al., 
2009) 
AVP Protease 23 10, 43 (Silvestry et al., 
2009) 
Protein VI monomer 22 (360?)  
pVII Pre-histone-like 
nucleoprotein 
22 800,  
 
633 
(Perez-Berna et al., 
2009)  
(Silvestry et al., 
2009) 
PVII Histone-like nucleoprotein 19 (800)  
PIX Hexon interlacing protein 14.3 240 (Campos and Barry, 
2006, Silvestry et al., 
2009) 
PVIII Hexon-linking Protein N 12.1 (120)  
pX Pre-core protein X 11 126-160  
PVIII Hexon-linking Protein C 7.6 (120)  
PX Core Protein X 8.8 125 (Silvestry et al., 
2009) 
Table 1.1-2. Summary of protein molecular weight and prevalence in adenovirus 
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Of the structural differences between influenza and adenovirus the critical one is 
likely to be the unenveloped nature of the latter.  In the mechanism by which they 
penetrate and release from the cell non-enveloped viruses differ considerably from 
enveloped (Garoff et al. (1998), Wiethoff et al. (2005)). 
For adenovirus the entry route is by clathrin-mediated endocytosis, via the coxsackie 
adenovirus receptor (CAR) (Dimitrov, 2004).  Transcription, replication and assembly 
occur in the cell nucleus and release is by cell lysis (McLean et al., 2008), via 
viroporins introduced to the cell membrane (Hulo et al., 2011).  This release is 
described as inefficient by Gros and Guedan (2010) as much of the virus remains 
inside the cells.  This may be linked to the similarity in concentration of virus between 
the cell pellet and liquor, although there appears to be a preponderance of 
processes which focus on extraction of viral product from the former as oppose to 
the latter, and some uncertainty about the relative qualities (Altaras et al., 2005).   
One additional complexity of particular concern within gene therapy is the presence 
of empty or partially filled capsids, which may provoke a greater immune response 
without providing any additional therapeutic benefit, generating vector-immunity by 
the host.  This is one of a long list of product characteristics which is likely to 
constitute the regulatory requirements for release (Scherman (2014), Altaras et al. 
(2005), Silva et al. (2010)).   
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1.1.2. Downstream Processing 
Downstream processing covers the stages between the outlet from the bioreactor 
through to the final purification stages.  The stages of downstream processing may 
include: cell recovery; product inactivation; initial separation and purification steps, 
which may also provide volume and therefore cost reduction for subsequent process 
units; ultrafiltration and/or diafiltration, which allow buffer exchange in preparation for 
subsequent processing steps or for formulation purposes; and final purification, e.g. 
filtration (Rathore and Sofer, 2005). 
Recovery stages separate whole cells from supernatant, where the biological 
product is likely to reside predominantly in one or the other.  This is typically done by 
centrifugation or filtration, depending on the volume or flow to be processes and the 
solids quantities to be handles in each batch.  If the biological product is contained 
within the cells there are the additional stages of cell lysis using either high pressure 
homogenisation, or agitation with beads, heat or chemical lysis or freeze thaw. This 
is usually followed by another stage of either centrifugation or filtration to remove cell 
debris (Yarmush, 2003). 
Removal of the product from in process impurities (or visa-versa) at later stages 
relies on smaller differences, e.g. in density, size, hydrophobicity or charge, with or 
without treatment.  Density gradient centrifugation is one such later stage unit, and is 
commonly used for viruses for both concentration and purification.  (Yarmush, 2003)  
Optimisation of yields at the upstream stage in cell culture based processes has 
been the focus of considerable effort.  This has resulted in downstream separation in 
some cases being limiting and representing a higher proportion of costs (Wolff and 
Reichl, 2011), with values given for the percentage of operating costs incurred at the 
downstream separation stage as high as 70% (Morenweiser, 2005). In addition 
safety and reactogenicity concerns continue to drive towards greater purity 
processes, with potential particularly in filters and highly specific chromatography as 
material science progresses (Yarmush, 2003).  
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1.1.2.1. Continuous Centrifugation 
The principle of centrifugation is that particles of a different size and density will 
respond differently under the effects of a centrifugal force, which acts in a manner 
analogous to gravity (Hsu and Perry, 1981).  It is a common unit operation for solid-
liquid separation.  The force acting on a particle is proportional to its mass, the 
square of the angular velocity and the distance from the centre of rotation.  The 
movement of the particle is inhibited by the viscosity of the fluid and its own size.  
Under the effects of gravity alone the back diffusion of solute particles can play a 
significant role in maintaining small particles with minimal differential density in 
suspension.   
Centrifuges are used to separate cells and particulates from liquids and for 
fractionation. For cell harvesting the disc-stack configuration is the most commonly 
used.  The feed is continuous as is the liquid extraction at the top.  The solid removal 
may be either continuous or batch.  The centrifugal force throws the cells or particles 
outwards, so that they do not flow with the lighter fluid but hit the discs and run down 
to the solids settling area (Rathore and Sofer, 2005). 
Disk-stack centrifuges offer poor de-watering levels (~50-60% (Salte et al., 2006)) 
when compared to bowl centrifuges,  which can be problematic when it comes to 
maximising the recovery of an extra-cellular product (Lopes and Keshavarz-Moore, 
2012).  However, bowl centrifuge operation is constrained by other factors such as 
the requirement for manual intervention (Salte et al., 2006). 
1.1.2.2. Filtration 
The principle of filtration is that larger particles will pass with greater difficulty, or not 
at all, through a membrane whose pores are below a certain size, whilst smaller 
particles may still pass relatively unhindered; filtration is a particulate separation 
technique based on the size or molecular weight of a heterogeneous feed stream.  
Filtration is classified according to the filter pore size into microfiltration or 
ultrafiltration.  Microfiltration can be used instead of centrifugation to remove 
microcarriers, cells and cell debris (Wolff and Reichl, 2011) and for the concentration 
of viruses, Whilst ultra-filtration is generally used for purification, exchanging buffer 
for a formulation or prior to a purification step such as chromatography (diafiltration) 
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and concentrating the product (Sharma et al., 2011), although depending on product 
size there can be overlap in the application of filters with different pore sizes. 
For large volumes at an industrial scale tangential flow filtration is usually used.  This 
involves flow on the retentate side parallel to the surface of the filter, minimizing the 
build-up of cake, and thus minimizing the resistance to flow of the permeate (Saxena 
et al., 2009).  A slight modification of this is high performance tangential flow filtration 
involving co-current feeds of retentate and some of the permeate; maintaining a 
more stable transmembrane pressure (Wolff and Reichl, 2011) and reportedly 
allowed a closer approach between the sizes of particles being separated (vanReis 
et al., 1997). Key parameters which can be controlled during operation are 
transmembrane pressure (TMP), feed flow rate and flux of permeate (Wolff and 
Reichl, 2011).   
There are many different geometries available for filtration including: spiral wound, 
tubular, hollow fibre, flat sheet.  Each has their pros and cons: for hollow fibres the 
pros are low shear due to laminar flows and high compaction; for flat sheet the 
advantages are ease of cleaning and unit replacement. (Wolff and Reichl, 2011, 
Sharma et al., 2011) 
The biggest issues with filtration are fouling and the cost of the units (Sharma et al., 
2011).  Pore size (cut off molecular weight) and size distribution, membrane material, 
process stream (e.g. contamination, viscosity etc.), virus/product size, aggregation 
behaviour, buffer used, flux and pore blockage all effect recovery.  Product losses 
can occur due to mechanical damage, separation efficiency, trapping within pores or 
by adsorption to the membrane surface.  Depth filters with reducing pore size 
reduces blockage. (Wolff and Reichl, 2011) 
Viscosity, which is expected to impact upon filter performance, is a function of the 
process stream make-up particularly in terms of concentration of proteins, nucleic 
acids and product and concentration and molecular weight of DNA fragments.  
These concentrations may depend both upon the culture media, culture conditions 
and the preceding separation processes, for example the degree of shear 
experienced at cell recovery.  Viscosity may also change as filtration proceeds. 
(Wolff and Reichl, 2011) 
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Virus particles tend to be quite different in size from most common soluble 
biomolecules allowing an efficient and economic separation.  The size is also 
relatively independent of strain where this changes regularly.  However, the nominal 
molecular weight cut-off of a membrane only represents the average that a 
membrane will allow to pass through.  Therefore, in practice, larger particles will 
pass through than the molecular weight cut-off would suggest.  A margin must 
therefore be allowed below the virus size to prevent product loss.  Equally smaller 
pore size increases resistance and thus decreases flux, and therefore increases 
processing time, and increases TMP.  It also means that more large contaminants 
are retained.  (Wolff and Reichl, 2011) 
Potential sources of damage to virus particles during filtration might include shear 
forces introduced by pumps and turbulent shear forces on the membrane screens 
exacerbated by longer processing time:  Li and Qiu (2013) discuss the relative merits 
and faults of various pump types, highlighting the high levels of shear in lobe pumps 
and variability in flow/ discharge pressure in peristaltic pumps, both effecting product 
stability; whilst Bekard et al. (2011) highlight the importance of the duration of 
shearing on protein stability. 
1.1.2.3. Density Gradient Ultra-centrifugation (DG-UC) 
Density gradient centrifugation allows for a more complete separation of particulate 
types and can be used to separate out particles of a far lower mass than other forms 
of centrifugation.  There are a number of different modes of operation described in 
more detail below, however the common feature is a density gradient in the solvent 
initially filling the centrifuge to which the sample is added (Hsu and Perry, 1981).  
The usual density gradient media are caesium chloride (CsCl), iodixanol or sucrose 
and the density of the solution increases with increasing distance from the centre of 
rotation (Wolff and Reichl, 2011).  The ideal density gradient media will have a 
maximum density greater than the particle for retention, be inert and safe, should not 
disrupt measurement of the target product or impurities, have a density determinable 
by physiochemical analysis, be separable from the target product, have a low 
viscosity and be iso-osmotic with the target product (Frei, 2011).  The US 
Pharmacopeia (1043) defines density gradient media as a tier 2 auxiliary media, and 
recommends using for auxiliary media chemicals which are already licenced in a 
therapeutic context; so iodixanol for example has already been widely used, and was 
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developed as a contrast medium and sucrose is widely used as a sweetening agent 
(British Pharmacopoeia). 
Density gradient ultra-centrifugation (DG-UC) may work in a number of different 
modes: rate zonal, isopycnic and differential centrifugation, and may also be used to 
fractionate products.  (Wolff and Reichl, 2011) 
The principle of density gradient centrifugation is to an extent dependent on the 
mode of operation.  Rate zonal centrifugation relies on the particle size and mass, 
which gives a different rate of travel for each species, resulting in layers of different 
macromolecules forming over a period of time.  Isopycnic centrifugation relies on the 
buoyant density; the centrifuge is left to run until the particles have migrated to a 
position in the density gradient where their density is equal to that of the surrounding 
solution.  With rate zonal centrifugation the sample in its solution will be layered at 
the top of the centrifuge, while with isopycnic centrifugation the sample for 
separation may either form the initial top layer or be mixed with the density gradient 
solution and substantial time (36-48 hours) allowed for gradient formation and 
sedimentation. Differential centrifugation allows the separation of the 
macromolecules fractionally, by pelleting against a sucrose cushion at different 
centrifugal speeds through a media which is less dense than the particles 
themselves, so that their rate of sedimentation is dependent upon the particle size; 
thus a partially purified product may be obtained by removing and washing (and re-
centrifuging) the pellet after a certain length of time.  The gradient material 
introduces a resistance to flow, either through increased viscosity or back diffusion or 
both, further accentuating the differences, based on the sedimentation coefficient 
between the species to be separated. An ultracentrifuge typically operates at a much 
higher rate of revolutions than standard centrifugation and in many cases offers 
better resolution of lower molecular weight species.  (Thermo, 2006, Hsu and Perry, 
1981). 
Density gradient ultra-centrifugation is currently commonly used as one of the later 
steps in the purification of viruses (Yarmush, 2003).  Morenweiser (2005) suggests 
that sucrose gradient centrifugation is being used less in favour of “more 
sophisticated methods”.  Whilst Wolff and Reichl (2011) suggests that, like standard 
size dependent filtration, centrifugation will continued to have relevance in that it can 
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give consistent results across multiple strains, so is less susceptible to problems with 
viruses like influenza which change frequently and because it can be used to 
separate the protein shell of the virus (capsid) from the viral vector.    
Morenweiser (2005) identify a number of disadvantages of DG-UC including that it is 
labour intensive, time consuming, difficult to scale down or up and that it may not 
separate host cell DNA well from viruses.  In addition the author states that if a virus 
is labile its ability to infect (transduction ability) may be reduced due to shear in the 
ultra-centrifuge, exacerbated by the long processing times required.  It is 
hypothesised that this shear will be concentrated in the entry and exit zones, as with 
continuous centrifuges (see section 1.1.3.1), and may also be encountered during 
gradient re-orientation.  Meriño (2013) states that some smaller ultracentrifuges use 
a single dual-flow port which exacerbates shear problems at the inlet and outlet. Hsu 
and Perry (1981) identify a number of complexities in using density gradient 
centrifugation including selection of the appropriate density range and gradient 
shape, balance between sample loading amount and gradient stability and 
resolution. 
1.1.2.4. Application to vaccine processing 
Acceptable purification techniques for a virus will depend upon its surface 
characteristics (such as charge or hydrophobicity), whether it has an envelope, its 
equivalent diameter and how easily it can be damaged (lability) (Morenweiser, 2005). 
Many of the existing separation techniques do not require a very refined 
understanding of the vaccines molecular make-up.  Methods typically used in virus 
purification include density gradient ultra-centrifugation, ultrafiltration, precipitation, 
two-phase extraction and size exclusion chromatography (Morenweiser, 2005), of 
which chromatography is today the most popular method for vaccine/ viral product 
purification at a large scale (Wolff and Reichl, 2011).  However, there are a number 
of vaccine types for which chromatography is typically not used, including enveloped 
viruses (Morenweiser, 2005) and it is, in other cases, used in combination with 
ultracentrifugation (Rappuoli, 2006). 
For viral downstream processing (DSP) overall recoveries of greater than 30% are 
generally considered acceptable. Residual host DNA levels should be below 10pg 
per dose (Wolff and Reichl, 2011).  There are regulations which govern the purity, 
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biological activity and separation of infective and non-infective vectors and capsids 
which are acceptable (Morenweiser, 2005). 
There are many legacy processes still in use today for the production of vaccines, 
the transition from which is hampered by the need for clinical trials following any 
modification to the process, and thus potentially the efficacy of the product. This 
difficulty is exacerbated by the fact that these vaccines, developed before many 
modern analytical techniques became available, have rarely been fully analysed in 
molecular terms (Yarmush, 2003). 
Vaccine process design is becoming more systematic, prompted in part by the 
changing technological platforms, to more well defined systems, such as cell based 
production, and regulatory frameworks with the introduction of Quality by Design 
(QbD).  As a result many of the old barriers to entry which once protected exclusivity 
for older vaccines no longer apply. The company will therefore have a shorter period 
of exclusivity, and the commercial pressure for a faster rate of process development 
have therefore increased (Mukhopadhyay, 2012). 
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1.1.3. Ultra-Scale Down 
Ultra-scale down (USD) involves use and creation of laboratory scale devices, 
procedures and methodologies, which can be conducted on process material to 
imitate the effects of industrial scale processing.  Scale-down is required to:  
- Allow initial development of downstream purification steps, including selection, 
optimisation and identification of key process stream / product properties and 
potential problems associated with these, and thus reduce the risk of delays 
and failures at a later stage.  This is of particular importance given tightening 
timeframes as the time of exclusivity of a vaccine product decreases (Wolff 
and Reichl, 2011, Titchener-Hooker et al., 2008) 
- Mitigate the prohibitive costs of pilot scale studies, where large quantities of 
material are required and equipment is more expensive, takes longer to use 
and clean, and is in demand  (Pampel et al., 2008). Evaluate the performance 
of the selected process in terms of impurity removal, product damage and 
robustness, i.e. the range of conditions (including variations in feed 
properties) over which the performance is acceptable (Rathore and Sofer, 
2005); 
- Troubleshoot existing processes, including evaluating the impact of a process 
change or assessing factors effecting process performance (Rathore and 
Sofer, 2005);  
- As more scale-down models become available, and are shown to be accurate 
and robust, it will be possible to evaluate the degree of interactions between 
steps.  Ideally scale-down models should be linked, providing enough material 
of sufficient fidelity to the industrial product from each stage to accurately 
assess the impact of a particular step in the downstream process on the 
performance of the next and allow optimisation of the whole process 
(Titchener-Hooker et al., 2008).  
- Future, early use of scale down models should allow more fundamental initial 
development route decisions to be made in the realms of target product, 
culture platform, formulation etc.  For example:  
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o Purification process will depend on the upstream processing 
parameters, such as cell type or growth media, or use of alternative 
vaccine sources, e.g. serum versus cell culture (Yarmush, 2003);   
o Biologically similar molecules not only increase commercial pressure to 
begin producing and marketing a product which has been proved 
effective, it also points to another potential benefit in early process 
analysis in that the processability can be taken into account in 
choosing between similar molecules. (Titchener-Hooker et al., 2008) 
- Meet biosafety concerns, mitigating the risks of introducing pathogens into 
process equipment and facilities and reducing the amount of pathogen to 
which the operators may potentially be exposed (Rathore and Sofer, 2005); 
Development in this area is also motivated by the need to meet increasingly stringent 
regulatory requirements, which push for ever improving product quality and safety 
and the introduction of Quality by Design (QbD), which increases requirements to 
understand how process conditions impact upon product qualities (Wolff and Reichl, 
2011). 
To increase the usefulness of the technique and push for the production of directly 
useable output data, such as a window of operation and systematisation of the ultra-
scale-down development a Design of Experiments (DoE) methodology has been 
proposed. This can allow for the identification of key process parameters.  Scale-
down models with high throughputs and automation along with good mathematical 
models will help to speed up optimisation (Wolff and Reichl, 2011).   Thus, scale-
down model validation needs to develop to the point where it conforms to current 
good manufacturing practice (cGMP) covering planning of studies and thorough 
documentation in the form of experimental protocols and reporting of results 
(Rathore and Sofer, 2005). 
The literature (Titchener-Hooker et al. (2008), Pampel et al. (2008), Rathore and 
Sofer (2005)) attempts to offer some guidance on systematisation, identifying the 
following stages in a scale-down analysis: 
- Identification of the engineering system variables and biological material 
properties which will affect the outcome and which will differ between 
laboratory scale and large scale. Engineering system parameters which vary 
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with time and space, such as concentration gradients establishing 
themselves, parameters which vary just with time and interfacial phenomena 
are highlighted as typically where the small scale and large scale systems 
differ. This highlights in particular the difference in residence time between 
small and large scale systems. Identifying the important, desirable, process 
properties that effect function or are significantly impacted by the engineering 
variables. 
- Locate where these engineering variables will have their impact.  
Computational Fluid Dynamics (CFD) has played a key role in development of 
a number of scale-down systems.  In particular the work done to date on 
centrifuge scale-down at UCL has relied on unverified and unverifiable CFD 
modelling.  The rotational shear device used in these studies and in those 
described in this report has also only been characterised using CFD; this 
therefore potentially represents an important source of error in the 
development procedure for the shear mimic system.  It may be that the USD 
system itself is more amenable to verification of flow patterns using Particle 
Image Velocimetry (see section 1.1.4) than the centrifuge whose shear 
pattern and level it is designed to mimic. 
- Measure the impact of these variables on the biological materials. The 
process of experimentation can be used not only to assess the likely 
significance of factors, but also to identify new ones. 
- Summarize the results in an accessible manner through choice of the right 
parameters and presentation. 
- Consider interaction with subsequent and previous stages and the impact of 
ancillary equipment such as valves and pumps.  
- Inform the pilot scale studies and consider costs and “process variability”. 
Future challenges may also be presented by the switch, highlighted by Wolff and 
Reichl (2011), to single use systems and to continuous flow systems, potentially 
requiring development of modified ultra-scale down techniques.   In addition a 
number of developments in the biopharmaceutical industry have increased the 
pressure on downstream process development including shifts in upstream 
production process technologies towards the use of mammalian cells, and increasing 
cell and product concentrations.   
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Scale down models are identified as having been used in the analysis of expanded 
bed adsorption, chromatography, homogenisation, membrane separation, extraction, 
filtration, centrifugation, pumping or a sequence of these (Titchener-Hooker et al., 
2008).  Sections 1.1.3.1 to 1.1.3.3 review the development of key ultra-scale down 
approaches used for centrifugation, filtration and ultra-centrifugation to date.  
Although a number of authors including Wolff and Reichl (2011) claim that both 
filtration and chromatography are likely to be used more and more broadly as 
material technologies advance, the separation technologies focused on in this review 
are those on which this work is intended to focus. 
1.1.3.1. USD Continuous Centrifugation  
Centrifugation is popular because it is relatively robust, easy to clean, and has a 
large throughput (Sharma et al., 2011).  In addition centrifuges come in a number of 
designs including bucket, tubular and disc-stack which each have their particular 
uses (Rathore and Sofer, 2005).  However, the centrifuge is challenging to scale 
down because of the number of different models and modes of operation.  
Centrifugation can introduce high shear. This depends on its design and type, 
various points of entry and exit, bowl impact (Pampel et al., 2008). 
Rathore and Sofer (2005) suggest scale-down parameters for a centrifuge should 
include flowrate at inlet, centrifugal force, back pressure, process stream properties 
and temperature.  The measured outputs suggested by these authors include 
product yield, centrate turbidity, shear damage, clarification and temperature 
increases.  Pampel et al. (2008) further suggest that it may be desirable to consider 
the solid compaction, product damage, product loss, feed flow rate, solids content, 
solid extraction interval, and contamination.  However, monitoring all these 
parameters may be limiting and Maybury et al. (2000) measured only the 
clarification, solid protein concentration and particle size distribution. 
A good deal of work has been done on the derivation of an ultra-scale-down mimic of 
the centrifuge, particularly the disc-stack centrifuge.  In summary, this work followed 
a number of incremental development steps, including:  
- closing off a number of discs in the full scale disc stack centrifuge to reduce 
the process volume by a factor of 10 (Mannweiler and Hoare, 1992); 
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- Deriving a modified sigma (settling area) to account for the acceleration and 
deceleration of the laboratory centrifuge and demonstrating the importance of 
shear to the clarification quality at large scale.  Sigma, mentioned above, 
refers to a parameter used to scale between different centrifuges and scales, 
and is described in more detail in section 1.1.3.1 below (J. Maybury, 1999);  
- CFD analysis was conducted on a multi-chamber bowl centrifuge and a 
rotating disc used to recreate the energy dissipation rate (EDR) for a smaller 
volume of material (Boychyn et al., 2001):  At a laboratory scale the material 
was first sheared in the rotating disc, at the appropriate speed, then separated 
using a laboratory centrifuge.  A similar principle was used for a filtering 
centrifuge (Boulding et al., 2002) and a disc stack (Boychyn et al., 2004).   
The CFD predictions of EDR for the disk stack and USD device are shown 
side by side in Figure 1.1-3, below.  This combined rotating disc shear device 
and laboratory centrifuge constituted the scale down mimic and was shown to 
give clarification comparable to the full scale centrifuges; 
 
Figure 1.1-3 CFD output for modelling of a disc stack centrifuge and the rotating disk shear device 
(Boychyn et al., 2004) 
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- The methodology developed was then used for optimisation of a 
centrifugation process’ rotational speed and centrifugation time for recovery of 
a virus (Lotfian et al., 2003b) and mammalian cells (Hutchinson et al., 2006); 
- A modified version of the rotating shear device was developed to look at the 
effects of hydrodynamic forces on proteins in the absence of an air-liquid 
interface and with temperature control (Biddlecombe et al., 2007). 
- The methodology was also used in concert with other ultra-scale down 
devices to demonstrate a procedure for recreating the overall process 
performance of a large scale process (Pampel et al., 2008).  
The starting point of these studies was the poor correlation between industrial scale 
machines and laboratory centrifuges.  This has historically been based on equating 
the settling time of different centrifuge models, known as sigma theory, which gives 
the following formula: 
  [Eq. 1] 
The sigma for any given centrifuge is derived based on the time needed for a particle 
of a given size to reach the sedimentation surface and the time taken for a package 
of fluid (containing the settling particles) to pass from the centrifuge inlet to the outlet. 
Maybury et al. (2000) describe the derivation of a sigma value for the laboratory 
scale centrifuge which accounts for acceleration and deceleration periods:  
 
   [Eq. 2] 
For a disc stack machine the equation for sigma is  
 [Eq. 3] 
However, sigma theory and the equations derived involve a number of assumptions 
including plug flow through the centrifuge with uniform radial velocity, uniform 
distribution of particles at point of entry to the clarification sectors, no impedance or 
interference between particles and no entrainment.  It also ignores complexities 
introduced by feed and discharge zones (Leung, 1998). Rathore and Sofer (2005) 
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discuss for example initial attempts to scale-down disc-stack centrifuges, which was 
achieved by decreasing the number of disks between which the fluid could flow and 
using sigma theory to equate the separation efficiency in laboratory centrifuges.  
Causes of inconsistencies between the full scale and scale-down suggested by 
Rathore and Sofer (2005) include disturbance of solids by turbulent flows, solids not 
being evenly distributed entering the disc-stack channel and between disc-stack 
channels, acceleration and deceleration times and the disturbance caused by solids 
discharge with as many as seven to eight bowl volumes needing to pass through the 
centrifuge before steady state has been restored. Maybury et al. (2000) used 
polyvinyle acetate particles, which are shear insensitive, to characterise some of 
these non-ideal factors in the centrifuge in to a single correction factor to multiply the 
sigma value.  For the disc stack centrifuge used in this study the correction factor 
identified was 0.4. 
The study by Maybury et al. (2000) also showed that for shear sensitive material a 
large inaccuracy was still seen when using a laboratory centrifuge to predict the 
performance of an industrial scale machine.  Shear was identified as the likely cause 
of this discrepancy.  The greatest EDR in the centrifuge is located in the feed 
distributor at the disc region.  It was therefore assumed that accounting only for the 
shear that occurred in the centrifuge feed zone would be sufficiently representative.  
A shear device was therefore used to imitate the EDR contours and peak EDR in this 
region, matching that calculated by CFD.  Sigma analysis was then used to predict 
the residence time (based on full scale flow rate) and centrifugal speed equivalent to 
the industrial scale machine for a laboratory centrifuge, as in the previous studies.  A 
variety of studies on the impact of centrifuge shear on E. coli, mammalian cells and 
protein precipitates show that significant damage may occur at the impact on the 
solids collection chamber, in the feed zones or at the discharge depending on the 
strength of the material concerned, the details of the centrifuge design and the mode 
of operation (Titchener-Hooker et al., 2008). 
In some cases the centrifuge performance prediction quality was shown to be better 
in ultra-scale down than in pilot because energy dissipation can be adjusted  and 
because in a small pilot scale centrifuge, the control of volume removal is difficult 
and some sediment may therefore be pulled through in the supernatant effecting 
measurement of clarity (Pampel et al., 2008).  
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Hu et al. (2011) question the fact that these experiments were conducted at lower 
than industrial cell concentration and therefore may have missed some factors such 
as release of intracellular enzymes. This might for example impact upon the 
conclusion where this USD mimic showed production of more fine solids, causing 
problems for subsequent filtration and chromatography steps, but the product 
structure was not indicated to change. 
Westoby et al. (2011) have produced the only other ultra-scale down approach to 
modelling of centrifuges identified during this literature review.  They have done so in 
response to contended problems which they identify with the UCL shear device; in 
particular, its specific design and custom manufacture, the only controllable variable 
is speed, the difficulty of scale-up, and characterisation of the maximum EDR which 
must be calculated by CFD.  They further criticise studies using the shear device 
citing lack of studies using mammalian cell cultures, and the fact that no correlation 
between EDR in the scale-down and industrial scale devices has been attempted. 
The capillary device described by Westoby et al. (2011) uses a syringe pump and 
capillaries with reducers and expanders at the inlet and outlet to reduce shear and 
prevent jetting.  As with the UCL shear device, they then used a laboratory centrifuge 
to separate the solid and liquid phases with the revolution rate and centrifugation 
time adjusted to make it equivalent to the pilot scale model and flowrate against 
which they compare. 
The maximum EDR in the capillary device is expected to occur in a narrow volume at 
the pipewall boundary layer and for laminar flow can be calculated from the following 
equation (Westoby et al., 2011):  
 [Eq. 4] 
The main benefit of this approach is clearly the simplicity of the relationship between 
EDR and pressure drop, a controllable factor.  Westoby et al. (2011), however, do 
not state whether the volume to which this applies has been calculated or give the 
relationship.  It might be expected that this boundary layer volume would also be a 
function of the flow rate.  Boychyn et al. (2001) give an admittedly complicated 
formula for volume at maximum EDR in the rotatory shear device.  It may be 
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assumed that from a CFD model the EDRs and volumes over which they apply could 
be derived. 
Westoby et al. (2011) identified the appropriate maximum EDR (i.e. system pressure 
drop) to use in the capillary system by conducting a trial and error comparison of the 
particle size distribution achieved in the scale down device as compared to the pilot 
scale it was intended to mimic.  The same pressure drop was subsequently applied 
to different cell stocks from which they showed that the correlation between the pilot 
and bench scale results remained good. 
Westoby et al. (2011) subsequently ran for a range of pressure drops in their 
capillary device and a range of speeds in their centrifuge, derived a linear 
relationship between the USD capillary system maximum EDR and turbidity of the 
supernatant and between the pilot scale angular velocity and supernatant turbidity 
and equated the two to derive a relationship between the centrifuge angular velocity 
and the maximum EDR which should be used to mimic it. This study measured 
turbidity, particle size distribution and the fraction of viable cells.  They identified the 
key size of interest as 3 μm, as it is difficult to remove by centrifugation but large 
enough to cause blockage in filters. 
The key advantages Westoby et al. (2011) identify for their system are that it can be 
adapted for continuous operation and that calculation of the maximum EDR is 
simple.  However, their comparison was against a pilot scale centrifuge, which 
Pampel et al. (2008) previously showed can correlate poorly with the industrial scale 
machine. In addition the maximum EDR values they used were 1.8 x 105 W/kg, 
where for the industrial scale disc stack 2 x 105 W/kg has previously been identified; 
they do not state whether their capillary system could function at these higher shear 
rates or has been tested. 
Both Maybury et al. (2000) and Westoby et al. (2011) identified that at lower Q/Σ the 
error increased and matching clarification became more difficult. 
1.1.3.2. Ultra-filtration 
The mode of filter operation is a critical parameter identified by Rathore and Sofer 
(2005), however ultrafiltration is generally run in tangential flow mode. The measures 
identified for consideration were cross-flow rate for each feed channel, flux across 
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the membrane, the transmembrane pressure drop, pore size, the number of 
diafiltration volumes required and set up in terms of parallel or series flows.   The 
values measured to assess the success of the filtration step include the yield of 
product, the volume concentration factor defined as the ratio of the initial feed 
volume to the final feed volume, the diafiltration volumes, permeate turbidity, cell 
lysis / damage, permeate filterability, aggregation generation, contaminant removal 
and extent of buffer exchange.  (Rathore and Sofer, 2005) 
If a filter scale-down system is to be re-used a cleaning procedure to return the 
membrane permeability to the same level consistently must be demonstrated.  
Limitations on the scale-down of filtration include: the difference in the nature of the 
pumps used at the different volume flow rates and pressure generated, which is 
significant particularly for tangential flow where the fluid is re-circulated a number of 
times; flux needs to be normalised to transmembrane pressure to account for the 
different pressure on the feed side; this also gives different process times though 
larger surface areas can be used to compensate.  The internal pressure drops and 
uniformity of flow distribution may also be different between the scales.  (Rathore 
and Sofer, 2005) 
CFD has been used with ultra-filtration to identify and quantify the presence of slug 
flow (under gas sparged conditions) and wall shear stresses and changing viscosity 
across the membrane with changing concentrations (Sharma et al., 2011). 
1.1.3.3. Density gradient Ultra-Centrifugation 
Alfa Wasserman produce a series of density gradient ultra-centrifuges, designed to 
be run in rate zonal mode.  These include a benchtop centrifuge (Promatix 1000TM), 
a pilot scale centrifuge (PKII) and an industrial scale centrifuge (KII).  It is claimed 
that by scaling for processing time these different scales can be made equivalent to 
one another. 
Although density gradient centrifugation is a standard laboratory technique a number 
of parameters are likely to vary between the industrial and laboratory scale which 
prevent linear scaling between the devices, in particular the geometries giving 
different settling path lengths and local flow effects (Merino et al., 2003).  Merino et 
al. (2003) also highlights residence, rotational speed and gravitational force as 
   
Page 51 of 308 
 
parameters to be maintained constant in scaling.  The authors claim that their lower 
volume device allows linearity in terms of achieving the same gradient and 
concentration profiles. 
Hsu and Perry (1981) indicate that there may be levels of shear rate sufficient to 
cause damage to biomaterials simply from the passage of the particles through the 
changing solvent environment.  The authors, however, highlight the period of 
acceleration and deceleration, where gradient re-orientation is taking place, as the 
key periods of interest with respect to fluid mechanical considerations.  Meriño 
(2013) highlights the dual inflow-outflow design of many density gradient centrifuges 
as a source of shear. 
As described elsewhere it may also be that processing time is a significant factor 
with respect to the product response, potentially limiting the efficiency of any scale 
down model trials in terms of time, though set-up at a smaller scale and parallel trials 
should theoretically be easier and perhaps ideally should be designed into any 
system developed. 
1.1.3.4. Computational Fluid Dynamics (CFD) in bioprocessing 
CFD has been used in modelling for fermentation, centrifugation, chromatography, 
ultrafiltration, microfiltration and freeze drying as part of the parameterisation of the 
scale-down models.  It is also useful to identify key design parameters, quantify 
power dissipation and shear rates, test design improvements, inform experiments 
and optimise operating conditions (Sharma et al., 2011). 
CFD is based on applying mass, momentum and energy conservation equations, 
using numerical methods on discretized systems.  However, complete resolution of 
these equations is computationally very difficult and a number of simplifications are 
therefore routinely made including isotropic turbulence (Doran, 2013).  Another 
limitation of CFD is that the computational time is linked to the shape and size of the 
mesh, i.e. degree of discretization.  It may be expected that the impact of turbulence 
on biological products may be seen at the scale of the smallest eddies, as Doran 
(2013) indicates that the volume over which a given amount of energy is dissipated 
(i.e. the distribution or intensity) has an impact on how damaging it will be, but 
discretisation to this extent would be unmanageable. This is the basis of interest in 
the maximum energy dissipation rate and linking this to shear damage .  Parameters 
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to correlate to energy dissipation at the smaller scale and variable mesh sizes are 
therefore employed.  
In building a CFD model one needs to consider system geometry, fluid properties 
(which may be changeable), meshing (discretization) and boundary conditions.  
Building of the CFD model is therefore complicated with many possible sources of 
error.  As it stands today validation by experimentation is standard procedure for 
CFD models (Sharma et al., 2011). 
The complexity of CFD modelling software and the computational power of standard 
computers is continuously evolving however.  Comsol Multiphysics for example, the 
software previously used for a number of CFD simulations, incorporates a number of 
functionalities which allow different kind of physical phenomena to by modelled in 
parallel, where at one time iteration between separate models would have been 
required.  Comsol Multiphysics also incorporates a variable parameter, allowing 
multiple simulations to assess the importance of a given parameter, for example the 
meshing size (Comsol Workshop). 
1.1.4. Shear within the process environment 
Hydrodynamic shear is a feature of the process which is frequently identified as 
requiring special consideration in terms of the difference between the large scale and 
small scale process, the impact upon the therapeutic efficacy of the biological 
product and the removal of impurities/ efficiency of product isolation and 
concentration (Titchener-Hooker et al., 2008).  Indeed it has been demonstrated on a 
number of occasions that incorporating shear into ultra-scale-down mimics renders 
them more representative of larger scale processes.  However, our current 
understanding of turbulence is incomplete, complicated by the unsteady and 
unpredictable nature of the phenomena (Doran, 2013).  Hu et al. (2011) suggest that 
this lack of understanding of turbulent flow particularly at the cellular scale has 
contributed perhaps to the perception of shear as a key detrimental determinant.  
In examining the impact of fluid shear on biopharmaceutical processes energy 
dissipation rate, shear stress and shear strain rate are quoted in the literature.  It is 
therefore important to define explicitly what is meant by these various terms.  Shear 
strain rate or shear rate is the rate at which the local fluid velocity changes with 
distance and has the units s-1.  Shear stress is a force applied to a fluid volume 
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divided by the area, perpendicular to a given axis, over which that force is applied 
and has the units N.m-2 or kg.m-1.s-2.  Strictly ‘shear stress’ refers to the tangential as 
oppose to normal stress on the fluid, but in this thesis is used to refer to all the 
various turbulent shear related stresses. In turbulent flow these phenomena are 
localised within vortices or eddies through which the energy introduced in to the fluid 
is dissipated and which manifest as spatio-temporal fluctuations.  The energy 
dissipation rate (EDR) is the rate at which the kinetic energy dissipates and is 
defined mathematically later in this section. (De Nevers, 1991, Morshed et al., 2014) 
Figure 1.1-4 illustrates the stages of the viral vaccine production process under 
investigation.   Of these stages the most significant shear rates are expected in the 
feedzones of the disc stack centrifuge and, as shown in this thesis, the density 
gradient ultracentrifuge.  Cell culture also involves substantial, though lower, shear 
levels over a substantially longer period of time.  Finally the tangential flow 
ultrafiltration stage may be expected to generate not insignificant levels of shear, 
particularly in the pumps, as well as concentration of the virus especially in proximity 
to the membrane, where shearing will also be experienced. 
 
Figure 1.1-4.   Schematic of the early steps in the influenza vaccine production process under 
investigation 
Turbulence can only be represented statistically as it is too sensitive to conditions at 
the start and at the boundary to be 100% reproducible, with the complex spatial and 
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temporal variations in shear stresses (Hu et al., 2011).  Flow on the x, y and z axes 
are therefore represented by mean and deviation from the mean (root mean square 
of deviations).   In addition the small size of the smallest eddies, being 30 to 100 m 
for a low viscosity fluid such as water, means that a very large number of 
discretization is required to accurately capture turbulent behaviour computationally. 
In addition the complexity of the equations describing turbulent behaviour mean that 
significant simplifications are required for numerical solutions.  These simplifications 
include (Doran, 2013): 
- Kolmogorov's theory.  This theory states that large eddies lose their energy by 
passing it to the smaller eddies which they form, and thence on to 
progressively smaller eddies until dissipation, based on the Richardson 
energy cascade.  At a small enough scale this energy is finally dissipated as 
heat when the viscosity of the fluid slows its motion; thus increasing Reynolds 
number (i.e. increasing fluid velocity and decreasing viscosity) decreases the 
size of the smallest eddies.  The size of the largest eddies is typically dictated 
by the container geometry, but is generally not considered important.  The 
assumptions made within the equations derived by Kolmogorov's theory 
include high Reynolds number, a wide distribution of eddy sizes, at the 
smallest scale the only factor which effects the eddy properties are the rate of 
energy supply (breakdown of larger eddies) and the viscous dissipation. 
- Homogeneous turbulence, where the extent of turbulence is independent of 
the location, both in terms of the average flow and the average turbulent 
deviations.  This simplification can be applied with some accuracy over a 
small volume, of the order of a small turbulent eddy as described by 
Kolmogorov's theory. 
- Isotropic turbulence is a useful simplification although not seen in many 
practical scenarios; however at small scales it may be assumed that the 
directionality imposed by the bulk fluid has been lost by the chaotic nature of 
progressively smaller eddy formations.  Isotropy can also be expected to 
apply in the regions of highest turbulence. 
Hu et al. (2011) suggest that as a rule of thumb if the Kolmogoroff's microscale is of 
a similar size to the size of the cells in suspension then cell death will occur at a 
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significant level.  The formula for the Kolmogorov scale, which represents the 
average size of the dissipative eddies, is:  
 [Eq. 5] 
However, this simple approach relies on the calculation of the local EDR value for 
which Hu et al. (2011) give the formula:  
 [Eq. 6] 
However, a simplification with the assumption of isotropy gives ((Doran, 2013)):  
 [Eq. 7] 
In either case the EDR must be either estimated by modelling or measured 
experimentally.  Typically CFD modelling of turbulence will require experimental 
confirmation given the complexity, number of assumptions, and need to confirm that 
adequate discretization in terms of both space and time have been applied.  
Previous studies, (Boychyn et al. (2001), Boychyn et al. (2004)) have to some extent 
circumvented this by demonstrating comparable impact upon the biological product 
of interest, the centrifuge being too complicated a system to measure shear rates in 
directly (Boychyn et al., 2001).  To measure turbulence, methods must be quick, to 
catch an event before direction changes, with good resolution at a small scale, 
unaffected by a prolonged period of use in order to gain enough measurements over 
a long enough period to be statistically relevant.  The two main methods identified 
are Laser Doppler Velocimetry (Laser Doppler anemometry) and Particle Image 
Velocimetry (Doran, 2013). 
Laser Doppler Velocimetry relies on the fact that the shift in laser light frequency is 
proportional to the velocity of particles (constructed of e.g. polystyrene or similar 
plastic) which are suspended in the fluid.  The advantages of the technique include 
that it requires no calibration and is non-invasive.  However the process equipment 
must be constructed from a material transparent to laser and account taken for the 
effects of diffraction in the light path.  It measures only one small volume (10-6 to 
10-4m3) at a time and only one directional velocity component (Doran, 2013). 
   
Page 56 of 308 
 
Particle Image Velocimetry measures the instantaneous velocity across a large flow 
area by illuminating and imaging a plane of fluid, again with suspended neutrally 
buoyant particles, twice in quick succession.  The two images are then processed 
computationally to give velocity vectors.  The pros and cons are largely identical to 
those identified for Laser Doppler Velocimetry above, except that a measurement is 
taken for a large area in one hit, but less frequent measures are taken so rapid 
fluctuations may be missed (Doran, 2013).  
Much of the research to date on shear has focused on shear rates in impeller driven 
mixing where turbulence is necessary to good mixing (Doran, 2013).  Indeed this 
interest in shear in bioreactors continues as advances in the fields of cell 
engineering, culture media formulation and bioprocess engineering allow higher cell 
densities and larger bioreactors, making mass transfer more problematic and more 
aggressive mixing / aeration (for oxygen feed and CO2 removal) is required (Hu et 
al., 2011).   
The changing nature of the feed from upstream and desire to realise the increased 
product yield, that these advances have produced, through to downstream recovery 
and purification phases will require a review of hydrodynamic forces in downstream 
systems.  Here hydrodynamic shear has already historically been seen as more of 
an issue, creating limits for feasible operations and dictating equipment and 
operational design changes.  Further work is needed in downstream systems to 
quantify hydrodynamic conditions and for design optimisation in terms of minimizing 
stresses. 
The ways of understanding and interpreting shear are also diverse.  Shear stress 
can be divided into normal, perpendicular and elongation stresses with Hu et al. 
(2011) suggesting that the latter may possibly be the most damaging for cells and 
Doran (2013) states that cumulative energy dissipation may also be important, with 
limits of 105-109J/m3 for cells.  The most significant source of shear stress also 
appears to be a matter for debate with Biddlecombe et al. (2007) identifying the 
formation and breakdown of air-liquid interfaces, such as bubbles or a reactor liquid 
surface, and the velocity gradients caused by non-slip at the interface between a 
solid surface and the nearby liquid.  The centrifuge studies by Boychyn et al. (2001) 
incorporate the air-liquid and air-solid, liquid-solid interfaces with no slip assumptions 
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but do not suggest the dominant damage mechanism, calculating instead an energy 
dissipation rate.  Biddlecombe et al. (2007) excluded the air-liquid interface from the 
system to quantify the impact on protein stability and shows improved stability.  
Doran (2013) states that the high velocity gradients at small eddies give rise to high 
shear rates.    
The analysis by Hu et al. (2011) does not seem to indicate any correlation between 
the maximum EDR and average EDR or the fraction of the volume to which the 
maximum EDR applies.  The works referenced use both studies which concentrates 
exclusively on maximum EDR and studies which use average EDR values.  Doran 
(2013) suggests a link between these: by measuring the dissipation rate in the region 
of highest turbulence and subtracting this local energy dissipation from the energy 
input in to the system an average dissipation for the rest might be obtained. 
The biological products employed in vaccines are extremely varied, resulting in 
particles of very different properties, including strength, size and density.  Sections 
1.1.4.1 to 1.1.4.3 therefore explore in more detail the impact of hydrodynamic forces 
on two broad categories of product of specific relevance: cells and proteins, viruses 
and virus-like particles respectively.  The degree of variability between these 
products in terms of their mechanical strength and other factors pertaining to their 
separation are also quantified briefly.  It is worth noting that due to the wide 
variabilities seen it will always be necessary to conduct tests on the biological 
material in question, including in most cases mimicking the large scale production 
techniques, in order to fully parameterize it. 
1.1.4.1. Impact of shear rates on cells 
Damage to cells in the downstream process can reduce product recovery, damage 
the product itself and impact negatively on the efficiency of subsequent purification 
steps (Hu et al., 2011). 
It is worth quantifying at the outset the degree of variability within this category. 
Comparing plant, bacterial and mammalian cells for example, the first has a strong 
cellulose cell wall, the second a cell wall or secondary membrane and the last a 
single membrane. Typical diameters might be 1.1m for E. Coli, 5m for Yeast and 
20 m for a mammalian cell (Milo et al., 2010) whilst aggregates of plant cells may 
be between 50 and 2000m (Kolewe et al., 2010). Densities will be approximately 
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1.095g/ml for a tobacco plant cell (Kumar et al., 2003), 1.1-1.4g/ml for a yeast cell 
(Bryan et al., 2010), 1.05g/ml for a CHO cell (Anderson et al., 1970), but will vary 
with the cell age, solution properties, infected status etc. Even the cell shapes are 
likely to be different. 
Yim and Shamlou (2000) compare the size and strength ranges for bacterial, 
mammalian, yeast and plant cells, amongst others; their diagram is reproduced 
below in Figure 1.1-5.  Their scale shows that plant cells are stronger than the other 
categories, followed by yeast cells, approximately 4 orders of magnitude weaker and 
then bacteria, which are a further 5 orders of magnitude weaker.  Mammalian cells 
were the weakest of the species listed, being 2 to 4 orders of magnitude weaker than 
the bacterial cells.  As mammalian cells are of increasing industrial relevance and 
are likely to be the most susceptible to shear as they are the structurally weakest 
species and because of their relatively large size, this project will concentrate on 
development of a mimic for mammalian cells in particular.  The following section 
therefore concentrates on exploring their response to shear forces. 
 
Figure 1.1-5.   Diagram giving an indicating the relative size and strength of the different cell classes (Yim 
and Shamlou, 2000) 
The paper by Hu et al. (2011) summarises the results of studies conducted to 
quantify the impact of hydrodynamic stresses in industrial processes on animal cells. 
The authors discuss the quantification of hydrodynamic stresses in terms of the EDR 
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which result in sub-lethal and lethal effects.  The paper gives levels of shear rate 
from bubble rupture, membrane filtration, centrifugation (bowl and disc stack) and 
capillary scale-down for centrifugation as having similar shear levels (EDR) 
associated with them.  These shear levels were also in the region of shear rates 
leading to cell death for the majority of studies referenced, where the exceptions 
used anchored cells.  For the sub-lethal effects only a couple of studies are 
presented, both of which appear to be relevant to culture rather than DSP.   As 
mentioned above Doran (2013) suggests that cumulative energy dissipation may 
need to be limited for cells to levels of the order 105-109J/m3 to avoid damage. It is 
assumed that the breadth of this range reflects either uncertainties (e.g. different 
studies using different techniques to measure and quantify significant damage) or 
the impact on different cell types, although this is not stated in the text. 
The impact of turbulent environments on cells is complicated, for example damage to 
cells may result from the physical stresses such as impact and fluid shear but may 
also be exacerbated by the release of intracellular enzymes (Mccoy et al., 2009).  In 
addition there are big differences between the shear sensitivity of cells in suspension 
and cells on microcarriers and additives such as PF-68 can be used to protect cells 
from damage in bioreactors. The primary mechanism by which PF-68 reduces cell 
damage is not clear, but two possibilities are integration into cell walls and lowering 
of interfacial tensions lowering the energy release from bubble rupture or impacting 
cell to bubble attachment.  The latter would be less significant in a centrifuge as 
oppose to a bioreactor (Hu et al., 2011).  The ultra-scale down centrifuge model has 
shown no time dependence for shearing beyond 5 seconds with respect to solid 
formation (Hutchinson et al., 2006), although Mccoy et al. (2009) did show time 
dependence with respect to membrane quality indicators. 
The shear sensitivity of the cells have also been shown to be dependent on cell type, 
cell line, the upstream culture conditions and the culture duration (Lu et al., 1992).   
A number of human cancer cell lines have been shown to be more sensitive to shear 
stresses in terms of cell lysis and changes to cell marker receptors.  This may have 
implications for future cell lines entering mass production (Hu et al., 2011). 
In order to measure the effects of shear rate, cell viability measurement can be 
taken, as well as, amount of debris (Hutchinson et al., 2006), amount of released 
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intracellular protein (Chan et al., 2006), structural changes to released proteins 
(Hutchinson et al., 2006) and structural changes in cell surface markers (Mccoy et 
al., 2009). 
The impact of shear forces/rate on virus infected cells has not been widely discussed 
in the literature.  Silva et al. (2010) do state that infected cells are more ‘fragile’.  
That virus infected cells would be more easily damaged by stresses such as shear 
stress seems a logical assumption, and was one of the key hypotheses underlying 
this thesis work.  Due to lack of literature on the topic it is also one of the key 
novelties / interests of this project. 
1.1.4.2. Impact of shear rate on proteins 
There are large variations in size, structural and chemical properties of proteins, 
limited only by their construction from a group of 22 standard amino acid building 
blocks.  Protein density has been shown to be approximately a function of molecular 
weight with the density of large proteins being approximately 1.4g/ml (Fischer et al., 
2004).    Susceptibility to shear is a function of protein size and structure, particularly 
secondary and tertiary although on occasions even very small differences at the 
primary structure level have been shown to give rise to significant difference in shear 
response (Bekard et al., 2011).  Biddlecombe et al. (2007) singled out monoclonal 
antibodies as being particularly vulnerable to the effects of shear forces. 
They identify a number of possible effects of shear stress on proteins including 
affects to their secondary, tertiary and/or quaternary structures, altering their activity 
and causing them to aggregate.  Boulding et al. (2002) also identify shear stresses 
as significant, giving 2 x 104W/kg as the value of the local energy dissipation rate 
which had been shown to effect antibody activity.  Bekard et al. (2011) suggest that 
extensional forces may lead to aggregation and that the shearing period may in 
some cases be more important that the shear rate. 
A number of authors, by contrast, indicate that the effects of shear stresses on 
proteins occur in conjunction with other more significant factors and that it is not the 
shear stress itself that causes damage to the protein structure.  Thomas and Geer 
(2011) state that fluid mechanical shear may not have significant impact; instead it is 
phenomena linked to “high shear” such as interfacial phenomena, with aggregation 
linked to collisions or surface phenomena and/or nanoparticles from solid surfaces.  
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Flickinger and Drew (1999) suggest that shear forces at gas-liquid interfaces causes 
proteins to unfold, stating that they have demonstrated no aggregation or impact on 
bioactivity for shear rates greater than 105 s-1 without gas-liquid interfaces.  The 
authors also link protein damage to adhesion to solid surfaces.   
In order to measure the effects of shear Enzyme-Linked Immuno-Assays (ELISA) 
can be used to assess for conformational changes to significant structural elements 
using monoclonal antibodies.  Many early tests on proteins were conducted on 
enzymes because their activity could be measured easily as a test for significant 
degradation or damage.  For  laxoperoxidase the activity was measured by reacting 
with a substrate, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and 
measuring the rate of change of absorbance at 405nm (Pampel et al., 2008).  Dilute 
solutions of unbranched homopolymers have been used as a simplified model 
system for proteins in shearing environments (Bekard et al., 2011). 
1.1.4.3. Impact of shear rate on viruses and virus like particles 
Like cells, viruses are extremely diverse in nature. They can be constructed of a 
single or double strands of either Deoxyribonucleic acid (DNA) or Ribonucleic acid 
(RNA) with a protein coat and with or without a lipid envelop. They range in size from 
20-300nm (Lackie and Blackshaw, 2007) and may have a density of the order 1.1 to 
1.4 g/ml. They exhibit variations in size, shape, composition, surface chemistry 
(Wolff and Reichl, 2011), beyond the Baltimore classification (Xu et al., 2011).  The 
presence of the delicate envelope may make enveloped viruses more susceptible to 
shear stresses (Morenweiser, 2005) and as such the main distinction which will be 
made in this study, between different virus types, will be between enveloped and 
non-enveloped viruses.  Virus like particles (VLP) are designed to mimic the virus 
protein capsid by combining many protein particles, typically produced by 
recombinant technology, into a regular structure, with diameters of between 20 and 
120nm (Roldao et al., 2010).  The focus of what literature there is on enveloped 
viruses and VLPs, suggests that these are more sensitive to shear stresses.  
Although viruses are evolved to maintain integrity, they also need to be capable of 
releasing the viral genome through disassembly (Castellanos et al., 2012).   
The impact of shear stresses on viruses is a possible loss of infectivity (Wolff and 
Reichl, 2011).  This can be measured by plaque assays or detection of early cellular 
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events associated with viral infection (Pheasey et al., 2006).  Pheasey et al. (2006) 
criticise existing methods for quantifying the amount of infectious virus in a sample 
as not robust and time consuming.  It may be for this reason, or because of the 
complicated and varied nature of viruses, that the number of articles found dealing 
with the impact of the shear stresses on viruses was limited.   
Andreadis et al. (1999) found a reduced recovery of infective enveloped viruses, 
which they attribute to shear of the membrane. In non-enveloped viruses such as 
herpes, shear rates of 14.5 x 103s-1 have been shown to damage Herpes virus in one 
study by Lotfian et al. (2003a), although the author attributes this to heat damage 
due to viscous heating.  Morenweiser (2005) by contrast, identifies viruses as 
particularly susceptible to shear stress, citing their non-spherical nature and the fact 
that they are of such a scale as to be too large to avoid damage by the smallest 
eddies.  Michalsky et al. (2008) found no impact on baculovirus following stirring and 
pumping experiments. 
Sviben et al. (2016) used pipetting and vortexing on measles and mumps, two 
enveloped viruses, and showed an impact from vortexing, but not from pipetting.  
Although neither of these methods are well quantified in terms of shear rate, this 
result probably represents the difference between simple hydrodynamic shear and 
shear in the presence of an air-liquid interface. 
The large size of VLPs is thought to contribute to their immunogenicity, therefore any 
reduction of stability or change to their complicated structure is likely to be significant 
(Srivastava, 2012).  However, this attitude appears to be partly a result of the lack of 
fundamental understanding as yet of the interaction of these particles with the 
immune system. 
Given the complexity of VLPs and their interaction with the immune system, and the 
fact that they are not themselves capable of infecting cells, it is not a trivial problem 
to measure their response to shear stresses, particularly without the requirement to 
measure the vaccine’s continued efficacy using animal models which is costly and 
time consuming.  Fortunately there are also a wide array of analytical techniques 
which can be applied, and from which inference can be drawn on the similarity of the 
vaccine conformation to that of the verified product. A number of these are 
enumerated here by way of illustration. ELISA may be used to measure potency, 
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identify components and give conformational information. Size exclusion HPLC will 
show the proportion of the different constituent proteins. Micro-calorimetry can be 
used to test the vaccine in terms of number of ‘active sites’ on addition of a given 
ligand and stability under heating which can show changes in secondary or tertiary 
structure. Circular dichroism spectroscopy can be used to assess the fraction of 
alpha helix, beta sheet and random coil structuring there is within the protein, again 
highlighting any conformational change in the secondary structure (Srivastava, 
2012).  It is perhaps for this reason that the literature on virus-like particle response 
to shear also appears to be relatively sparse. (Roldao et al. (2010) and Peixoto et al. 
(2007)) 
The complex nature of the viral product, combined with the current sparse nature of 
the literature, adds motivation and value to the results presented in this report. 
   
Page 64 of 308 
 
1.1.4.4. Shear mimics 
For avoidance of confusion: 
- Ultra scale-down laboratory mimics refers to a device or collection of devices, 
and associated protocols, which use millilitre quantities of material and imitate 
the effect of process scale equipment on the process stream (described in 
detail in section 1.1.3); 
- The cell/virus shear mimic is a novel concept, describing a particulate 
material, which either by design or as an observed feature can be said to be 
changed by shear stress in some manner analogous to that seen in 
(mammalian) cells/ viruses, such as might be used / produced in 
biopharmaceutical processing.  
The aim of employing a non-biological cell/virus shear mimic is to decrease biosafety 
concerns and validate the comparability of shear rates between the USD and 
pilot/industrial scale using a more robustly and easily characterised material.  The 
concept is discussed in more detail in sections 4.1, 4.2.1, 5.1 and 5.2.1. 
Although artificial materials have been used as cell mimics for the purposes of 
studying minimum requirements for cellular life (Luisi and Stano, 2011), producing 
blood cell substitutes (Doshi et al., 2009) and plain liposome products as a mimic for 
cell membranes (Encapsula) there do not appear to be many instances where 
microparticles have been used to try to replicate the effects of shear stress on cells. 
Lu et al. (1992) used nylon micro-capsules with dextran inside as a mimic system for 
cells in a bio-reactor in order to analyse where the greatest cell breakage might 
occur from physical impacts.  However, the size range of their mimic system was not 
in the required size range identified for this project (see section 4.2.1). 
It is worth noting, however, that a number of other important properties will differ 
between the artificial material and the biological, for example the homogeneity of 
artificial micro-capsules versus biological ones with respect to Young’s Modulus was 
highlighted by Mercade-Prieto and Zhang (2012). 
In addition to searching for particle suppliers a limited literature survey was 
conducted into methods of making micro and nano particles with the aim of 
identifying any particle materials or categories which may not have been identified 
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but might still be commercially available and to identify any particle technologies 
which might be simple and robust enough to use without being too onerous.  The 
outcome of this literature survey indicated that much of the interest in nano/micro-
particles to date has been due to their potential use in drug delivery.  Factors which 
research has focused upon tuning therefore have included rate and nature of 
diffusion from the interior, particles size, solubility (material hydrophobicity), 
interaction between encapsulated and encapsulating materials, shape, functionalized 
surfaces (via adsorption, electrostatic interaction, covalent bonding etc.).  However, 
particles in the size range of 10-100nm are likely to have been developed for this 
application as this is suitable for biological applications in terms of how the body 
deals with and processes the foreign material (Goldberg et al., 2007).  This 
technology would not therefore be appropriate to the mimicking of all biological 
products of interest.  In addition there was insufficient data to assess whether 
particulates produced using any of the protocols presented in the literature might be 
sensitive to shear stresses.  For these reasons it was decided not to pursue any 
attempt to produce micro or nanoparticles in-house for testing as potential shear 
mimics. 
   
Page 66 of 308 
 
1.1.5. Summary 
1.1.5.1. Trends 
There are a number of changes on-going in upstream processing which are likely to 
impact upon future developments in downstream processing.  These include: 
- Cell engineering, which may for example allow greater control of 
whether the product is produced in the intra or extra-cellular space (Nesbeth, 
2012).  
- Higher cell density and titre culture conditions (Wolff and Reichl, 2011). 
There are a number of vaccine categories: from classic vaccines such as dead or 
attenuated bacteria and viruses, developed in the 1700s, to conjugate and 
recombinant vaccines, developed in earnest in the 1980s (Plotkin and Plotkin, 2011).   
Regulatory and market forces are providing impetus for improved quality, systematic 
development, well characterised products and product process-interactions and 
reduced time scales respectively.  Development of laboratory scale mimics, such as 
this project intends to explore, will contribute in this respect.   
Ultra-scale down models have seen a great deal of interest over the past decade, 
and the focus appears to be shifting to developing the usability of the output for 
existing models, linking models to make predictions for overall process performance 
and process stage interactions and microwell plates to automate testing of a wide 
range of conditions. 
Early production of vaccines was in animal based systems such as embryonic 
chicken eggs, followed by regulatory permission for use of primary cells, and in the 
1960s diploid cells.  Continuous cells lines use was only permitted in the 1970s, and 
in vaccine manufacture in the 1980s, due to fears surrounding the potentially 
tumorigenic nature of immortalised cell lines.  Early cell lines in vaccine manufacture 
were Vero and MDCK cells.   A number of avian cell lines are currently under 
development, a number of which are at advanced stages, with the Biologics Master 
File for EB66 being filed with the FDA in 2008.  (Reiter et al., 2014) 
For influenza vaccine production there is a move towards production in continuous 
cell lines to replace traditional egg based production.  A number of cell line options 
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are being considered, and new industrial scale processes are being developed to 
accommodate the different requirements of these production platforms. These 
processes are required to overcome the limitations of the traditional production 
process and allow for large scale pandemic vaccine production alongside improving 
cost of goods for seasonal influenza.  Influenza produced in eggs will have already 
been subject to the stresses and strains of a large scale purification process, 
although virus quality may vary depending upon the host.   
For gene therapy vectors the move is from adherent cell line production at laboratory 
scale, towards production in bioreactors, and the attendant industrial scale 
downstream separation train.  In contrast to influenza, for adenovirus there is limited 
experience to date of large scale production processes, though manufacturers such 
as Crucell (Johnson and Johnson) have heavily invested in adenovirus vector 
production using their proprietary PER.C6 cell line system. 
1.1.5.2. Remaining Questions & Areas of Debate 
There appears to be some debate about the future of density gradient centrifugation 
as an industrial separation method, with some authors (Wolff and Reichl, 2011) 
implying expanding possible uses (e.g. gene therapy) and others (Morenweiser, 
2005) that it will be supplanted by other techniques. 
There does not appear to be any literature on the scaling of density gradient 
ultracentrifugation (DG-UCF), and although there is a laboratory scale DG-UC 
available the documentation associated with it does not state whether biological 
function is included in the scaling parameters against which it has been designed. 
Development of a scale-down device for density gradient will be the focus of this 
project.  The initial approach to this problem was based upon existing centrifuge 
scale down models, with the focus on quantifying and accounting for non-idealities in 
settling (likely to be high given the high impedance) and shear effects. There is 
potential to characterise further the existing Promatix 1000 system in order to take 
the work in this thesis further. 
The impact of solid build up and discharge upon the performance of the centrifuge 
immediately afterwards and when averaged over the centrifugation cycle cannot 
currently be accounted for in the scale-down mimic (Pampel et al., 2008).  This is not 
addressed in this project. 
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Due to its complex nature turbulence cannot be fully modelled nor is its impact upon 
biological particles understood (Hu et al., 2011).  Most studies correlate using energy 
dissipation rates, either maximum or average, for which there are also a number of 
calculation approaches.  This is further complicated by the degree of variability 
between biological products, their responsiveness to their environment, identifying 
and measuring their response(s) to shear stresses and the number of co-variants 
associated with low or high shear rate conditions.  Development of a physical model 
for shear will require a fairly robust understanding of the factors influencing shear.  It 
is therefore anticipated that this project will contribute towards answering this 
question by further parameterising the response of a number of sample biological 
materials (mammalian cell and virus) to shear stresses using a Design of 
Experiments approach to identify which process parameters show the strongest 
effect on shear susceptibility.  In particular the effect of shear stress on viruses and 
virus infected cells, for both of which there is highly limited data in the literature, was 
explored.  Further Computational Fluid Dynamics analysis, and application of a 
simplified population balance analysis method to both the rotating shear device and 
centrifuges will further add to existing approaches to understanding shear, and the 
similarities and differences between these two systems. 
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1.2. Project Introduction 
The project was focused on the use and development of ultra scale-down (USD) 
models for purification steps in a vaccine manufacturing process.  The specific 
vaccine of interest was an inactivated viral (flu) vaccine, but the aim was that the 
USD models should be as generic as possible.  Both with this aim in mind, and to 
address cost and safety concerns, the first stage of the project was to develop and 
characterise synthetic shear tracer particles which can be used as a mimic for 
various biological products (cells and viruses).  The focus on shear rates is based on 
previous work (Maybury et al., 2000, Boychyn et al., 2004) in scaling down 
continuous centrifugation which showed shear rate to be the key scaling parameter.  
The methodology already developed for disk stack centrifugation USD was applied 
to a previously uncharacterised large scale centrifuge model, using the shear mimic 
tracer particles.  The focus then shifted to Density Gradient Ultra-Centrifugation (DG-
UCF), which was modelled using Computational Fluid Dynamics to identify shear 
zones and rates and this information applied to initial work on the creation of a USD 
for industrial/pilot scale DG-UCF. 
The sponsoring company’s industrial process included the steps of centrifugal 
harvest, micro and ultrafiltration, and density gradient ultracentrifugation, at which 
stage formation of a semi-solid impurity was seen.  It is this phenomena which 
motivated the sponsoring company’s interest in the use of scale down as a 
parameterization and troubleshooting tool. 
1.3. Objectives 
The completed objectives of the EngD project were to: 
- Develop a set of shear mimics, to be used in place of the biological process 
stream, to measure the equivalence between shear damage inflicted at 
industrial scale and in the USD rotating shear device.  The set of shear 
mimics comprises a shear mimic for mammalian cells, and another shear 
mimic for viruses. 
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- Characterise a previously uncharacterised centrifuge in terms of shear levels 
and separation efficiency, based on: 
o The methodology previously employed as described in section 1.1.3.1 
o Use of the above mentioned cell shear mimic 
o CFD and population balance modelling over various centrifuge 
geometries, and operating conditions. 
- Investigate the impact of shear stress in virus production processes at the 
harvest stage, with the aim of answering the hypothesis that virus infected 
cells will be more shear sensitive, and that consequently minimizing shear in 
centrifugal harvest is of paramount importance in these industrial units. 
- Characterise an industrial density gradient ultra centrifuge (DG-UC) (PKII) in 
terms of shear levels and separation efficiency, based on: 
o Use of the above mentioned virus shear mimic 
o CFD and population balance modelling 
- Investigate the impact of shear stress on viral products, with the aim of 
answering the hypothesis that viral particles are too small to be impacted by 
hydrodynamic shear in the absence of an air-liquid interface, and to explore 
the challenging question of how to measure the impact of shear, if any. 
- Begin to explore the question of how the industrial DG-UC may be imitated at 
laboratory scale in order to provide tools for process development and 
troubleshooting. 
Additional objectives which were not addressed, but which have been explored in the 
future works section (7) of this thesis included: 
- Use of USD tools for predicting the performance of the filtration stages in a 
virus production process; 
- Interaction studies between the centrifugation, filtration and density gradient 
ultracentrifugation stages. 
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2. Materials and Methods 
2.1. Chapter by Chapter Overview:  
This chapter is designed largely as a source of reference for subsequent results 
chapters.  Sections 2.1 provides a high level overview of the sequence of work 
performed and can be read in isolation, whilst section 2.2 provides a more specific 
list of materials and individual assays or procedures performed. 
2.1.1. Chapter 3: Validated CFD of Process Shear Environments 
2.1.1.1. 2D-Axisymettric model  
In order to characterise the fluid flow patterns inside the rotational shear device and 
PSC-5 disc stack centrifuge feed zone Comsol Multiphysics version 4.4 (Comsol Ltd, 
Cambridge, UK) commercial software was used, with the single phase turbulent flow 
model, solving RANS k-.  This was used to derive parameters allowing a broader 
interpretation of the results presented in this thesis, and to compare shear rates and 
flow patterns within the rotational shear device and industrial centrifuge. 
For the rotating disc shear device the meshing used the standard ‘physics-induced 
sequence’, with the following modifications:  at the disc tip ‘a custom mesh’ of 
minimum size 1m and maximum size 10m was employed, along the disc a 
predefined mesh size of ‘extremely fine’ (5 to 2500 x10-7m), and at the other walls a 
predefined mesh size of ‘fine’ (1.5 to 52.5 x10-5m).  A ‘normal’ mesh (3 to 67.5 
x10-5m) was used for the bulk.  The rotating shear device was modelled as 
axisymmetric, using the sliding wall boundary condition for the disc, as illustrated in 
Figure 2.1-1. 
The rotating disc shear device has previously been simulated in relation to a 
comparison to another model of continuous centrifuge (Boychyn et al., 2001).  
However, this simulation was repeated in order to validate the comparability of the 
turbulence modelling in Comsol to those previous Computational Fluid Dynamic 
(CFD) results. 
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For the PSC-5 centrifuge, the geometry was based upon manual measurements of 
the feed-zone.  The results of these manual measurements are summarised in Table 
2.1-1.  Again the standard ‘physics-induced sequence’ was used for meshing with 
the following modifications:  ‘fine’ setting for the mesh (6.2 to 218 x10-5m), with ‘finer’ 
setting at the boundaries (2.5 to 174 x10-5m) and ‘a custom mesh’ at the upper edge 
of the boundary near the outlet of the feed zone (1 to 20m).  As a first pass the 
centrifuge was modelled as axisymmetric, using the sliding wall boundary condition 
to represent the rotation of the equipment, as illustrated in Figure 2.1-2. 
It may be noted that Boychyn et al. (2001) also appear to have used an axisymmetric 
modelling approach for both the centrifuge and rotating shear devices. Physically this 
is a far closer match to the rotating shear device than to the continuous centrifuge, 
whose inlet is split into a number of self-contained branches in the feed distributor, 
with the fluid flowing through, and being moved as a bulk, by forces transmitted by 
walls moving into the space occupied by the fluid, i.e. normal to the fluid volume, in 
addition to the movement transmitted through the moving surfaces of the upper and 
lower walls, i.e. parallel to the fluid volume.  For this reason it was considered likely 
to be a more accurate representation to use the rotating machinery function available 
in Comsol, as described in section 2.1.1.3. 
 
Figure 2.1-1.  Schematics of rotating disc shear device 2D axisymmetric CFD model, illustrating the key 
constraints and boundary conditions imposed (where omega is the angular velocity and r is the radial 
distance) 
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Figure 2.1-2.  Schematics of PSC-5 continuous centrifuge feed zone 2-D axisymmetric CFD model, 
illustrating the key constraints and boundary conditions imposed 
2.1.1.2. CFD Analysis 1:  Peak shear rate and shear characterisation 
In the first pass analysis, as in the previous work by Boychyn et al. (2001), the peak 
shear rate was used, both for comparison to the aforementioned previous rotating 
shear device model and between the rotating shear device and centrifuge.  It may be 
noted that peak shear could be expected to be particularly dependent on meshing, 
and therefore a mesh refinement trial was conducted with the peak shear rate taken 
as measure of the minimum mesh size required for convergence.  How well the peak 
shear rates in these two very different systems reflects the likely impact on particles 
processed by those systems is clearly open to question. A further, novel refinement 
of the modelling approach, which attempts to take account of the broader shear 
environment is therefore discussed in section 2.1.1.4 below. 
In addition calculations of the Eigen values of the stress tensor and the angle 
between the direction of flow and the maximum shear rates were calculated.  These 
reflect the nature of the shear, i.e. whether it is for example simple or extensional 
shear.  The use of Eigen values and angle to characterise flow has not previously 
   
Page 74 of 308 
 
been applied to this particular problem.  The formulae derived from Harshe et al. 
(2011) were: 
  [Eq. 8] 
Where
The eigenvalues for this matrix (M) were derived using matlab, where the maximum 
eigenvalue is denoted as alpha (α), the minimum denoted as gamma (γ) and the 
remaining eigenvalue denoted as beta (β).  The angle between the eigenvector in 
the direction of the maximum eigenvalue and the vector field for the flow was then 
calculated.  Where an angle of 45° indicates simple shear, and an angle of 0° 
represents extensional shear. 
For the rotating disc the particles were assumed to follow a path which went (i) from 
the centre, just under the disc, and followed a path parallel to the disc surface until 
the outer wall was reached, then (ii) returned to the centre along a path midway 
between the disc and base of the chamber, (iii) returned to the surface of the disc, 
and (iv) passed along the disc again.  The number of passes was derived using the 
formulae in Zhang et al. (2007) (copied below).  It may be noted that a simplified 
particle tracing model in Comsol showed a movement consistent with the “pumping 
effect” described in the referenced paper.  
  [Eq. 9] 
  [Eq. 10] 
This analysis was completed in order to better understand the comparability of the 
shear environment in the two systems, and in recognition of the significance of the 
nature of the shear as well as its magnitude, which the literature implies. 
Data derived from Computational Fluid Dynamics (CFD) output was analysed using 
a matlab code, where the CFD output for the 
M 
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- PSC-5 was based on 500 slices in the xy-planes, with a shift of -0.165m to 
incorporate only the lower sections of the feed zone,  
- rotating shear device was based on 5 slices in the y-z planes, and  
- PKII ultracentrifuge was based on 1000 slices in the xy-planes, with a shift of 
0.12m to incorporate only the upper sections of the model, i.e. feed zone.   
2.1.1.3. 3D-Rotating Machinery model  
Whilst the axisymmetric model described in section 2.1.1.1 potentially provides an 
adequate first pass estimate of the shear conditions inside a continuous centrifuge 
feedzone, and is directly comparable to methods previously used for this purpose, it 
was considered necessary to assay a model which better represents the continuous 
centrifuge. 
Comsol Multiphysics version 5.2 (Comsol Ltd, Cambridge, UK) commercial software 
was used, with the rotating machinery, turbulent flow model, solving RANS k-. The 
model set up for the PSC-5 and PKII inlets are illustrated in Figure 2.1-3 and Figure 
2.1-4 respectively.  The standard ‘physics-induced sequence’ was used for meshing, 
with a setting of ‘fine’ (1.25 to 6.6 x10-3m) with the following modifications:  custom 
meshing at the boundary near the outlet of the feed zone (1 to 10 um) and for the 
boundary walls, with a minimum and maximum element size fixed at 40μm and 4mm 
respectively, and a parameter sweep used to confirm the impact of meshing 
tightness on CFD output.    
For the PKII only a rotating machinery model was built (i.e. no 2-D axisymmetric 
model), with the geometry measured manually as for the PSC-5.  The results of 
these manual measurements are summarised in Table 2.1-1.  The standard 
‘physics-induced sequence’ was used of meshing with minimum and maximum mesh 
sizes of 1.7 and 9.1 x10-3m respectively; at the boundary walls, excepting in the inlet, 
a maximum mesh size of 3.9x10-3m and in the feed 5.2x10-3m. 
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PSC-5 PSC-1 PKII 
Inlet angle to 
horizontal Deg 0 -30 0 
Distributor Branch 
Diameter mm 7.36 7.36 1.5 
Number of Branches - 8 8 6 
Radius at distributor 
branch inlet mm 6.97 6.97 10 
Distributor Branch 
Diameter at outlet mm 11.51 11.51 1.5 
Radius at Distributor 
Branch outlet mm 57.3 57.3 55 
Table 2.1-1.   Key feed zone geometry parameters for the PSC-5, PSC-1 and PKII centrifuges 
Details of the PSC-5 and PKII models have been exported and copied into 
appendices A and B respectively. 
 
Figure 2.1-3.  Schematics of rotating machinery CFD model of the PSC-5 continuous centrifuge feed 
zone, illustrating the key constraints and boundary conditions imposed 
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Figure 2.1-4.  Schematics of rotating machinery CFD model of the PKII density gradient ultracentrifuge, 
illustrating the key constraints and boundary conditions imposed 
2.1.1.4. CFD Analysis 2:  Population Balance Modelling 
Population balance modelling is a method used to track the number of discrete 
elements (gas bubbles, liquid drops or solid particles) in each size bracket within a 
continuous liquid or gas fluid.  It usually incorporates birth and death processes 
within each size bracket range.  In a continuous liquid- discrete solid particle system 
new particles, within a given size range, may be formed (birth) by aggregation due to 
interparticle collision through various mechanisms, and through breakage of larger 
particles through various mechanisms including hydrodynamic stresses and 
interparticle collision.  Both of these phenomena result in the loss (death) of particles 
within a different size range.  A wide range of functions exist to model each 
mechanism of birth and death which represent different sets of assumptions.  In this 
work, however, a simplified ‘population balance model’ has been adopted, which 
incorporates only the breakage phenomena due to hydrodynamic shear, and focuses 
only on tracking the number of particles in a single size bracket, close to the size 
range of interest.  (Yeoh et al., 2014) 
Previous work has been based on the reasonable assumption that two systems, in 
which the maximum shear rates are comparable, are systems which exert similar 
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shear damage on particles within them.  This assumption ignores, however, certain 
complications, such as the proportion of the volume for which the shear rate is high, 
whether the flow or forces are such that particles will be directed into these areas of 
high shear, and the length of time for which the particles will be exposed to different 
shear levels.  In other words the physical realities of the environment are not fully 
accounted for simply in comparing maximum shear rates or energy dissipation rates. 
Comsol offers an ideal solution to this problem:  particle tracing, in to which a 
stochastic breakage model could be incorporated which responds to environmental 
factors such as local shear rate and characteristic, and wall/ interparticle collision 
forces.  However, the computational cost and time required for such a model made it 
infeasible within the time frame of this EngD project. 
A compromise solution was therefore devised using a simplified breakage model, as 
described above, and assumed particle flow paths, and applied to the Computation 
Fluid Dynamics (CFD) output data using a mixture of matlab, vba macros and excel 
calculations.  With interpolating between the nearest data points available from the 
CFD output.  The formula applied for the breakage kernel / rate, representing the 
frequency with which the particles are disrupted, (Yeoh et al., 2014) was: 
 [Eq. 11] 
Where C4, β, α and γ are constant parameters for which the values in the range 10
-4 
to10-3, 0.25 to 0.9, 0.5 to 2 and 0.25 to 3 respectively are suggested in the literature.  
Sensitivities were conducted on the effect of the constants, within the suggested 
ranges, and the particle size.  In addition the effect of extensional flow was 
incorporated by increasing the Energy Dissipation Rate (EDR) linearly, up to 10 fold, 
for angles less than 10 degrees (see section 2.1.1.2). 
In the inlet zone of the PSC-5 and PKII centrifuges the assumed flow path was an 
even distribution across the cross section of the inlet arms of the centrifuge, with the 
time to pass from the centre of the centrifuge to the outlet of the arms based on the 
volumetric flowrate.  No account was taken of wall effects (slowing flow in proximity 
to the walls) or acceleration due to centrifugal forces.  Equally no attempt was made 
to model the particle-particle interactions.  Finally the particle size is treated as 
largely homogeneous, and it is implicitly assumed that the particles are completely or 
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largely destroyed by shear, therefore only the number of particles in the original size 
bracket need to be tracked. 
For the rotating disc the particle path was based on use of the particle tracing 
physics option, using 1000 particles.  This effectively ignores the effect of particle 
interaction on the flow path. 
In all cases no attempt was made to incorporate particle breakage due to 
interparticle collision or wall collisions.   Rough calculations based on estimated 
speed and mass of mammalian cells indicate that the forces involved in such 
collisions would be considerably smaller than those produced by fluid shears in 
these environments. 
2.1.1.5. Validation of disc stack model 
As discussed in section 1.1.3.4, for a number of reasons it is standard procedure to 
validate Computational Fluid Dynamics (CFD) models experimentally where-ever 
possible.  The main reasons include the inaccuracies in geometries, which were 
measured manually in the absence of any detailed data being provided by the 
manufacturer, the uncertainties inherent in the turbulent models themselves, which 
are known to be inaccurate to the order of 50%, and the impact which meshing can 
have on the modelling output. 
Whilst particle image velocimetry is the ideal methodology for validation of velocity 
field predictions for fluid systems this is impractical in the case of the centrifuge.  
Two separate approaches were therefore adopted as described below. 
On the PSC-5 the clarification of two mammalian cell stocks were measured at a set 
speed and flowrate, matching the operating conditions used in the flu process. The 
measured clarification was compared to that produced by the Ultra Scale-Down 
(USD) mimic as described in section 1.1.3.1, for a range of rotating disc shear device 
speeds. 
On the PSC-1 the particle breakage for a ‘cell shear mimic’ was measured and 
compared to that produced by the rotating disc shear device.  The development of 
the shear mimic was proposed by GSK biologicals, the industrial sponsor on this 
project, on the basis of potentially safer, easier and cheaper CFD validation.  The 
process of development is described in section 2.1.2.  The use of the shear mimic 
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provides a somewhat orthogonal method of validation to that described above, in the 
sense that the shear mimic is a substantially different material from mammalian or 
bacterial cells which have previously been used in this application, particularly with 
respect to the apparent mode of breakage.   Results which agree with the CFD and 
mammalian clarification outputs therefore add to the body of evidence that the shear 
in the rotating shear device and that in the centrifuge feed zone are comparable in 
scale and character.  It will be noted that the model of centrifuge used for the shear 
mimic work and that used for the CFD and mammalian clarification runs was not 
identical.  This is because the former were carried out at GSK and the latter at UCL.  
However, the PSC-5 and PSC-1 are understood to be designed to be produce 
scalable separation within the same product range.  This is discussed further in 
section 2.1.1.7. 
2.1.1.6. Validation of PKII model 
As for the PSC-5 (section 2.1.1.5) experimental validation of the CFD model 
predictions for the PKII was necessary.  For this purpose the particle 
breakage/damage for a ‘virus shear mimic’ was measured and compared to that 
produced by the rotating shear device.  The development of the shear mimic was 
proposed by GSK biologicals, the industrial sponsor on this project, on the basis of 
potentially safer, easier and cheaper CFD validation.  The process of development is 
described in section 2.1.3.  
2.1.1.7. Geometry Sensitivities 
Only rough rules of thumb exist for the expected level of shear in a previously 
uncharacterised centrifuge.  From discussion which Professor M Hoare (UCL) the 
shear level is anticipated to depend on the outer radius of the feed zone distributor, 
the speed of rotation and above all the nature of the centrifuge, in terms of 
hermetically sealed versus not.   However, it was noted during the development of 
the CFD model, and in preparing to use the USD model for continuous centrifugal 
harvest, that no quantitative answer could be given on the likely impact of specific 
geometric features.  In addition it was noted in dismantling the PSC-5 and PSC-1 
centrifuges, that their geometries showed a number of differences, the significance 
of which needed to be confirmed.  Figure 2.1-5 illustrates the key difference between 
the distributor in the PSC-1 and PSC-5 centrifuges, namely that the inlet branches of 
the PSC-1 slope, whilst the inlet branches for the PSC-5 are horizontal.  As a result 
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the inlet branch length for the PSC-1 is longer, and the acceleration of the wall in 
proximity to the fluid is lower.  In addition the recommended flow rate range is 
substantially lower for the PSC-1 (15-30l/hr) than for the PSC-5 (100-200l/hr).   
 
Figure 2.1-5.   Photograph demonstrating a key difference between the PSC-5 and PSC-1 inlets, as 
indicated by the arrow.  The PSC-1 inlet branches are pointed upwards at an angle from the base of the 
centrifuge, in order to exit in to the separation area at the base of the discs, which start higher up in the 
lower capacity PSC-1 centrifuge.  The PSC-5 by contrast has horizontal inlet branches, such that the inlet 
on one side is in a direct line of sight with the opposite inlet. 
The other key geometric features (Figure 2.1-6), including the number and diameter 
of the branches in the feed distributor, the diameter of the inlet areas which proceed 
the division of flow into branches, the outer radius of the centrifuge as it feeds in to 
the separation zone (tip of the distributor) and the operating speed range are 
identical in both the PSC-1 and PSC-5.   
 
Figure 2.1-6.   Photograph of the PSC-5 central section as seen from the side / slightly above (left) and 
from below (right).   
In order to understand the significance of these differences, as well as the impact of 
any inaccuracies in the geometry measurements and provide an indication for future 
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similar work, some sensitivities were conducted around the PSC-5 geometry.  The 
scope of this sensitivity analysis was limited due to time constraints, and was entirely 
simulation based, using the breakage function derived population balance (section 
2.1.1.4) as the parameter of comparison between different geometric arrangements.   
The range of geometries used in this sensitivity analysis are illustrated in Figure 
2.1-7, and the geometry parameters are listed in Table 2.1-2.  The run parameters 
used are based on a factorial analysis based around the centre point of the PSC-5 
geometry, and derived using Design-Expert® (Stat-Ease).  
 
 
Table 2.1-2.   Geometry parameters for the sensitivity analysis runs 
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Figure 2.1-7.   Schematics of centrifuge geometries for sensitivity analysis runs, where each run had a 
version with a narrower (upper) and wider (lower) diameter on the inlet branches   
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2.1.2. Chapter 4: Cell Shear Mimic Development 
2.1.2.1. Stress testing Chromatography beads 
The first class of particles identified as a potential cell shear mimic, on the basis that 
these materials are already routinely used in bioprocessing, were chromatographic 
beads. Initial tests showed agarose was unresponsive to shear forces in the rotating 
shear device (section 2.2.1.1). 
Homogenisation was therefore used, as described in section 2.2.1.3, on 1 ml of 
Sepharose fast flow in 99ml phosphate buffer saline (PBS) and 100l of 10m highly 
cross-linked agarose beads suspended in 100ml PBS.  In both cases the aim was to 
confirm that at a substantially higher level of shear the material could be broken, and 
would formed debris on breakage which the selected particle sizing methods could 
measure. 
These homogenisation assays did show damage.  Therefore a number of acid 
treatment methods were assayed for the various agarose species, including: 
- 10ml of Sepharose fast flow was added to 40ml of PBS, and 20ml of 1 Molar 
H2SO4 subsequently added (final pH 0.7).  This mixture was left for 30 
minutes before being neutralised with 1 Molar NaHCO3 (final pH 6.3). 
- 10ml of Sepharose fast flow was added to 40ml of PBS, and 20ml of 1 Molar 
H2SO4 subsequently added (final pH 0.7).  This mixture was left (not agitated) 
overnight before being neutralised with 1 Molar NaHCO3 (final pH 6.46). 
- 10ml of sepharose CL-4B was added to 40ml of PBS, and 16.7ml of 1 Molar 
HCl subsequently added (final pH 0.69).  This mixture was left (not agitated) 
over the weekend before being neutralised with 1 Molar NaHCO3 (final pH 
6.46). 
- For all agarose types except the 10m superfine highly-crosslinked agarose 
(ABT) 5 millilitres of agarose was added to 20 ml of PBS, and 8 ml of 1 Molar 
HCl was subsequently added (final pH 0.73).  These mixtures were left (not 
agitated) overnight before being neutralised with 1 Molar NaHCO3 (final pH 
~6.57). 
- For sepharose fast flow two sets of 5 ml was measured, and added to 0ml 
and 12ml PBS respectively and ~3 ml of concentrated H2SO4 subsequently 
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added to each.  These mixtures were left (not agitated) for 30 minutes before 
being neutralised with 1 Molar NaHCO3 (final pH ~6.4). 
- For sepharose fast flow, Iberagar, CL-4B, P6-XL agarose types 5 ml of 
agarose was measured, and ~5 ml of concentrated H2SO4 subsequently 
added.  These mixtures were left (not agitated) overnight before being 
neutralised with 1 Molar NaHCO3 (final pH 6.55-7.45). 
- For CL-6B and 10m highly cross-linked agarose types 10 ml and 10l was 
measured respectively, and ~3 ml of concentrated H2SO4 subsequently 
added.  These mixtures were left (not agitated) overnight before being 
neutralised with 1 Molar NaHCO3 (final pH 7.3). 
- For CL-6B and 10m highly cross-linked agarose types 10 ml and 10l was 
measured respectively, and ~4.5 and 2.5 ml respectively of concentrated HCl 
subsequently added.  These mixtures were left (not agitated) overnight before 
being neutralised with 1 Molar NaHCO3 (final pH 7.4/3). 
- As concentrated H2SO4 was shown to reduce all agarose types to fine debris 
following overnight treatment the acid concentration was optimised to find a 
concentration which would not destroy the particles.  For CL4B 10ml agarose 
was added to 1, 2.5 and 3 ml of PBS, then 3, 2.5 and 1 ml respectively of 
concentrated H2SO4 was added.  These mixtures were left (not agitated) 
overnight before being neutralised with 1 Molar NaHCO3 (final pH 6.32, 6.4 
and 6.15 respectively).  In the second iteration for CL4B 10ml agarose was 
added to 1.7 and 1.3 ml of PBS, then 2.3 and 2.7 ml respectively of 
concentrated H2SO4 was added.  These mixtures were left (not agitated) 
overnight before being neutralised with 1 Molar NaHCO3 (final pH 7.31and 
7.26 respectively).   
Both acid and base addition was done at an uncontrolled rate and the shear device 
used subsequently, as described in section 2.2.1.1, to assess whether the agarose 
particles susceptibility to shear stresses had been impacted.  In all cases no shear 
sensitivity within the range of interest was identified and experimentation with 
chromatographic beads was discontinued.  Details of acid and base preparations 
and material vendors can be found in Appendix G. 
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2.1.2.2. Adju-Phos validation and use as shear mimic  
Subsequently similar experiments were conducted with adjuvants, and a promising 
candidate quickly identified in Adju-Phos. 
Figure 2.1-8 summarises the experiments conducted using Adju-Phos as a cell 
shear mimic to validate the Computational Fluid Dynamics (CFD) results.  In 
summary, both the cell shear mimic and a sample set of mammalian cells were 
subjected to shear using a rotating shear device (section 2.2.1.1) and the response 
to shear measured through the change in particle size distribution (section 2.2.7.6).  
Having demonstrated that the Adju-Phos responded to shear rates in the appropriate 
range and in a comparable manner to mammalian cells the shear mimic was run 
through the CSA-1, CARR and PSC-1 centrifuges (section 2.2.1.2).  The CSA-1 and 
CARR centrifuges both being well parameterised were used to validate the use of 
the cell shear mimic for prediction of shear rate at large scale, and confirm what 
particle size distribution parameter should be used, as discussed further in section 
4.2.4. 
 
Figure 2.1-8.   A. Schematic of parallel runs shearing Adju-Phos at laboratory scale and subjecting it to 
shear in the industrial scale centrifuge.  B.  The same laboratory scale procedure was also used with 
mammalian cells to demonstrate comparability of the response to shear 
The CFD prediction of shear in the PSC-5 centrifuge was also validated using 
mammalian cells as illustrated in Figure 2.1-9.  The cells were harvested as per the 
standard operating conditions in the PSC-5 centrifuge (section 2.2.1.2).  The same 
cell culture material was subjected to shear in a rotating shear device (section 
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2.2.1.1), and subsequently clarified using a laboratory scale centrifuge (section 
2.2.1.3) at a range of conditions covering conditions comparable to those at 
industrial scale (section 1.1.3.1). 
 
Figure 2.1-9.   Schematic of parallel runs, shearing and clarifying mammalian cells at laboratory scale and 
harvesting using the PSC-5 centrifuge 
2.1.3. Chapter 5: Virus Shear Mimic Development 
2.1.3.1. Stress testing nanobeads & assay optimisation  
Of the potential virus shear mimics only one was examined in detail.  The virus shear 
mimic was a streptavidin coated nanobead (section 2.2.3.1), with the assays 
identified which might allow measurement of shear rate being particle size 
distribution and assaying for the streptavidin layer using a biotinylated fluorescein 
which quenches on binding to streptavidin. 
The choice of streptavidin coated nanobeads was prompted by the potential parallel 
which might be drawn between the outer coating of streptavidin and the viral protein 
coat.  Damage to proteins in the outer coating of a virus would be expected to 
seriously compromise the virus’ ability to interact with cells during the various stages 
of the virus life cycle / infection processes: sections 1.1.1.1 and 1.1.1.2 list, for 
example, a number of identified viral proteins in influenza and adenovirus and their 
roles.  Although this approach does rely on the assumption of streptavidin being 
equally sensitive to the effects of hydrodynamic forces as a viral protein, it was felt 
none-the-less to be an interesting potential parallel to explore. 
For the fluorescence based assay the checkboard method was used in an attempt to 
optimise the concentration of both fluorescein and nanobead.  The methodology 
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adopted was to compare the fluorescence of unsheared beads to that of beads 
damaged in one of three ways: by the shear device at speeds up to 12krpm, by acid 
treatment and by homogenisation.  A z-factor (Kada et al., 1999) was used to asses 
for significance of difference between damaged and undamaged beads.  This was 
based on the original hypothesis that damage to the streptavidin layer might impact 
upon its ability to quench the fluorescein-biotin when bound. 
Acid (Appendix G) was also used to try to create a negative control for the 
streptavidin coated nanobeads (for the optimisation of the fluorescence assay, 
section 2.2.7.8): 
- 12.5 ml of PBS with nanobeads, to which 5ml of 1 Molar H2SO4 was added 
(final pH 0.66).  This mixture was left (not agitated) for 1 hour before being 
neutralised with 1 Molar NaHCO3 (final pH 6.1). As fluorescence measures 
may have been effected by pH these results were discarded. 
- 50l of nanobeads was washed and added to 12.5ml of PBS, and 5ml of 1 
Molar H2SO4 subsequently added (final pH 0.66).  This mixture was left (not 
agitated) overnight before being neutralised with 1 Molar NaHCO3 (final pH 
6.35). As fluorescence measures may have been effected by pH these results 
were discarded. 
- 50l of nanobeads was washed and added to 12.5ml of PBS, and 5ml of 1 
Molar HCl subsequently added (final pH 0.63).  This mixture was left (not 
agitated) over weekend before being neutralised with 1 Molar NaHCO3 (final 
pH 6.35).  The acid treated nanobeads were then washed 3 times and 
concentrated x2 using the vivaspin centrifugal filters. 
Both acid and base addition was done at an uncontrolled rate. 
100l of streptavidin nanobeads, were first washed using vivaspins and added to 
100ml PBS, then subjected to homogenisation as described in section 2.2.1.3. 
These initial assays did not show any significant difference between damaged and 
undamaged nanobeads, which agrees well with later work implying that there is no 
significant difference in terms of maximum fluorescence quenching by streptavidin 
on damaged versus undamaged beads.  However, the checkboard titration was used 
to set an order of magnitude value for the fluorescein and nanobead concentration, 
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i.e. which gave a clear fluorescence quenching in the presence of beads, and strong 
fluorescence signal in their absence.   
A titration of a fixed quantity of nanobeads against diluted fluorescein showed a 
difference between undamaged and damaged nanobeads, without being able to 
distinguish between different levels of shear rate (Melinek, 2013).  A method deemed 
likely to be more accurate, modelled on 96 well plate based immunoassays, was 
therefore adopted: generating a 4 parameter logistic fit curve of apparent streptavidin 
concentration with constant fluorescein concentration.  This latter is described in 
more detail in section 2.2.7.8. 
2.1.3.2. Finalised methodology  
Figure 2.1-10 illustrates the use of the virus shear mimic to validate predicted shear 
rate in the PKII centrifuge.  In summary, the nanobeads appear to form aggregates 
which when sheared in the rotating shear device (section 2.2.1.1) break down to 
form a different particle size distribution (section 2.2.7.6), for which there is a 
relationship to shear rate.  The additional step of fractionating the nanobead sample 
in a density gradient centrifuge (section 2.2.1.4) was completed for direct 
comparability to the PKII centrifuge (section 2.2.1.2).  As the particle size distribution 
was not maintained, or not easily measured, when suspended in the sucrose 
gradient / after fractionation, the Nanosight was used to count particles and a 
fluorescence assay (section 2.2.7.8) used to normalise this count for the quantity of 
streptavidin attached to the beads. 
It may be that this combination of shear device and laboratory scale density gradient 
ultracentrifugation may have potential as a scale down model for the PKII centrifuge.  
However, due to lack of time its application to the viral vaccine process stream 
remains to be assayed. 
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Figure 2.1-10.   Schematic showing use of nanobeads as a virus shear mimic for fractionation in the PKII 
density gradient ultracentrifuge 
2.1.3.3. Assays for impact of shear on virus particles  
The harvest scale down experiments (section 2.1.4) on the virus infected material 
were also used to provide sheared viruses, which were assayed for the impact of 
that shear on the viruses. Figure 2.1-11 illustrates the sequence of assays applied, 
including infectivity assays (sections 2.2.7.3 and 2.2.7.4), and particle size 
distribution (section 2.2.7.6) and SDS-PAGE (sections 2.2.7.14 and 2.2.7.18) / 
western blots (sections 2.2.7.13 and 2.2.7.17) for fractionated viruses (section 
2.2.1.4).  
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Figure 2.1-11.   Schematic showing assays used to assess the impact of shear on adenovirus and 
influenza virus.  Note the viruses was not purified before being subjected to shear, and are thus exposed 
to all the elements present at cell harvest in the whole cell lysate 
2.1.4. Chapter 6: Ultra-Scale Down (USD) for Virus Harvest 
Figure 2.1-12 illustrates the procedure used to validate the USD tools for continuous 
centrifugation, as developed previously be UCL and described in section 1.1.3.1, for 
the harvest of influenza viral vaccine culture.  No literature has previously been 
published on the use of the USD tool for centrifugal harvest of any viral vaccine.  The 
cells were harvested as per the standard operating conditions in the PSC-5 
centrifuge (section 2.2.1.2).  The same cell culture material was subjected to shear in 
a rotating shear device (section 2.2.1.1), and subsequently clarified using a 
laboratory scale centrifuge (section 2.2.1.3) at a range of conditions covering 
conditions comparable to those at industrial scale (section 1.1.3.1).  The same ultra-
scale down procedure was also followed for adenovirus infected HEK cells, to 
investigate the effect of time of infection on both influenza and adenovirus harvest, 
and for uninfected HEK and EB66 cells to investigate the effect of the infection 
process itself (sections 2.2.5 and 2.2.6). 
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Figure 2.1-12.   Schematic of parallel runs, shearing and clarifying influenza infected EB66 cells at 
laboratory scale and harvesting using the PSC-5 centrifuge, and runs shearing and clarifying adenovirus 
infected HEK293 cells (laboratory scale only) 
2.2. Protocols & Materials 
2.2.1. Process Equipment 
2.2.1.1. Rotating Shear Device & Ultra Scale-Down (USD) 
A rotating disk shear device, constructed at UCL, consisting of an aluminium alloy 
disk of 4cm diameter and 0.1cm thickness within a chamber of 5cm diameter and 
1cm height was used to apply shear to the samples.  The model of shear device 
used for all the results presented in detail in this thesis is shown in Figure 2.2-1 and 
the motor model was USD SD001 (asset ID 1236).  Some initial screening work was 
completed with earlier versions of the shear device, although the only changes were 
in external design factors, such as the motor and power pack, which should not have 
had a substantial impact on the results.  The rotating disk is described in detail 
elsewhere (Boychyn et al., 2001, Boychyn et al., 2004, Hutchinson et al., 2006, Levy 
et al., 1999, Zaman et al., 2009, Boychyn et al., 2000).   
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The disk was rotated via a shaft and motor at a number of fixed speeds for a number 
of fixed time periods.  The shear device has a volume of 20ml.  The procedure was 
repeated a minimum of twice for each shear rate to give 40ml of sample for analysis, 
and as a ‘repeat’. 
 
Figure 2.2-1.   Equipment: Shear device and power pack 
For uninfected CHO, HEK and EB66 cells and infected EB66 cells at GSK, and for 
uninfected CHO and HEK cells and infected HEK cells at UCL, and Adju-Phos, the 
rotating shear device was used to shear the material for a period of 20 seconds at 
fixed speeds of 0, 6, 8, 10 and 12krpm.  These speeds are equivalent to a maximum 
energy dissipation rate of 0, 27, 90, 210 and 420kW/kg respectively.  For both 
infected cell samples an additional shear condition was included, running the shear 
device at a speed of 18krpm for 1 minute.  For experiments focused on clarification 
the samples were also spun down in a laboratory centrifuge (see section 2.2.1.3) 
after all samples had been sheared. 
Further sensitivities were conducted at 0 and 12krpm for 5 seconds and 30 seconds 
with Adju-Phos at the same concentration and at lower and higher concentrations 
(see section 2.2.2.3).   The shear rate selected for cells and cell mimics are those 
which have been shown elsewhere to have a measurable impact on mammalian 
cells (Hutchinson et al., 2006).    
The rotating shear device was used to apply shear to the diluted nanobead samples, 
by running the motor at a rate of 0, 6, 12 and 18 krpm for 1 minute.  Further a 
sensitivity analysis was conducted running the motor at a rate of 9 and 15 krpm for 
0.5 minutes and for 1.5 minutes.  Initial work used similar time frames and speeds as 
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for Adju-Phos, but it was deemed unlikely that such low shear rates, for such a short 
period would show any impact on nano-scale particles. 
Water was used to measure the change in temperature after shearing, with 20 
seconds at 12krpm giving an increase of less than 2°C, and shearing at the same 
speed for a minute gaving a temperature increase of 3.4°C.  The ramping rate of the 
disc is extremely quick, combined with the fact that both cells and Adju-Phos reach 
an unchanged condition after only 5 seconds; the ramp rate of the disc is therefore 
not recorded here. 
2.2.1.2. Pilot & Industrial Centrifuges 
Centrifugation of Adju-Phos was carried out using the CSA-1 disc stack centrifuge 
(Westphalia Separator, AG, Oelde, Germany) and the CARRPowerfugeTM P6 bowl 
centrifuge (Carr Centritech Separation Systems, Clearwater, FL), representing 
characterised, low and high shear centrifuges respectively.  The CSA-1 operating 
conditions were a speed of 9810rpm and a feed flow rate of 100L/hr. The 
CARRPowerfuge running conditions were a speed of 15000rpm and a feed flow rate 
of 60L/hr. 
Operating conditions in the CSA-1 and CARRPowerfuge are selected according to 
conditions at which these centrifuges have previously been characterised (Lau et al. 
(2013) and Lopes and Keshavarz-Moore (2012)).   The CSA-1 is an hermetically 
sealed disc stack centrifuge which has been shown to operate at low shear 
conditions.  The CARRPowerfuge by contrast is a high shear tubular bowl centrifuge.  
Thus these two centrifuges represent the extremes of possible process conditions in 
terms of shear rate. 
The PSC-5 disc stack centrifuge (Westphalia Separators, AG, Oelde, Germany) was 
used by GSK for the centrifugal clarification of uninfected HEK cells, uninfected CHO 
cells (Section 2.2.5.2) and infected EB66 cells (Section 2.2.6.2).  The operating 
conditions were a speed of 8500rpm and a feed flow rate of 200L/hr. 
Samples of the supernatant were taken at 30 second intervals and the Optical 
Density (OD) at 650nm was measured (as per section 2.2.7.7).  Steady state was 
taken as 3 similar consecutive OD measures, with this steady state value being used 
to calculate the clarification.  This steady state was reached within the first 1 minute 
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30 seconds.  For infected EB66 cells, however, this was not possible for biosafety 
reasons; so a sample of the final well mixed supernatant harvest was taken and 
measured instead.  The feed and well spun OD were based on those measured for 
the laboratory scale clarification experiments (section 2.2.1.3). 
Centrifugation of Adju-Phos was carried out using the PSC-1 disc stack centrifuge 
(Westphalia Separator, AG, Oelde, Germany) as a substitute for the PSC-5 
centrifuge, in the absence of the expertise at GSK to disassemble and reassemble 
the centrifuge for sample extraction and the equipment to measure particle size 
distribution.  The operating conditions used were a speed of 13500rpm with a feed 
flow rate of 40L/hr, and a speed of 8000rpm with a feed flow rate of 81L/hr. 
The Q/ (m/s) for the PSC-5 disc stack centrifuge was calculated as follows (see 
section 1.1.3.1): 
 
 
With addition of a geometric correction factor for the non-idealities in a disc stack 
environment of 0.4, this gives  
 
bowl speed min-1 8500 
angular velocity  rad/s 890 
Flow l/hr 200 
Table 2.2-1.   PSC-5 run specific parameters 
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number of discs n - 60 
half disc angle  Deg 40 
inner radius r1 M 0.034 
outer radius r2 M 0.0635 
number of caulks ZL  - 8 
caulk width BL M 0.006 
Table 2.2-2.   PSC-5 physical parameters 
The parameter in Table 2.2-2 were confirmed by taking the centrifuge apart and 
physically measuring components.  These measurements were completed by the 
author, at GSK, whilst the centrifuge was being serviced. 
Centrifugation of nanobeads at pilot scale was conducted using a PKII centrifuge 
(Alfa Wasserman, Germany).  The PKII was loaded with 200ml 55% sucrose and 
200ml PBS (pH 7.4) and bought up to speed, with an hour allowed for the gradient to 
form.  The PKII centrifuge, with a K3 rotor was run at a speed of 35000rpm and 
100ml of suspended nanobead fed at a flow rate of 20ml/min.  Banding was then 
performed over 1 hour, using PBS (pH 7.4) at a flow of 20ml/min.  Offloading was 
performed automatically in ~12ml fractions.   
2.2.1.3. Laboratory Centrifuges & Clarification 
Cell samples were first sheared, as described in section 2.2.1.1, then clarified using 
a laboratory scale centrifuge.  As described in section 1.1.3.1 the Q/ for the PSC-5 
centrifuge (calculated in section 2.2.1.2) was matched by the volume, speed and 
time of centrifugation at laboratory scale. 
For uninfected and adenovirus infected HEK cells (at UCL) the sheared cells were 
clarified using an Eppendorf 5430 centrifuge with an FA-45-30-11 rotor (Eppendorf, 
UK).  The conditions used were 1ml, 1.5ml and 2ml, spun down for 5 minutes at 
3000rpm, and the same volumes spun down for 5 minutes at 6000rpm.  Well spun 
samples were generated by centrifuging 2ml for 30 minutes at 6000rpm.  These are 
the standard conditions used at UCL in the centrifuge USD practicals. 
For uninfected and influenza virus infected EB66 cells (at GSK) the sheared cells 
were clarified using an Eppendorf 5427R centrifuge with an FA-45-48-11 rotor 
(Eppendorf, UK), and using a larger laboratory scale centrifuge, Allegra X-15R with 
an SX4750A rotor (Beckmann).  In the Eppendorf centrifuge the conditions were 
identical to those used at UCL.  It was observed that the clarification as predicted by 
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the Eppendorf centrifuge did not match the industrial scale or the larger Beckmann 
centrifuge used to give a sterile supernatant sample for infectivity assays.  
Subsequent runs therefore included clarification over a full range of V/t for both the 
larger and smaller laboratory centrifuges.  In the Beckmann centrifuge 15ml falcon 
tubes were used to spin down 7ml and 14ml for 7 minutes at 3000rpm, and the same 
volumes for 10 minutes at 4000rpm, in addition to 13, 10, 7, 5 and 2ml centrifuged 
for 5 minutes at 4000rpm.  The same well spun samples were used as for the 
smaller Eppendorf centrifuge. 
The conditions listed above for the larger laboratory scale centrifuge are equivalent 
to a V/tΣ of 6.7, 1.5, 2.8, 5.7, 10.5, 7.8, 5.3, 3.7 and 1.4 x10-8 m/s respectively. The 
first condition was designed to match the Q/Σ conditions in the PSC-5 centrifuge 
(6.3x10-8 m/s).  In the Eppendorf 5430 centrifuge the centrifuge conditions listed are 
equivalent to a V/tΣ of 9.0, 13.2, 17.1, 2.2, 3.3 and 4.3 x10-8 m/s respectively, and in 
the 5427R Eppendorf centrifuge to 5.3, 7.7, 9.8, 1.3, 1.9 and 2.45 x10-8m/s 
respectively.  However, it should be noted that the g-forces will also differ between 
this centrifuge, the smaller laboratory centrifuge and the PSC-5.  It has been shown 
elsewhere that for certain cell types, specifically algal, the g-forces may also be of 
interest with respect to the clarification and settling (Xu et al., 2015b).  The g-forces 
for the various centrifuges are therefore summarised as follows: the small Eppendorf 
centrifuge has a g-force ranging from 1,600 to 14,000xg, the larger laboratory 
centrifuge has a g-force ranging from 5,900 to 41,000xg and the PSC-5 has a g-
force ranging from 7,000 to 20,000xg, over the operating ranges used.   
For biosafety reasons influenza infected samples were pipetted into the cuvettes 
under a (micro) biosafety cabinet II and stoppered with a cap.  The samples were 
then agitated just before measurement, by inverting several times, to ensure that 
particle settling did not affect the accuracy of measurements. 
For earlier work at GSK on uninfected CHO and HEK cells the sheared cells were 
clarified using another large laboratory centrifuge, a 5810 eppendorf centrifuge 
(VWR, Belgium).   A standard 50ml falcon tube with a starting volume of 20ml of 
process material was spun-down at speeds of 1000 and 2000rpm and 1ml samples 
of the supernatant taken at intervals of between 5 and 10 minutes.  In calculating 
V/Σt the acceleration and deceleration times were discounted and the removed 
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sample volume accounted for by assuming uninterrupted centrifugation at the time 
averaged volume.  Well spun samples were generated by centrifugation of 25ml of 
unsheared material at 4000rpm for 30 minutes. 
  Eppendorf 
5430 (UCL) 
Eppendorf 
5427R (GSK) 
Allegra X-
15R (GSK) 
Eppendorf 
5810 (GSK) 
Outer Radius (m) R2 0.095 0.101 0.208 0.075 
Angle from vertical 
(degrees) 
θ 45 60 90 90 
Tube type  2ml Eppendorf  15ml falcon 50ml falcon 
Minimum Volume 
(ml) 
V 1 14 20 
Maximum Volume 
(ml) 
2 2 30 
Table 2.2-3.   Physical parameters of laboratory centrifuges 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Calculation of V/t for Eppendorf 5427 centrifuge: 
R2 (m) θ (degree) Volume Speed (krpm) Time (mins) 
0.101 60 2ml 3 5 
Height of Eppendorf centrifuge tube to 2ml is ~4cm. 
 
 
 
 
   
Page 99 of 308 
 
The absorbance of the samples were measured as per section 2.2.7.7.  By 
comparing the absorbance of the supernatant to that seen in the feed stock, and in 
the supernatant of a well spun sample, the clarification was derived (Maybury et al. 
(2000)): 
 [Eq. 12] 
For EB66 (influenza infected, and uninfected) the supernatant samples used for 
western blots and protein assays were produced by spinning down 7ml of the 
sheared sample at 3000rpm for 7minutes, conditions which should roughly match the 
Q/Σ of the PSC-5 centrifuge at the run conditions used in this process. 
2.2.1.4. Laboratory-scale batch density gradient ultracentrifugation 
In order to look for impact on the adenovirus and influenza virus these needed to be 
separated from the whole cell lysate, removing the background from measurement of 
the particle size distribution (section 2.2.7.6), and average protein composition of the 
virus particles (sections 2.2.7.13, 2.2.7.14, 2.2.7.17 and 2.2.7.18).  The protein 
composition assays were also used in this case to confirm the presence, and attempt 
to confirm the relative purity of, the viruses in the fractions for which the particle size 
distribution was measured. 
In order to obtain relatively pure virus density gradient centrifugation was used to 
fractionate the sample.   
Influenza infected EB66 cell supernatant was fractionated in a sucrose gradient.  
Heavy, medium and light sucrose was made up at a concentration of 55, 30 and 5% 
respectively.  A 40ml Ultra-clear tube was partially filled manually with 10ml heavy 
density sucrose, overlaid with 10ml medium density sucrose, overlaid with 10ml low 
density sucrose, and left overnight at 4°C.  10ml of the supernatant sample was 
overlaid on the sucrose density gradient, and spun at 26000rpm for 2 hours, and 
subsequently the visibly identifiable virus fraction was removed manually. 
Whole cell lysate of adenovirus infected HEK293 cells was fractionated in a caesium 
chloride (CsCl) gradient.  Heavy and light CsCl was made up from 146g 10mM Tris-
HCl buffer (pH 8.1) and 107.4 and 54g of CsCl (562602-1KG, Sigma Aldrich) 
respectively.  The CsCl gradient was created manually.  First 5.5ml of heavy CsCl 
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was pipetted into a 14ml ultra-clear tube (BECL344059, VWR international), and 
overlaid with 5.5ml of light CsCl.  200μl of the whole cell lysate was added to 1ml of 
10mM Tris-HCl buffer (pH 8.1), and 1ml overlaid on the light CsCl in the centrifuge 
tube.  A further 1ml of 10mM Tris-HCl buffer (pH 8.1) was overlaid on the sample.  
The tubes were spun at 20500rpm in an SW41 Ti rotor, and a Beckman Optima-L-
100XP ultracentrifuge, for 2 hours at 4°C, and subsequently offloading was 
performed manually in 0.5ml fractions.   
The fractions containing adenovirus were identified using the Nanosight, and 
combined and further concentrated (x10) using Vivaspin 500 centrifuge filters (VSO 
111, Sartorius) before westernblots against adenovirus coat proteins were performed 
(see section 2.2.7.13). 
In order to assess the impact of fractionation in a CsCl gradient, and compare to 
nanobeads fractionated in the PKII centrifuge, pre-sheared nanobeads were also 
fractionated at laboratory scale.  A sucrose (04821713, MP Biomedicals, UK) 
gradient was prepared as for influenza, but in 14ml ultra-clear tube (BECL344059, 
VWR international).  For sensitivities using a shallow density gradient, high and mid-
range concentrations of 41.2 and 24% sucrose were used, and for a steeper density 
gradient a mid-range concentration of 34%. 2ml of sheared nanobead sample was 
added to each tube.  All tubes were spun at 42000rpm for 1hour 27 minutes at 4°C 
using an SW 41Ti rotor and in a Beckman Optima-L-100XP ultracentrifuge.  
Offloading was performed manually in 0.5ml fractions using a standard laboratory 
pipette, from the top downwards. 
2.2.1.5. Homogenisation 
The two sets of operating conditions used on the APV lab 40 homogeniser (Gaulin 
GmbH, Germany) were 2 passes at a set pressure of 1200bar, and 3 passes at a set 
pressure of 500 bar.  The homogeniser was used to stress test shear mimic 
candidates, with the aim of demonstrating that the assay techniques chosen / 
developed were capable of measuring damage to the shear mimics. 
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2.2.2. Cell Shear Mimic Candidates 
2.2.2.1. Agarose 
4% highly cross-linked agarose beads “superfine” with a mean diameter of 10m 
dispersed in 20% ethanol were purchased from Agarose Bead Technologies (ABT).  
It was ensured that particles were uniformly distributed in the 5ml delivery container 
by inversing the container three times before removing a portion of the sample for 
testing.   
For the initial test 88l was extracted by pipette and dispersed in 40ml of PBS 
solution.   A second test with a higher concentration of 500l was extracted by 
pipette and dispersed in approximately 40ml of PBS solution, with the aim of 
generating a mixture whose particle size distribution could be accurately measured 
using the Mastersizer.  Subsequent tests have been conducted with 330l of 
agarose dispersed in 150ml of PBS solution, with the aim of creating a uniform initial 
concentration for the no shear, low shear and high shear cases. 
A range of other agarose derived materials were tested, these include sepharose 
CL-4B (Amersham Biosciences, 17-0150-01), sepharose CL-6B (Amersham 
Biosciences, 17-0160-01), DEAE sepharose fast flow (Amersham Biosciences, 17-
0709-01), 2% cross-linked agarose (Iberagar) and P6XL (origin unknown).  The aim 
being to test whether the preparation of the beads and resultant properties, such as 
extent of cross-linking, had a significant impact upon the response to shear; following 
initial assays with agarose showing minimal shear impact. 
2.2.2.2. Aluminium hydroxide 
250ml of Alhydrogel was kindly donated by Brenntag Biosector.  8ml of aluminium 
hydroxide was diluted in 150ml of RO water, prior to shearing. 
2.2.2.3. Aluminium Phosphate 
Initially 250ml of Adj-Phos was kindly donated by Brenntag Biosector.  8ml of 
aluminium phosphate was diluted in 150ml of RO water, prior to shearing. 
For later work 250ml bottles (Brenntag Nordic A/S, Frederikssund, Denmark, cat. no. 
3471) were purchased, with concentration reduced to 1ml per 100ml PBS made up 
with milliq water.  The work for which results are presented in chapter 4 is all based 
on this concentration.  A sensitivity analysis was run at laboratory scale at 
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concentrations of 5ml Adju-Phos per 100ml PBS, and 15ml of Adju-Phos per 100ml 
PBS. 
2.2.3. Virus Shear Mimic Candidates 
2.2.3.1. Streptavidin Coated Polystyrene Nano-Beads 
10ml of 0.109m (adsorbed) streptavidin coated polystyrene beads at a 
concentration of 10mg beads/ml suspension were purchased from Bangs 
Laboratories.  The quoted binding capacity of these beads is given as 7.66g GFP-
biotin/mg bead.  The quoted material density was 1.06g/ml. 
Nanobeads were allowed 10minutes out of the fridge to warm towards room 
temperature.  To ensure uniform distribution the container was inverted three times 
and placed on a vortex shaker for 20 seconds. Nanobeads were added to PBS, 
using a pipette, at a concentration of 100μl of nanobeads for 100ml of PBS. 
For some early initial trials nanobeads were washed before being suspended in 
PBS.  If this is the case it is indicated in the method description.  After vortexing 
200l of nanobeads were extracted by pipette and washed three times using a 
vivaspin-20 (with 300,000 MWCO filter) tube (Sartorium Stedim UK ltd) and an 
Eppendorf centrifuge 5810R at 3220 x g.  Washed beads were added to PBS to give 
a total volume of 200ml.  Use of vivaspins was discontinued as they appeared to 
strongly effect the apparent nanobead concentration, as measured by fluorescence 
assays and Nanosight.  The latter, along with a substantial decrease in vivaspin 
water flux after use, was thought to imply that the nanobeads were sticking to the 
vivaspin filters. 
2.2.4. Fluorescent Labels 
0.1mg of anti-GFP labelled biotin was purchased from 2B Scientific ltd.  5ml of anti-
GFP labelled biotin was added to 10ml PBS (milliq). 
0.3mg of Green Fluorescent Protein (GFP) was purchased from Millipore UK ltd.  
The GFP in its original container was allowed approximately 10 minutes to reach 
room temperature then centrifuged at 5000rpm for 5 minutes in an Eppendorf 5415R 
centrifuge.  In addition the contents was mixed using a pipette.  Aliquots were then 
created, as advised on the manufacturer’s instructions, by diluting 5l in 1ml of a 
   
Page 103 of 308 
 
PBS glycerol mixture.  Initial work with GFP showed no promising results.  The 
easier fluorescein system was therefore adopted for the majority of the project. 
1mg of biotin (5-fluorescein) was purchased from sigma Aldrich ltd (53608 Sigma).  
As this was received in powder form a small amount (~1.4g/ml) was diluted in water 
to form a stock solution, and 1ml aliquots frozen at -20°C.  Details of assay 
methodology are described in section 2.2.7.8. 
2.2.5. Cells 
2.2.5.1. UCL based cell work 
CY0 CHO cells (Lonza, UK) were grown in 250ml working volume shake flasks at 
37°C, 5%CO2, in chemically defined media containing TMX (Life technologies, 
Paisley, UK).  Cells were harvested on day 7 with a viability of 95% and cell density 
of 4x106cells/ml.  These cells were used to generate particle size distributions 
exemplifying the effects of shear on mammalian cells as measured on the casy 
counter and mastersizer.   
HEK293 cells (85120602-1VL SIGMA293 Cell Line, European Cell Bank) were 
grown as adherent cell cultures in T-175 flasks (660160, greiner bio-one, UK), using 
defined DMEM media (21969-035, Gibco, life technologies, UK) with 10%FBS 
(10270-106, Gibco, life technologies, UK) and 5.5ml L-glutamine (25030-024, Gibco, 
life technologies, UK), and in a Sanyo incubator at 37°C and 5%CO2. These cells 
were used in adenovirus production studies, to compare the shear sensitivity of virus 
infected and uninfected cells.   
Virus infection stages are discussed in section 2.2.6.1. 
For non-virus infected runs the cell culture conditions were similar in range to those 
seen in virus infected runs at the time of infection (see Table 2.2).  For both virus 
infected and uninfected runs, in order to remove the samples from the T-flasks and 
prepare them for shearing the following steps were undertaken:  (i) free liquid was 
removed from the T-flask, (ii) any remaining attached cells were washed with PBS, 
then trypsin added for a maximum of 3 minutes at 37°C, the trypsin neutralised by 
addition of fresh media and the cells spun down, and the pellet re-suspended in the 
free liquid removed in step (i). 
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2.2.5.2. GSK based cell work 
15 litres of CHO and HEK cells were kindly provided by GSK Vaccines (Rixensart, 
Belgium) for analysis of separation in the PSC-5 (GEA, Milton Keynes, UK) 
centrifuge.  CHO cells were grown in shake flasks over a 7 day period, and induced 
at low temperature to produce a recombinant product.  The HEK cells by contrast 
were grown in a stirred bioreactor.  Details of upstream processing were not 
considered relevant to this analysis.  Total cell count was approximately 1.9 x 106 
cells/ml for both, i.e. below the 2% wet w/v, which has been shown to require 
modification of the USD methodology (Tustian et al., 2007). 
EB66 cells (Valneva, France) were produced by GSK Vaccines (Rixensart, Belgium) 
for trials and analysis of the influenza production process.   The cells were grown to 
a concentration of approximately 10 x106cells/ml, and diluted in fresh media and 
other constituents for viral propagation, before infection.    Infection Culture occurred 
in a 50L single use bioreactor.  Sample volumes were taken at 4 and 5 days after 
infection, and subjected to the shear conditions of interest (within 2 hours), and then 
clarified, and OD measured (within the same day).  For the non-virus infected culture 
a small volume was taken from the main bioreactor and diluted in the same material 
as for infection, except without the addition of the virus seed.  As with the virus 
infected samples the non-virus infected sample volume was subjected to a range of 
shear conditions within 2 hours of being extracted from the bioreactor / diluted, and 
then clarified and OD measured within the same day. 
2.2.6. Viruses 
2.2.6.1. UCL based virus work 
The Adenovirus kit used was supplied by the Clinical BioManufacturing Facility 
(Oxford, UK).  It was an Ad5 control stock (D419, p53).  HEK 293 cell cultures, 
grown as described in section 2.2.5.1, were used to propagate this virus.   The aim 
was to infect HEK cells at a confluence of 70-80%.  Actual confluence on infection is 
included in Table 2.2, which summarises the key parameters of the adenovirus 
culture. 
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Table 2.2.  Summary of culture conditions for adenovirus / HEK cell runs 
 
Run# Confluence1 Cell 
Count1 
MOI2 TOI3 TOH4 Cell 
Passage # 
% 106/ml hrs hrs 
1 93.7+/-1.4 4.9+/-0.03 8 110 159 6 
2 67.3+/-5.0 3.4+/-0.37 12 105 168 7 
3 90.7+/-2.0 4.8+/-0.16 8 104 169 12 
4 89.7+/-4.3 4.8+/-0.09 8 98 211 12 
5 75.8+/-3.6 4.6+/-0.08 8 97 241 14 
6 61.0+/-6.3 3.9+/-0.29 5 93 237 16 
7 63.4+/-6.3 4.1+/-0.28 7 99 235 8 
8 56.9+/-2.3 4.0+/-0.17 7 48 114 11 
9 42.9+/-7.3 1.5+/-0.29 13 129 168 18 
10 45.0+/-7.5 1.5+/-0.35 13 129 217 18 
1 On infection, measured by taking 5 images per T-175 flask and analysing using cell 
counting tool (referenced section 2.2.7.1) 
2 Multiplicity of Infection, based on a P2 stock virus count of 1010 measured using 
TEM.  MOI is the ratio of virus count to cell count. 
3 Time of Infection, i.e. time from start of cell culture to seeding of the virus, in the 
same culture vessel 
4 Time of Harvest, i.e. time from start of cell culture to harvest, in the same culture 
vessel in which virus seeding occurred. 
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2.2.6.2. GSK based virus work 
The flu virus runs used four separate flu strains:  A/Shanghai/2/2013 (H7N9), 
A/Gyrfalcon/Washington (H5N8) from the centre for disease control (CDC) and 
A/Duck/Bangladesh/19097/2013(H5N1) from St Jude Children’s Research Hospital.   
EB66 cell cultures, as described in section 2.2.5.2, were used to propagate these 
viruses. 
2.2.7. Analytics 
2.2.7.1. Optical Microscope 
The optical microscope can be used for automated cell count and size distribution 
evaluation. However here it was used to perform manual counts and look for any 
visibly distinguishable morphological changes to micro-particles.  
For early work with micro-particles, whilst trying to identify whether any visible impact 
from shear could be distinguished a haemocytometer was used for number counting 
and a Leica microscope with camera was used to create a record of measurements. 
A Haemocytometer was also used to count cells in virus free and adenovirus 
infected HEK cells, subjected to different shear levels, using an optical microscope.  
A number of runs were completed with Trypan blue used to distinguish between 
viable and non-viable cells. 
An EVOS digital microscope was used to take photographs at representative points 
in the T-175 flasks and an in-house developed software (Asselborn et al., 2015) 
used to estimate cell count and confluence on infection. 
2.2.7.2. Beta Galactosidase Staining Kit 
Cells were washed with PBS, and stained with staining solution, from the β-
Galactosidase Reporter Gene Staining Kit (GALS, Sigma Aldrich, Saint Louis, USA), 
prepared as per manufacturer’s instructions.  0.5% gluteraldehyde was used for cell 
fixing.  The infectivity assay protocol is described below. 
2.2.7.3. BFU Infectivity assay 
The blue forming units (BFU) assay was used to test for infectivity of the adenovirus 
by identifying cells which had been transfected with the LACz gene (Mittereder et al. 
(1996), Cell_Biolabs_Inc (2004b)). A 96 well plate was coated with Poly L Lysine 
(PLL) (P4832, Sigma) by incubating with 30μl per well for 5 minutes, removing the 
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PLL and leaving for a further 2 hours to dry, all at room temperature. 100μl of 
HEK293T cells at a concentration of 105cells/ml were added per well, and left 
overnight in an incubator (conditions in incubator as per section 2.2.5.1 throughout). 
The frozen sample of sheared virus was thawed on ice, and dilutions, in cell media, 
prepared with dilution factors of 2x103, 2.5x104, 5.1x104, 7.2x104, 2.1x105, 4.3x105, 
8.5x105 and 1.7x106.  The media in each well was removed and replaced with 100μl 
of diluted sample.  Each dilution was prepared in triplicate, with fresh media added to 
3 of the columns, acting as a blank.  The plate with infected sample was left in the 
incubator for 1 hour, then the adenovirus containing media was removed and 
replaced with 100μl of fresh media, and the plate incubated overnight. 
Wells were washed twice with 30μl of PBS, left in 30 μl of fixation solution for 
5minutes, washed twice again with 30μl of PBS, and left in the incubator overnight in 
30μl of staining solution (see section 2.2.7.2 for reagent details). 
 
Figure 2.2-2. Illustrative image of HEK cells exposed to diluted adenovirus, fixed and stained (BFU 
assay) 
The total number of cells which stain blue (see Figure 2.2-2) was counted for each 
well at a magnification of 5x and, where this number was between 50 and 200, 
corrected for dilution and averaged, to give the BFU/100μl. 
   
Page 108 of 308 
 
The above describes an optimised BFU assay, developed by Jelena Ruscic and 
Bernice Wright (with the author locating and providing Cell_Biolabs_Inc (2004a)).  An 
earlier iteration of the BFU assay was also used in a non-quantitative manner to 
confirm the presence of adenovirus, but did not allow the quantification of infective 
virus due, most likely, to overgrowth of cells and loss of transfected cells during 
washing.  The problem with the original BFU assay was identified by the author 
when it was observed that there was a relationship, which should not have existed, 
between dilution and predicted BFU/ml.  The original protocol used 24 well plates, 
not coated in PLL.  1ml of cells, at a concentration of 2.5x105 cells/ml, was added to 
each well, and the plate left in the incubator for 1 hour, before 1ml of media diluted 
virus was added to each plate at dilutions of 1 in 2000, 1 in 20000 and 1 in 200000.  
After a further 48 hours in the incubator, the cells were fixed and stained as above 
(with correction for the larger volume), except that the Beta-galactosidase staining kit 
fixation solution was used instead of gluteraldehyde.  The number of blue stained 
cells at 5 well spaced locations, was counted at a magnification of 10x and the total 
number of blue stained cells per well extrapolated.  A count of between 50 and 200 
at each of the 5 locations was taken as acceptable. 
2.2.7.4. TCID50 Infectivity assay 
TCID50 infectivity assays for influenza were performed at GSK, by members of the 
team at GSK.  No further details are available. 
The TCID50 of adenovirus was measured in a 96 well plate, on HEK293 cells seeded 
at a density of 105cells/ml with 100μl cells per well.  Cells were left a minimum of 2 
hours to adhere before virus dilutions were added.  Sheared adenovirus samples 
were thawed on ice and 8 different dilutions were used for each sample, with a 
dilution factor ranging from 1x105 to 1x1012, with 10 replicates per plate used to 
estimate each TCID50, and triplicate plates prepared for each sample, with the 
TCID50 being estimated from the average, excluding any obvious outliers. 
2.2.7.5. Transmission Electron Microscopy (TEM) 
A model JEM-1010 transmission electron microscope (Joel, Japan) was used to look 
for morphological changes in sheared virus, to count virus particles, to look for 
morphological changes in sheared nanobead, and to count anti-biotin gold tags per 
nanobead on sheared nanobeads. 
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The TEM was used to estimate the virus count by mixing virus samples with a known 
amount and concentration of nanobeads, and counting both nanobeads and virus 
particles over a number of grid squares.  2ml of Whole cell lysate of HEK cells 
infected with adenovirus was spun down at a speed of 3krpm for 5minutes in an 
Eppendorf centrifuge, and 100ul of supernatant removed and frozen.  Following 
thawing 100ul of glutoaldehyde was added to the sample.   For the count the 
adenovirus samples were mixed with a nanobead suspension, of known 
concentration in a known ratio.  The adenovirus and nanobeads were allowed to 
adhere to a copper grid over a period of 15minutes and blotted, followed by 
alternately blotting and washing in filtered buffer and distilled water for 20 seconds 
each, and staining with uranyl for 30 seconds.  Both adenovirus and nanobead were 
counted simultaneously at a focus of x60k, with an aim to count a minimum of 100 
nanobeads.   
2.2.7.6. Particle Size Distribution 
The following particle sizing equipment was used: 
- Nanosight tracker LM10 (Nanosight Ltd, Malvern Instruments, Malvern, UK), 
with the software version 3.1 and camera type CCD.   Nanosight uses a 
camera to track the Brownian motion of individual nanoparticles highlighted by 
a laser beam, and can be used to derive a particle size distribution and count. 
Typically for nanobeads the camera level used was 9, with a threshold of 9 in 
post processing.  Typically for fractionated adenovirus (section 2.2.1.4), and 
HEK cells with and without adenovirus, the camera level used was 12 and the 
threshold approximately 3.  A dilution of 1 in 10 was used for cell supernatant 
and lysate samples.  The Nanosight was also used on Adju-Phos 
supernatant, but showed very low particle concentration. 
- CPS Disc Centrifuge (CPS instruments, Europe).  CPS uses a sucrose 
gradient between 4 and 18% inside a spinning disc, with samples injected at 
the centre, and the particle size inferred from the time taken to travel from the 
centre to the detectors.  CPS was used for the particle size distribution of 
fractionated influenza virus (section 2.2.1.4). 
- Mastersizer (Malvern Instruments, Malvern, UK).  The mastersizer uses static 
light scattering, whereby the degree of laser scatter is greater for larger 
particles (Malvern_Website).  The sample is pumped through an optical 
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window, through which a laser is shone, and the scattered light from which is 
detected on a semi-circular array of detectors.  Both blue and red lasers are 
used to broaden the instruments measurement range.  Dispersant used was 
milliq-PBS, to prevent a change in dispersant generating any agglomeration, 
destruction of cells etc.  Early work was done with the Mastersizer 2000SM 
series, using Mastersizer 2000 5.53 software version.  Later work was done 
using Mastersizer 3000 HydroMV and HydroSV dispersion units, and using 
v3.10 of the software.  An obscuration target of 11% was used.  The refractive 
index for agarose, polystyrene nanobeads, CHO, aluminium hydroxide and 
aluminium phosphate were 1.58, 1.6, 1.6, 1.57 and 1.5295 respectively, with 
an absorption of 0.1 for Adju-Phos and 0 for all other materials.  Further 
details are given in Melinek (2013). 
- Casy Counter and analyser, Model TTC (Scharf System GmbH, Reutlingen, 
Germany). The Casy Counter measures the change in electrical resistance 
across a constricted aperture as particles suspended in an electrolyte solution 
are pulled through a capillary.  For agarose and CHO cells a capillary size of 
150μm was used with a dilution of 50μl in 10ml (or as required).  For 
aluminium phosphate the dilution factor was 10200 (100μl in 10ml, further 
diluted 100μl in 10ml of triple filtered casytone), and a 45μm capillary was 
used. 
- Vi-Cell (XR Series) (Beckmann Coulter, UK) with software version 2.03.  The 
Vi-Cell works as an automated haemocytometer, mixing a sample with trypan 
blue, and taking a series of images, which are analyses for individual objects 
of the appropriate circularity, brightness and size, all of which need to be 
calibrated for each cell line.   Pre-prepared cell types for CHO, EB66 and 
EB66 post infection were used. 
- Flow cytometer (XL, Beckmann Coulter, Expo32).  Use of this machine was 
trialled for measurement of nanobeads, sheared and incubated with 
fluorescein and separately with GFP; neither showed a strong enough signal 
for detection against background. 
- Zetasizer NanoZS (Malvern Instruments, Malvern, UK), using version 7.01 of 
the software.  The Zetasizer uses dynamic light scattering, measuring the rate 
at which the intensity of scattered light generated by particles fluctuates as a 
result of their movement under Brownian motion.  The Zetasizer was used to 
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measure nanobead particle size distribution but was not as repeatable as the 
Nanosight.  It was also used on Adju-Phos supernatant, but showed no 
repeatable measurement due to low particle concentration. 
2.2.7.7. Optical Density (OD) measurements 
At UCL OD measurements were made using  
- Biomate 3S Spectrophotometer (thermo scientific, UK) for CHO cells, and 
Lowry assays; 
- And an InfiniTe 200 plate reader (Tecan, UK) for HEK cells and BCA assays.   
Readings in a translucent 96 well plate (82.1581, Sarstedt, UK). 
At GSK OD measurements were made using: 
- UltraSpec 2000 (Pharmacia Biotech, Uppsala, Sweden) for EB66 cells, 
influenza infected EB66 cells, and sucrose fractionated influenza virus 
- SpectraMax 190 (Molecular Devices, UK) for Lowry assays. 
2.2.7.8. Fluorescence measurements 
An assay, based on immunoassays for protein concentration, was developed based 
on the interaction between the streptavidin on the streptavidin coated nanobeads 
(section 2.2.3.1) and the biotinylated fluorescein (section 2.2.4):  The fluorescence of 
the fluorescein is quenched when the biotin is bound to streptavidin.  Figure 2.2-3 
shows a schematic summary of the steps involved in this simple assay.  The 
concentration of nanobeads and fluorescein was optimised to give a clear curve, with 
initial concentrations being selected as discussed in section 2.1.3.1. 
 At UCL an InfiniTe 200 plate reader (Tecan, UK) was used for measurement of 
fluorescein fluorescence curves against nanobead concentration.  At GSK a 
SpectraMax M2 (Molecular Devices, UK) was used for measurement of fluorescein 
fluorescence curves against nanobead concentration. 
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Figure 2.2-3.  Schematic showing Stages of Fluorescence assay and principle by which it works.  A.  In a 
black well plate a fixed quantity of PBS is prepared in all but the first 4 wells of column 1 and last 4 wells 
of column 12. B. Duplicates of the sample are added to one of the first 4 wells in column 1, and the 
symmetrically opposite well in the last 4 wells of column 12.  C.  The sample is serially diluted across the 
plate, with the top 4 wells diluted, from left to right, and the bottom 4 wells diluted from right to left.  D.  A 
fixed quantity of fluorescein is added to all wells, as rapidly as possibly, and the plate left at least 15 
minutes.  Where the nanobead sample is in high concentration the biotinylated-fluorescein molecules 
will all be attached to streptavidin and the fluorescence quenched.  At lower nanobead concentrations 
there will be a significant amount of free biotinylated-fluorescein, and the fluorescence will therefore 
increase.  If the resulting fluorescence curve does not have a flat region at both extremes, and at least 5 
points in the sloping region then the dilutions may need to be adjusted.  E. Diagrammatic representation 
of fluorescence assay principle.  Blue circles represent nanobeads, yellow circles fluorescein, black 
squares are streptavidin and orange-black circles are quenched fluorescein.  F. Initially hypothesised 
impact of shear on nanobeads, which was disproved – clusters of nanobeads are broken down, but the 
attached streptavidin remains undamaged in the range of interest. 
2.2.7.9. Density Gradient Concentration 
The density of sucrose in fractionated density gradients was measured at GSK using 
a hand held BRIX device, pocket refractometer Pal-3 (atago, Japan). The density of 
sucrose and CsCl in fractionated density gradients was measured at UCL using a 
balance to measure the weight of 0.5 or 0.4ml removed by pipette.  
2.2.7.10. UCL: Gel electrophoresis 
Samples for gel electrophoresis were first suspended in NP40 (Appendix G) in a 
ratio of 1:1. The NP40 with sample was added in a ratio of 1:1 to Laemmli buffer 
(Appendix G).   
Volumes to be added to each well were calculated such that the amounts of protein 
were equal, with the protein concentration being determined using the modified 
Lowry method (section 2.2.7.11) or BCA (section 2.2.7.12). 
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20x NuPAGE MES SDS running buffer (NP0002, novex, life technologies) was 
diluted to 1x in milliq water. 
The gel used was a BOLT 4-12% bis-tris 10 well mini gel (Invitrogen, Thermo Fisher 
scientific, UK) using a mini gel tank (Invitrogen, Thermo Fisher scientific, UK) and 
PowerEase 90W unit (Thermo Fisher scientific, UK) run at 200V.  Set-up and use of 
equipment was as per manufacturer’s instructions (Lifesciences, 2014). 
Molecular weight markers were SeeBlue pre-stained protein standard (LC5625, 
Thermo Fisher scientific, UK). 
2.2.7.11. UCL: Modified Lowry 
Where stated, the protein concentration was measured using the modified Lowry 
method (reagents 500-0114, 500-0113 and 500-0115, Bio-Rad, UK) in acrylic semi-
micro cuvettes (67.740, Sarstedt, UK), with the OD at 750nm measured on a 
biomate3s spectrophotometer (thermo scientific, UK).  A serial dilution of BSA (500-
0007, bio-Rad, UK) was used as standards. The following were added sequentially 
to the cuvette: 10μl of sample or standard, 100μl of reagent A, 800μl of reagent B, 
mixed with a pipette between each addition.  The samples were incubated at room 
temperature for a minimum of 15minutes and a maximum of 1 hour before being 
measured.  Samples were prepared in triplicate.  (Lowry et al., 1951) 
2.2.7.12. UCL: BCA 
The Pierce BCA protein Assay kit (233225, 23227, Thermo Scientific) was also used 
for some protein concentration assays at UCL for the purposes of the western blot, 
which used equal protein concentration in each lane. The standard protocol for use 
of this kit in 96 well plates was followed (Pierce_Biotechnology, 2015). 
2.2.7.13. UCL: Western blot 
The protein loaded per well was approximately 9μg, derived using the modified 
Lowry method (section 2.2.7.11), with the exception of the CsCl fractionated virus 
where the protein concentration was measured using BCA (section 2.2.7.12).  The 
gel was prepared and run as per section 2.2.7.10. Proteins and molecular weight 
markers were transferred from the bis-tris gel to a PVDF membrane (IB24001, 
Invitrogen, Thermo Fisher scientific, UK) using the iBlot 2 Dry transfer (Thermo 
Fisher scientific, UK).  The template method P0 was used, and manufacturers 
protocol was followed (Thermo_fisher_scientific, 2015). 
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5% milk (Marvel dried milk, Ireland) was used for blocking, and 2% milk was used 
when incubating first in primary and then secondary antibodies.   Tris Base 
(Appendix G) was used to wash between primary and secondary antibody, for 3 x 5 
minutes, and after secondary antibody, for 3 x 5minutes.  The blot was incubated in 
the primary antibody, at 4°C without agitation overnight, and in the secondary anti-
body at room temperature, under agitation for 2 hours. 
Two primary anti-bodies were used: a 1 in 4000 diluted rabbit adeno coat proteins 
primary antibody (ab6982, abcam, Cambridge, UK) and a 1 in 5000 diluted mouse 
hexon antibody (10R-8460, fitzgerald, UK).  The secondary anti-bodies used against 
these primary antibodies were respectively goat anti-rabbit HRP (ab6721, abcam, 
Cambridge, UK) diluted 1 in 8000, and rabbit anti-mouse HRP (ab6728, abcam, 
Cambridge, UK) diluted 1 in 5000. 
The chemiluminescence substrate used was Supersignal West Pico (34080, Thermo 
scientific, UK), in which the blot was incubated at room temperature for 45 seconds. 
Imaging was completed using a ChemiDoc MP (Bio-Rad, UK), and an exposure 
chosen which avoided saturation of all bands.  Image Lab version 5.2.1. (Bio-Rad, 
UK) was used for band position and strength identification. 
The final blot completed (adenovirus samples prepared as per the final paragraph of 
section 2.2.1.4) used the Amersham Imager 600 (GE, UK), with GelAnalyzer version 
2010a (GelAnalyzer.com, Lazar and Lazar) was used for band position and strength 
identification. 
2.2.7.14. UCL: SDS-Page 
Silver staining was used for identification of protein bands, according to standard 
protocols.  The amount of protein loaded per well was approximately 9μg, derived 
using the modified Lowry assay (section 2.2.7.11).  The gel was prepared and run as 
per section 2.2.7.10.  In summary the gel was stained as follows: agitated in fixing 
solution (Appendix G) for 1 hour, washed under agitation for 3 x 5 minutes in milliq 
water, left for 30 minutes under agitation in sensitising solution (Appendix G), 
washed under agitation for 3 x 10 minutes in milliq water, left for 20 minutes under 
agitation in silver stain solution (Appendix G), washed 3 times by manual rocking for 
2-5 minutes in milliq water, left under agitation in developing solution (Appendix G)  
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(until it was judged that the fainter bands had started to show, or that the intense 
bands were becoming too smudged) then transferred to stopping solution (Appendix 
G), and left under agitation for a minimum of 30 minutes.  Before imaging the gel 
was washed under agitation 3 times for 5 minutes in milliq water and left in 
preserving solution consisting of 5% acetic acid until ready to image.  Imaging was 
completed using a standard scanner with a resolution of 600, in both colour and grey 
scale. 
For Sypro Tangerine stained gels the amount of protein loaded per well was 
approximately 32μg.  The gel was prepared and run as per section 2.2.7.10.  
Staining was conducted as per standard protocols (see Appendix G for solution 
recipes).  Imaging was completed using a typhoon with an excitation / emission 
wavelength of 490/640nm 
2.2.7.15. GSK: Gel electrophoresis 
An in-house produced and optimised non-reducing sample buffer was used.  The 
sample was boiled to denature the virus, for biosafety reasons.  No further details 
available.  MOPS (3-(N-morpholino) propane sulfonic acid) running buffer was used. 
The gel used was a Criterion XT precast 4-12% bis-tris 18 well comb gel (Bio-Rad, 
Ca) using a Bio-Rad criterion cell gel tank and Bio-Rad Power PAC 200 unit run at 
200V.  Set-up and running were as per manufacturer’s instructions (Bio-Rad(a)). 
For western blots molecular weight markers were Precision Plus Protein WesternC 
Blotting Standards (161 0376, Bio-Rad, UK), with Precision Protein StrepTactin-HRP 
conjugate (161 0380, Bio-Rad, UK) used in parallel with the secondary anti-body to 
enable visualisation of these markers. 
For gels molecular weight markers were Precision Plus Protein unstained Protein 
Standards, strep-tagged recombinant (161 0363, Bio-Rad, UK). 
2.2.7.16. GSK: Modified Lowry 
For the EB66 cells (infected with influenza, and uninfected) the sample was diluted 
to three different dilutions (x10, x20 and x40 dilution factor), and chemicals added to 
denatured and precipitate the protein.  It was then spun down, and the supernatant 
removed, leaving the protein pellet.  This procedure was followed for biosafety 
reasons and to remove interfering compounds.  The protein concentration was then 
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measured in duplicates, using a Lowry reaction, with a maximum variance of 10% 
accepted across the three different dilutions.  The exact protocol is confidential.   
2.2.7.17. GSK: Western blot 
Western blots were run in one of two ways, with equal volumes loaded per well or 
equal protein.  Equal volumes of 6μl were loaded for blots against EB66.  Equal 
volumes of 10μl were loaded following dilution 1 in 10 (approximately 1μg 
unsheared) of supernatant samples were loaded per well for blots against HA.  Equal 
protein amounts of approximately 1.5μg of sucrose fractionated influenza virus was 
loaded per well for blots against HA, where the relative concentration of the virus 
was estimated based on peak Optical Density (OD) (see section 2.2.7.7). 
Proteins and molecular weight markers were transferred from the bis-tris gel to a 
nitrocellulose membrane (162-0145, Bio-Rad, UK) using a wet blotting method, with 
a criterion blotter unit (Bio-Rad, UK), run using a Bio-Rad Power PAC 200 unit at 
100V with a standard solid re-usable ice pack to prevent the system overheating.  
Set-up and running were as per manufacturer’s instructions (Bio-Rad(b)).   A 
methanol based transfer buffer was pre-prepared by members of the team at GSK. 
Skim Milk (BD Worldwide, US) was used for blocking, and the same milk re-used at 
a lower concentration, which was used when incubating in primary and secondary 
antibodies.   
Two primary anti-bodies were used: a rabbit anti-EB66 host cell primary protein 
antibody (GSK) and anti-HA uni 1.  The secondary anti-bodies used against these 
primary antibodies were respectively Rabbit -sheep IgG HRP conj (AP147P, 
Millipore) and Polyclonal goat -rabbit IgG HRP (P0448, Dako). 
The chemiluminescence substrate used was Supersignal West Pico (34080, Thermo 
scientific, UK), which was added dropwise across the membrane surface and left 
with minimal disturbance whilst imaging. 
Imaging was completed using an Image Quant LAS4000 (GE), and an exposure 
chosen which avoided saturation of all bands.  GelAnalyzer version 2010a 
(GelAnalyzer.com, Lazar and Lazar) was used for band position and strength 
identification on Tif files, convert from .gel format using Imagej software (Wayne 
Rasband, Research Services Branch, National Institute of Mental Health, USA). 
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Further details of the method are confidential. 
2.2.7.18. GSK: SDS-Page 
SDS-PAGEs were run in one of two ways, with equal volumes loaded or equal 
protein.  Equal volumes of 10μl were loaded for most of the gels.  Equal protein 
amounts of approximately 4μg of sucrose fractionated influenza virus was loaded per 
well, where the relative concentration of the virus was estimated based on peak 
Optical Density (OD) (see section 2.2.7.7).   
Sypro ruby (S21900, Invitrogen) was used to stain the protein bands, as per the 
standard protocol (Molecular_Probes_Inc, 2007), with overnight agitation in sypro 
ruby stain.   
Imaging was as per western blots (section 2.2.7.17) 
2.2.8. Buffers 
Buffer recipes and material vendors are given in Appendix G. 
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3. Mapping the Process Shear 
Environments using CFD 
3.1. CFD Analysis – Continuous Centrifuge 
The PSC-1 and PSC-5 are part of a series of centrifuge bowls by GEA Westfalia 
fitted within the same housing designed to offer equivalent performance at 
progressively larger scales.  The PSC-1 has a bowl volume of 1litre and flowrate 
range of 15 to 30L/hr.  The PSC-5 has a bowl size of 1.4litres and flowrate range of 
100 to 200L/hr.  The speed range of both machines is identical, 8000 to 13500rpm.  
Although there are differences in the inlet geometry as a result of this difference in 
bowl size fitted within the same frame, these differences are unlikely to have a 
material impact on the shear rate, which is believed to be dictated largely by the 
hermetic nature of the model, speed of rotation and disc diameter, all of which are 
identical.  
3.2. Development Process  
3.2.1. 2D-Axisymmetric 
Early work on the continuous centrifuge Ultra Scale-Down (USD) model used 
Computational Fluid Dynamics (CFD) simulation to compare the environments within 
the rotating disc shear device and a continuous centrifuge model.  This work, by 
Boychyn et al. (2001), used an axisymmetric methodology for the modelling of both 
the rotating disc shear device and the continuous centrifuge, and concentrated on 
the shape of the shear zone and the maximum shear rate within the liquid as points 
of comparison between the two systems.  The authors show a maximum shear rate 
at the tip of the rotating shear device and at the furthest radial point of the centrifuge 
inlet zone, where the distributor branches open into the separation zone. This is 
where solids collect and fluid flows upwards through the discs.  Boychyn et al. 
(2001), however, used a different simulation software, and this work was completed 
a number of years ago. 
As a first pass, this modelling approach was replicated using COMSOL 
Multiphysics®, with the continuous centrifuge modelled by Boychyn et al. (2001) 
being replaced by the PSC-5 disc stack centrifuge which is of interest to this project.   
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The primary aim of replicating this earlier work was as an initial validation of the 
COMSOL model, and to explore in more detail the flow environment within the two 
systems.  However, it was felt that an axisymmetric model could not reasonably be 
treated as a good representation of the continuous centrifuge, or at least needs to be 
evaluated, as the centrifuge geometry is not axisymmetric.  The use of maximum 
shear rate as the primary point of comparison between the USD rotating disc shear 
device and the continuous centrifuge is also questionable.  Unlike bioreactors, where 
the process material is exposed to the process environment over an extended period 
of time and where the design is intended to maximise mixing, the process material 
passes only once and rapidly through -or through the region proximate to- the 
highest shear zones in the continuous centrifuge feed.  Use of maximum shear rate 
takes no account of the length of time for which particulates within the process 
stream are exposed to a given level of shear.  In addition the maximum shear rate is 
found only in a narrow volume.  Sections 3.2.1.1 and 3.2.2.1 touch on this issue in 
more detail.  Other modelling approaches are therefore considered in this chapter in 
particular in section 3.2.2.2. 
3.2.1.1. Comparison against Previous Studies 
Although it may not be expected that maximum shear rate will correlate against 
experimental damage, previous studies have used this parameter.  To confirm that 
the model build in Comsol matches these previous models the level of maximum 
shear was therefore used.  For this it is easier to focus first on the rotating disc shear 
device.  For both the continuous centrifuge and the rotating disc shear device the 
level of discretization used on the models was first validated by confirming the 
convergence of various parameters, but chiefly the maximum shear rate, as 
illustrated in Figure 3.2-1.  The slight dip in maximum shear rate for the highest 
speed at the maximum discretization is considered likely to be numerical in origin.  
The level of maximum shear rate in the rotating disc shear device could then be 
compared to results previously published in the recent literature, as shown in Figure 
3.2-2.  This comparison shows a good level of agreement between this model and 
the published values, although it may be noted that these more recently published 
values do not agree with the values published by Boychyn et al. (2001). Finally the 
minimum Kolmogorov’s scale is calculated based on these energy dissipation rates, 
showing minimum values of the same order as the size of a mammalian cell, 
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reflecting well the experimental observation that damage is seen to occur within this 
range of disc speeds within the rotating disc shear device. 
 
Figure 3.2-1.   Maximum energy dissipation rate with number of mesh elements for the rotating 
disc shear device and over the full range of rotating disc shear device disc speeds presented 
in this thesis, from highest (◆) to lowest (●), with the remaining symbols (▲,■) representing 
intermediate disc speeds. 
 
Figure 3.2-2.  Maximum energy dissipation rate with increasing disc speed for the rotating disc shear 
device as modelled by CFD.  Literature values from Lau et al. (2013) are also shown (■) for comparison.  
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Figure 3.2-3.  Minimum Kolmogorov’s scale, derived from maximum energy dissipation rate, with 
increasing disc speed for the rotating disc shear device (based on Eqn. 4, section 1.1.3.1) 
In order to further characterise the shear environment the shear tensor was broken 
down in to its three Eigen value components (section 2.1.1.2).  The results for the 
rotating disc shear device (Figure 3.2-5 to Figure 3.2-8) and continuous centrifuge 
(Figure 3.2-9 and Figure 3.2-10) reflect well those reported by Boychyn et al. (2001), 
in that the maximum shear rates are experienced in the same narrow locations; in 
the rotating disc shear device at the disc tip (at a radial distance of 0.02m), and in 
the continuous centrifuge at the furthest radial point of the centrifuge feedzone (at a 
radial distance of 0.057m).   
For clarity the eigen values for the rotating shear device are plotted along set flow 
paths, running in parralel to the rotating disc, as illustrated in Figure 3.2-4.  In the 
rotating shear device the particles are expected to follow a path running parallel to 
the rotating disc due to the pumping motion set up by the rotation of the disc, 
discussed further in section 3.2.2.2. At the rotating shear device disc speeds used in 
this work the particles are expected to pass along this path at least once within a 20 
second period.  In addition the path along the disc passes through the zone of 
maximum shear within the shear device.  It is for these reasons that it was decided 
to plot the results along these flow paths. 
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In the PSC-5 centrifuge the optimum presentation of the CFD derived shear rates is 
less obvious.  The particles are expected to pass through the centrifuge feedzone 
only once, and be evenly distributed across the inlet branch.  In addition the zone of 
highest shear appears to be less localised across the width of the inlet branch, whilst 
still remaining a function of the radial distance.  For this reason the eigen values are 
presented in Figure 3.2-9 and Figure 3.2-10 as a scatter plot of all datapoints at a 
given radial position, ensuring that the maximum shear rate will be amongst those 
plotted. 
It may be noted that the maximum shear rate in the rotating disc shear device and 
continous centrifuge is of a similar order of magnitude: compare the maximum eigen 
values in Figure 3.2-6 and Figure 3.2-8 to those in Figure 3.2-9 and Figure 3.2-10.  
As an hermetic low shear centrifuge, the PSC-5 is expected to be best modelled 
using a rotating disc shear device disc speed of the order of 6000rpm.  This work, 
however, does not show any direct comparability of the maximum shear rate values 
in the centrifuge to that in the rotating disc shear device at a speed of 6000rpm 
(Figure 3.2-6), as oppose to a speed of 12000rpm (Figure 3.2-8).  As stated above, 
this maximum shear rate was the basis of the justification given by Boychyn et al. 
(2001). 
However, comparing Figure 3.2-5 to Figure 3.2-6 and Figure 3.2-7 to Figure 3.2-8 
illustrates further the extreme narrowness of this maximum shear location: even at 
approximately a mammalian cell’s width distance of 15μm from the disc surface the 
maximum shear rate at a radial distance of 0.02m has dropped dramatically, and is 
far closer to the maximum levels seen in the continuous centrifuge.  The scatterplot, 
for which the density of points at a given shear will depend upon the areas of highest 
mesh density as oppose to volume, is not so useful in illustrating the degree of 
localisation for the maximum shear rates in the centrifuge.  The heat map of shear 
rate, however, which can be viewed in Comsol®, shows a similarly narrow volume 
for the maximum shear rate in the PSC-5 centrifuge (results not shown).  The issue 
of shear levels and spatial distribution is explored further in section 3.2.2.1 below. 
The above illustrates the first of the difficulties in simply comparing the maximum 
shear rates in the two systems.   
   
Page 123 of 308 
 
 
Figure 3.2-4. Schematics of the rotating disc device showing the axi-symmetric cross section (i.e. a 
cross section of half the device).  A.  An annotated schematic, designed to indicate the conventions 
adopted with respect to describing components of the rotating shear device.  B. A schematic indicating 
the flow paths for which data is plotted in the figures in sections 3.2.1.2 and 3.2.1.1, where (a, brown) 
indicates the highest shear zones at the tip of the rotating disc, (b, red) is a flowpath, parallel to the lower 
surface of the rotating disc, but offset, in the vertical direction, by a distance of 15μm, representing the 
approximate diameter of a mammalian cell (n.b. not to scale), and (c, green) is a flowpath along (in very 
close proximity to) the surface of the rotating disc.  The insets illustrate the predominant flow and shear 
stress vector components at two points along path b, where simple (left) and extensional (right) shear 
are present. 
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Figure 3.2-5. Eigen Values of the shear tensor along a path following the lower surface of the disc in 
the rotating disc shear device with increasing radial position, for a disc speed of 6000rpm 
 
Figure 3.2-6. Eigen values of the shear tensor along a path parallel to the lower surface of the disc, at 
a distance of 15μm (approximate mammalian cell diameter)  below, in the rotating disc shear device with 
increasing radial position, for a disc speed of 6000rpm.  The position of the tip is 0.02m. 
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Figure 3.2-7. Eigen Values of the shear tensor along a path following the lower surface of the disc in 
the rotating disc shear device with increasing radial position, for a disc speed of 12000rpm 
 
Figure 3.2-8. Eigen values of the shear tensor along a path parallel to the lower surface of the disc, at 
a distance of 15μm (approximate mammalian cell diameter) below, in the rotating disc shear device with 
increasing radial position, for a disc speed of 12000rpm.  The position of the tip is 0.02m. 
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Figure 3.2-9. Eigen values of the shear tensor with increasing radial position in the PSC-5 centrifuge 
for a rotation speed of 8100rpm, using an axisymmetric model assumption.  The three eigenvalues are 
shown using three different markers (◇, □, Δ ). 
 
Figure 3.2-10. Eigen values of the shear tensor with increasing radial position in the PSC-5 centrifuge 
for a rotation speed of 13500rpm, using an axisymmetric model assumption. The three eigenvalues are 
shown using three different markers (◇, □, Δ ). 
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3.2.1.2. The nature of the flow – Angle of the Eigenvectors 
Further complicating the interpretation of the results is that normal and extensional 
shear stresses may have substantially different impacts (as described in sections 
1.1.4 and 2.1.1.2). Understanding the nature of the shear, particularly in the regions 
where the shear rate is at its maximum magnitude, may therefore supplement our 
understanding of how these two systems compare.  In addition to maximum shear 
rate, therefore, the angle between the maximum Eigen value vector and the flow field 
vector was also plotted for the rotating disc shear device (Figure 3.2-11 to Figure 
3.2-14) and the continuous centrifuge (Figure 3.2-15 and Figure 3.2-16).  This angle 
gives an indication of the nature of the shear, where an angle of 0° is associated with 
extensional shear and an angle of 45° indicates normal shear.  The angle in the 
rotating shear device is plotted for the same flow paths, running in parallel to the 
rotating disc, as used in the preceding section for the eigen values and illustrated in 
Figure 3.2-4. 
The results (Figure 3.2-11 to Figure 3.2-14) show that in the same region where the 
shear rate in the rotating disc shear device reaches its maximum, i.e. at the disc tip, 
at a radial distance of 0.02m, the angle drops to 0°, representing an extensional flow.  
This can be seen far more strongly as we move down (or up) into the chamber and 
away from the surface of the rotating disc (i.e. onto flowpath b as illustrated in Figure 
3.2-4B), where the absolute shear rates are substantially reduced, but also 
potentially where more particles may pass through.   Elsewhere, at radial distances 
less than 0.02m, in proximity to the rotating disc the shear is normal / simple shear, 
with an angle of 45°.  These different shear types are illustrated in inset in Figure 
3.2-4. 
The centrifuge when modelled as axi-symmetric shows a similar pattern (Figure 
3.2-15 and Figure 3.2-16), in that the angle drop towards 0°, representing an 
extensional flow, towards the region of highest shear rate, at a radial distance of 
approximately 0.054m, as seen in figure Figure 3.2-9 and Figure 3.2-10.  Elsewhere, 
at radial distances less than 0.054m, simple shear predominates. 
Thus in both the rotational shear device and centrifuge, at the region of maximum 
shear rate (a radial distance of 0.02 and 0.054m respectively) the shear is 
extensional, whilst elsewhere the shear is more likely to be simple / normal shear.   
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It might be inferred from the above that the shear in the rotating disc shear device is 
not only of a similar order of magnitude to that the continuous centrifuge, with a 
similarly narrow spatial concentration, but it is also of a similar nature.  However, 
these conclusions are expected to be strongly dependent on the fact that the 
continuous centrifuge has been treated as axi-symmetric.  To test the impact of this 
modelling simplification, this approach has been extended to make use of the 3-D 
rotating machinery function available in the COMSOL Multiphysics® package.  
 
Figure 3.2-11. Angle between the direction of the maximum Eigen value vector and the flow field vector 
along a path running parallel to the lower surface of the disc, at a distance of 15μm (i.e. the approximate 
diameter of a mammalian cell) below in the rotating disc shear device with increasing radial position for a 
disc speed of 6000rpm.  The position of the tip is 0.02m. 
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Figure 3.2-12. Angle between the direction of the maximum Eigen vector and the flow field vector 
following the lower surface of the disc in the rotating disc shear device with increasing radial position, 
for a disc speed of 6000rpm.  
 
Figure 3.2-13. Angle between the direction of the maximum Eigen value vector and the flow field vector 
along a path running parallel to the lower surface of the disc, at a distance of 15μm (i.e. the approximate 
diameter of a mammalian cell) below in the rotating disc shear device with increasing radial position for a 
disc speed of 12000rpm.  The position of the tip is 0.02m. 
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Figure 3.2-14. Angle between the direction of the maximum Eigen vector and the flow field vector 
following the lower surface of the disc in the rotating disc shear device with increasing radial position, 
for a disc speed of 12000rpm.  
 
Figure 3.2-15. Angle between the direction of the maximum Eigen value vector and the flow field vector 
with increasing radial position in the PSC-5 centrifuge for a rotation speed of 8100rpm, using an 
axisymmetric model assumption.  Lines indicate the upper and lower bound values across the width of 
the inlet branch. 
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Figure 3.2-16. Angle between the direction of the maximum Eigen value vector and the flow field vector 
with increasing radial position in the PSC-5 centrifuge for a rotation speed of 13500rpm, using an 
axisymmetric model assumption.  Lines indicate the upper and lower bound values across the width of 
the inlet branch. 
3.2.2. Modelling the 3D-Rotating Machinery 
3.2.2.1. Maximum Shear Rate 
The continuous PSC-5 disc stack centrifuge was modelled in 3 dimensions, 
accounting for the division of the inlet into discrete sections or branches in the inlet 
distributor, using the rotating machinery function in COMSOL Multiphysics®.  
Comparing Figure 3.2-17 and Figure 3.2-9 the shear levels in the 3D model are 
highly comparable to those from the 2D axi-symmetric model.  The data points 
shown in both Figure 3.2-17 and Figure 3.2-9 are as per the mesh point outputs, i.e. 
areas of denser meshing will contribute disproportionately to the points shown.   
Intuitively, the time that particles spend in a given shear zone can be expected to be 
related to the size of that shear zone, and thus the probability of the particle being 
damaged by that given level of shear likewise.  For this reason the analysis was 
extended further, as shown in Figure 3.2-18, to account for the proportion of the 
liquid within the system that is subjected to a given level of shear.  It can be 
observed in both figures that the maximum shear rate in the rotating disc shear 
device is substantially higher than in the continuous centrifuge.  However, as a 
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proportion of the volume the PSC-5 centrifuge shows a greater volume in which the 
shear rate is high as compared to the rotating disc shear device.  It may be further 
argued that the exposure time will also be a function of the particle speed and flow 
path.  This latter issue is explored in more detail in section 3.2.2.2 below. 
Finally it may also be observed from Figure 3.2-18 that the level of shear in the 
ultracentrifuge is very much comparable to that seen in the PSC-5 centrifuge, 
suggesting that these two centrifuge types may cause a similar level of shear 
damage. 
With respect to the angle the comparison to the axisymmetric model is less clear cut 
(compare Figure 3.2-19 and Figure 3.2-15).  A mixture of extensional and normal 
shear can be seen along the length of the feed zone; however, there is no 
substantial move towards extensional shear toward the highest shear point, with a 
maximum shear rate in the sub 10 degrees angle range of the order 1x104/s.  This 
difference in the nature of the shear, in terms of normal versus extensional flow is 
accounted for in the population balance analysis described in section 3.2.2.2. 
It should also be noted that there will be differences in the way the axi-symmetric 
and rotating machinery physics approximate to shear.  It was intended to run 
additional simulations of the rotating disc shear device to confirm the significance of 
this, but there was insufficient time to debug and converge the model. 
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Figure 3.2-17. Shear rate in the PSC-5 as modelled using the 3-D rotating machinery method with 
increasing radial distance for a centrifuge rotatory speed of 8.1krpm.   
 
Figure 3.2-18. Cumulative % of volume for which the shear rate is below the value plotted on the x-
axis. For the rotating disc shear device at a disc speed of 6krpm (A) and 12krpm (B), for the PSC-5 
centrifuge modelled using the rotating machinery function for a rotating speed of 8.1krpm (C) and 
13.5krpm (D) and for the PKII centrifuge for a rotating speed of 35krpm (E).  Vertical lines are shown 
marking the 95%ile and maximum shear for the centrifuges. 
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Figure 3.2-19. Angle between the direction of the maximum Eigen value vector and the flow field vector 
(A) and shear rate for angles below 10 degrees (B), with increasing radial position in the PSC-5 centrifuge 
for a rotation speed of 8100rpm, using the rotating machinery function.  Lines indicate the upper, average 
and lower bound values across the width of the inlet branch.   
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3.2.2.2. Population Balance 
As described in section 2.1.1.4 a simplified population balance analysis has been 
conducted with the aim of accounting for the shear level, time of exposure to a given 
shear rate level and nature of the shear.  This simplified population balance involved 
applying an energy dissipation rate dependent breakage rate formula to particles 
traveling along set paths through the rotating disc shear device and industrial 
centrifuge feedzone. 
In doing so it is necessary to consider the particle behaviour within the rotating disc 
shear device and continuous centrifuge.  It is expect that this particle movement will 
be very different in these two systems.  Specifically, as illustrated in Figure 3.2-20, 
the disc sets up a pumping action in the neighbouring fluid, thus the particles in the 
rotating disc shear device can be expected to pass through, or close to, the highest 
shear zone a number of times.  Figure 3.2-21 further illustrates this, along with the 
narrowing and acceleration of the highest shear zone of liquid in proximity to the disc 
with increasing disc speed.  It may also be noted that further from the disc tip there 
appear to be more stagnant zones, with particles which are less likely to enter into 
high shear zones during the running period.  The particles in the PSC-5 centrifuge by 
contrast might reasonably be expected to travel parallel to the feed zone distributor 
branches’ walls, at a speed approximately equal to that of the suspending liquid, and 
be evenly distributed across the channel.  This assumption makes the exposure time 
of the particles to shear rates a strong function of the flow rate and the volumes over 
which different shear rates apply irrespective of precise position within the inlet zone. 
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Figure 3.2-20. Particle paths assumed in the rotating disc shear device and PSC-5 centrifuge.  The 
paths in the rotating disc shear device are based on output from the particle tracing model.  The PSC-5 
flow paths are parallel to the walls of the centrifuge inlet branches and for computational  efficiency were 
modelled in two sections: the core and, in finer detail / greater concentration of particles, around the 
outer rim where the changes in shear are steeper. 
 
Figure 3.2-21. Average number of passes through the zone in proximity to the disc tip for a particle 
over a 20 second period in the rotating disc shear device with increasing disc speed (◆), and, on the 
right hand axis, the approximate width of the high speed boundary layer at the disc surface with 
increasing disc speed (■).  
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Figure 3.2-22 shows the predicted particles breakage for the PSC-5 centrifuge for 
rotating speeds of 8100rpm and 13500rpm at flow rates of 100, 200 and 350lph, i.e. 
over the range of centrifuge operation.  The predictions produced by this 
methodology fall within the expected range, particularly towards the upper end.  The 
slightly lower than expected predicted rotating shear device speed may be due to the 
need for further optimisation of the breakage kernel parameters (see supplementary 
material in Appendix C) or uncertainties in geometries measured, the impact of 
which is explored further in section 3.2.2.3. It could also be a result of the 
assumptions around flow path, particle distribution and particle speed, which may for 
example be slower in proximity to the centrifuge distributor walls where the shear 
rate is highest. 
 
Figure 3.2-22. Predicted particle breakage for a selected set of particle breakage parameters (run 4), 
along the curve for the rotating disc shear device, indicating the equivalent disc speed for the given PSC-
5 operating conditions. The operating conditions cover the full range of flows and rotational speeds.  
PSC-5 for three flowrates and two speeds (⃝) and rotating disc shear device at 5 different speeds (■) 
3.2.2.3. Model Sensitivity analysis using ANOVA 
Sensitivities were conducted with two key aims.  Firstly due to the difference in the 
geometry of the PSC-5 centrifuge used by GSK, and the PSC-1 centrifuge available 
at UCL for runs with the shear mimic; differences which are described in section 
2.1.1.7.  Secondly due to the uncertainties inherent in manual measurements.  In 
addition, it is hoped that this analysis will provide some insight into the importance of 
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the various parameters when making predictions respecting the relative impact of 
shear that different centrifuge models are likely to suffer.   
Design Expert 10 (Stat-Ease, Inc., Minneapolis) was used to analyse the impact 
outputs, as measured by rotating disc speed required to replicate particle breakage. 
The ANOVA gave a significant model as follows: 
 [Eq. 13] 
Where the terms of greatest significance (all above 99%ile) are the rotational speed 
(RPM), the flow (Flow), the diameter of the distributor channels (Dbranch), and its 
angle from horizontal (Angle), followed by the outer radius of the inlet distributor 
(Router).  Where the variables have been normalised to the ranges 57.7 to 67.7mm for 
outer radius, 8100 to 13500rpm for rotational speed, 100 to 350lph for inlet flow, -30 
to +30degrees for angle, 6.36 to 8.36mm for channel diameter and 10.35 to 
14.35mm for inner radius, such that the minimum values are coded as -1 and the 
maximum values are coded as +1. And where the equivalent rotating disc shear 
device speed for the PSC-5 operating at 13500rpm and 350lph was 5000rpm. 
A reasonable match to the data is also achieved with a simpler formula, which will be 
used in later analysis: 
[Eq. 14] 
There is room for greater exploration of the impact of various parameters, in 
particular flow rate.  The impact on the Computational Fluid Dynamics (CFD) output 
was not substantial within the range considered. However, the impact on particle 
breakage predictions is substantial; a fact inherent in the assumption which ties 
exposure time based on particle speed to flow rate. 
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3.3. Experimental corroboration of CFD analysis  
The above, with its complexity, flexibility of interpretation, and the impact of 
modelling/analytical choices, demonstrates the difficulty of relying on Computational 
Fluid Dynamics (CFD) analysis alone and the need of experimental validation. 
In addition to the validation described below in sections 3.3.1 and 3.3.2, a novel 
shear mimic material was used to validate the CFD predictions, as described in 
Chapter 4. 
3.3.1. Testing using mammalian cell material 
The PSC-5 disc stack centrifuge was used to centrifuge two different types of 
mammalian cell, one CHO and one of HEK cells (see section 2.2.1.2).  The same 
cell batches were also sheared in the rotating disc shear device and centrifuged in a 
lab scale centrifuge using standard Ultra Scale-Down (USD) methodology, to give 
clarification versus Q/ relationships at different shear levels (see section 2.2.1.1 
and 2.2.1.3).  These results are shown in Figure 3.3-1. 
As shown in previous work, the level of clarification decreases with increasing shear 
as more cells are broken up into finer debris, taking a longer centrifugation time or 
higher centrifugation speed to achieve equivalent clarification.  The results also 
indicate a dependence of the clarification on specific culture conditions (shake flask 
versus stirred bioreactor) and/or cell type (CHO versus HEK).  This upstream 
process dependence means that simply knowing the shear level in the industrial 
centrifuge, whilst essential, is insufficient for parameterisation of the process. The 
USD experimental procedure will still have value both in allowing this shear rate to 
be interpreted in terms of clarification, host cell protein release, and in determining 
the sensitivity of these parameters to the operating conditions.  The process 
parameters of clarification and host cell protein release are selected as they are 
likely to impact substantially on the performance of subsequent downstream 
processing units, and are thus key to understanding the wider implications of the 
centrifuge operating conditions. 
It should be noted that the CHO and HEK cells used were provided by a research 
facility at GSK and were originally produced for upstream process development 
studies.  Production of large quantities of mammalian cells, particularly where 
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consistent properties are required, is not trivial.  It can also be observed that despite 
nearly identical operating conditions in the centrifuge the apparent level of shear for 
these two cell types does not appear to be identical.  This may be due to the 
assumption of a fixed value to account for non-idealities in the centrifuge, as 
discussed in section 1.1.3.1.  The appropriate value can be expected to vary in 
reality with particle concentration, size, type and media properties such as viscosity. 
In Figure 3.3-1 the large black circles, representing the clarification of the PSC-5 at 
the Q/Σ associated with these operating conditions (8500rpm, 200lph), sits more or 
less on the line representing laboratory scale clarification following shearing in the 
rotating shear device at 6000rpm (triangles).  More precisely, by extrapolation from 
the clarification at various shear levels, the corresponding shear device speed was 
6.1 and 4.6krpm for CHO and HEK cells respectively, whilst based on measurement 
of protein (Figure 3.3-2) the corresponding speed was 5.5krpm.  This result appears 
to validate the assumption that the PSC-5 centrifuge is a low shear centrifuge model, 
whilst also demonstrating the variability which comes from working with biological 
process material.  It may be noted from Figure 3.3-1 and Figure 3.3-2 that, with the 
exception of two outliers, the measured points match well to the lines fitted through 
them according to the standard methodology.  The difference in corresponding shear 
device speed noted above is unlikely therefore to be due to experimental variability.  
Further repeats, however, would be required to confirm that these two processes / 
cell-lines will consistency give the same result. 
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Figure 3.3-1.   Clarification of mammalian cells with varying flow rate to settling area ratio (V/t) for CHO 
cells (A) and HEK cells (B).   Samples were subject to different levels of shear in the rotating shear device 
and then processed using a laboratory centrifuge. Shear rates of 6krpm (△), 8krpm (✕ ), 10krpm ( ) and 
12krpm (◇ ) were used.  The large filled circle (●) is the steady state industrial scale clarification in the 
PSC-5 centrifuge.  The red point with hatched fill is an outlier. 
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Figure 3.3-2.   Supernatant protein concentration following clarification over varying flow rates to settling 
area ratio (V/t) for CHO cells.  At laboratory scale the samples were subjected to two different levels of 
shear in the rotating shear device: 6krpm (△), 12krpm (◇).  The large filled circle (●) is the protein 
concentration in the supernatant at steady state from the industrial scale PSC-5 centrifuge.  The red point 
with hatched fill is an outlier for which a repeated was requested.  Measurement provided by Emilie 
Boulanger at GSK, Rixensart.  
3.3.2. Review against Data Available in Literature 
Using Eqn. 14 (section 3.2.2.3), the formula from the sensitivity analysis, predictions 
can be derived for the centrifuges previously characterised in the literature.  For 
example comparing to results presented by Boychyn et al. (2004) and assuming the 
branch diameter is matched to the PSC-5: 
- The multi-chamber bowl would be expected to require a rotating disc speed of 
5,900rpm to accurately model process unit.  Using a rotating shear device 
speed of 6000rpm results in an over-prediction of the clarification by just 3%. 
- The disc stack would be expected to require a rotating disc speed of 6030 to 
6350 rpm for the highest and lowest flow rates respectively.  At a disc speed 
of 6000rpm the clarification is under predicted by 3% and 12.5% respectively.  
It may be observed that the most under-predicted laboratory scale clarification 
are at the condition for which a higher rotating disc speed requirement is 
predicted by the CFD methodology – which would only make the accuracy 
worse.  This may imply that at different flow rates, with different resultant 
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residence times, other factors than feed zone shear come into play.  For 
example, it may be that the pump shear represents a significant proportion of 
the shear damage experienced by the cells. 
- The production multi-chamber bowl would be expected to require a rotating 
disc speed of 3300rpm to accurately model the process unit.  Using the 
standard 6000rpm results in an under prediction of the clarification by 16%; an 
inaccuracy which a lower disc speed might improve. 
Further work to confirm the accuracy of and refine this prediction method is clearly 
required. 
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3.4. CFD Analysis – PKII Density gradient Ultracentrifuge 
3.4.1. Computation Fluid Dynamics (CFD) Prediction  
For the PKII ultracentrifuge a similar methodology was followed to that described 
above for the PSC-5, in that a 3D model was built from manual measurements, the 
rotating machinery function used and a simplified population balance approach used 
to predict the equivalent USD conditions required to mimic the shear levels seen. 
Figure 3.4-1 shows the final results of this analysis, with a rotating disc shear device 
disc speed of approximately 8.5krpm over a 1 minute period required.  The higher 
value predicted here makes sense in terms of the higher rotating speed, lower feed 
rate, and smaller inlet channel diameter, resulting in a greater proportion of the feed 
being exposed to the higher wall shear rates. 
 
Figure 3.4-1. Predicted particle breakage for a selected set of particle breakage parameters in the 
rotating disc shear device, for a range of run times: 5seconds (■), 20seconds (◆) and 1 minute (▲).  
Particle diameters assumed uniform at 100nm.  Red circles (⃝) are the predictions for the PKII centrifuge. 
3.4.2. Validation using shear mimic  
The development and use of the virus shear mimic is described in chapter 5.   
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3.5. Summary 
In this chapter the development of the Computation Fluid Dynamics (CFD) 
methodology is described.  Comsol multiphysics® was used, beginning with an axi-
symmetric modelling approach, directly comparable to work previously published by 
Boychyn et al. (2001), and the rotating disc shear device maximum shear levels 
compared with the literature values.  Both maximum shear stress and the narrow 
location of this high shear rate at the rotating shear device disc tip were consistent 
with the published literature. 
The modelling approach was further extended to incorporate the 3-Dimensional 
nature of the continuous centrifuge system, by modelling using the rotating 
machinery function.  In addition, by use of a simplified population balance model, the 
effect of the time of exposure to different shear levels and the nature of the shear (in 
terms of extensional versus normal) were also incorporated in to the final predictions 
of equivalent rotating shear device speed. 
The PSC-5 centrifuge modelling results were consistent with published literature in 
that the highest shear rates were seen at the distributor feed zone tip.  The 
equivalent rotating shear device speed was of the order 6krpm across the operating 
range of the centrifuge, as would be expected for an hermetically sealed, low shear 
centrifuge.  These results were confirmed by measurement of clarification and 
protein release using the ultra-scale down laboratory mimic and at industrial scale.  
The PKII showed similar levels of predicted shear rate. 
To further test the combined CFD and particle breakage modelling technique a cell 
shear mimic has been developed, which is described in chapter 4.  This mimic was 
used to confirm equivalent shear levels across a range of operating conditions in the 
PSC-1 centrifuge, which belongs to the same Pathfinder series as the PSC-5.  
Possible errors in the manual centrifuge measurements and the geometric 
differences between the PSC-5 and PSC-1 were accounted for by a sensitivity 
analysis.  The resulting formula can also potentially be used to predict scale down 
conditions over a range of centrifuge types and operating conditions as 
demonstrated by a comparison to experimental results previously presented in the 
literature. 
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In the following chapters (4 and 5) the development of cell and virus shear mimics is 
described.  These were used to validate the CFD and population balance modelling 
approach described in this chapter.  This understanding of the shear levels of 
interest was then applied to the interpretation of USD measurements on viral vaccine 
/ vector producing processes (Chapter 6). 
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4. Development of a Shear Mimic for 
Mammalian Cells 
4.1. The Objective 
The objective of this phase of work was to identify a material which could be used as 
a shear mimic for cells.  Shear has been shown, on a number of occasions, to be a 
key parameter in determining the impact of an industrial process unit on the process 
stream and cell based products (see Section 1.1.3).  In addition in a number of 
industrial process units, such as centrifuges, shear rate is difficult or impossible to 
measure directly.  Previously therefore, in developing ultra scale-down laboratory 
mimics tools and protocols for these industrial process units, computational fluid 
dynamics (CFD) has been used to equate the maximum energy dissipation rates in 
large scale and small scale systems; and the equivalence of response in biological 
materials used as validation.  There are a number of disadvantages to this approach, 
including the heterogeneous nature of the biological material, effecting in particular 
the predictability of settling in industrial centrifuges, and the complexity and cost 
associated with continuous cell line culture.  
The cell shear mimic therefore was intended for use in supplanting or supplementing 
biological material in the validation of CFD modelling.  Additionally, as new unit 
operations are developed, the shear mimic could also be used to characterise new 
equipment prior to usage to define shear intensive operating parameters without the 
need of generating cell material or CFD models.  
4.2. Development Methodology of the Cell Shear Mimic 
4.2.1. Setting criteria 
4.2.1.1. General 
In developing the cell shear mimic the first step was development of a set of criteria 
to describe what that cell shear mimic might look like and what it was intended to 
achieve.  The below summarised the original set of objectives.  Although the final 
shear mimic produced did not fulfil all criteria identified, the process of developing 
the shear mimic and associated assays allowed these criteria to be stress tested, 
and compromises reached. 
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The criteria originally developed for this shear mimic were: 
- To be a synthetic cell mimic, because biological products themselves are 
poorly characterised and highly variable, take considerable effort to produce, 
must be handled with due concern for biosafety issues and it may not be 
desirable to risk contamination of industrial process equipment with biological 
material.  
- To be approximately the same size range as the biological product of interest.  
If Kolmogorov’s theory is taken as physically representative – which fits with 
the rule of thumb identified for cells, that damage occurs to cells when the 
Kolmogorov’s micro-scale and cell size are similar (section 1.1.4.1) – then the 
degree of damage to any material at any given energy dissipation level should 
be linked to the size of that material. 
- To be approximately the same density as the biological product of interest.  
The qualities of the cell or biological particle which would be expected to 
impact on its separation and therefore flow path within a centrifuge include its 
hydraulic diameter and density (Boychyn et al., 2004).  As such the size and 
density ranges of these materials are of particular relevance.  If too dense the 
mimic would leave a centrifuge system, for example, only in the solids, if too 
light all the mimic material would not pass through the same areas of the 
centrifuge as the biological materials (e.g. cells) might potentially pass 
through and therefore may not be subject to the same forces.  However, the 
significance of this may depend on where and when the most significant shear 
rate is seen:  for example in the disk stack centrifuge the highest energy 
dissipation rate is predicted in the feed zone, where even material which was 
too light or dense might be expected to be fairly evenly distributed. 
- To be an off the shelf, commercially available product. This will limit the 
development time, potential for unexpected variability, and additional 
variables introduced by a bespoke manufacturing process. 
From which a number of potential acceptance criteria were developed, including: 
- A faithful and tune-able mimic of the biological product.  That is a material 
whose response to shear is in some way equivalent to that of the biological 
product of interest; e.g. if aiming to imitate a cell the size distribution of the 
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mimic particles would be impacted by shear, with a decreased 
volume/number at upper sizes and potentially creation of some fine debris. 
- A probe which has some measurable response to shear, even if it is not 
analogous to the biological product being imitated. Hence the mimic can be 
used for the purpose of validating the equivalence of the maximum energy 
dissipation rate between the large and small scale. 
- A probe or probes whose response can indicate the nature of the stress type 
(normal, perpendicular or elongational). 
- A probe for which some quantifiable physical characteristic(s) is impacted by 
shear and for which some quantifiable relationship can be found between 
degree of physical change(s) and level of shear. 
4.2.1.2. Response of cells to shear 
CHO cells were grown, as described in section 2.2.5.1, and used to obtain illustrative 
results of the response of mammalian cells to shear in the rotating shear device. 
Results for cell sample particle size distribution following shear are broadly in-line 
with previous results published in this area (e.g. Tait et al. (2009)), namely, as shear 
increases from low (6krpm, 26.8kW/kg) to high (12krpm, 417kW/kg), the amount of 
debris formed increases (Figure 4.2-1).  The rotational speeds quoted here are the 
speeds of the rotational shear device, where 6krpm has been shown to correspond 
to the level of damage in the feed zone of a low shear centrifuge and 12krpm to that 
of a high shear centrifuge.  The importance of this particles size distribution (PSD) is 
in the formation of fine debris and particulates, which do not settle so well, and are 
liable to carry through to subsequent process units.  Readers interested in how this 
cell particle size distribution varies with cell viability/age are referred to work previous 
published by Tait et al. (2009) who gives the most complete analysis in this respect.  
There is scope for further work on the impact of growth condition and additives on 
the breakdown of mammalian cells. 
At low shear whilst debris increases the number of cells (i.e. particles larger than 
10m) remains largely unchanged, indicating that few cells (in number terms) are 
actually destroyed at this lower rotational shear device speed. Whilst at high shear 
rates cell breakage occurs, indicated by a sharp spike at 2-3um.   It can be seen how 
substantially the relative quantity of debris to intact cells changes as the shear rate 
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increases.  This ratio of debris to whole cells appeared in this case to increase in an 
approximately linear manner (results not shown), however, there is no evidence that 
this is universally true for all cell types under all culture conditions, nor is it expected 
that it should be. 
This shear rate range is therefore the range over which the cell shear mimic needed 
to show a response. This was considered the key selection criteria. 
 
Figure 4.2-1.  Effect of shear on the particle size distribution for a mammalian cell suspension 
by a USD rotational shear device at no shear ( ), low shear of 6krpm (- - -) and high shear of 
12krpm (······), based on particle count (% number) using a Casy Counter. The particle size 
distribution and count for the debris is shown, with the full particle size distribution in inset.    
4.2.2. Identifying potential Cell Shear Mimic Candidates 
There are a large number of materials and structures available for synthetic 
materials at the nano and micro scale.  However, as the initial aim of this study was 
to identify micro or nano-particles which are available commercially only these, or 
materials which can be manufactured from commercially available material relatively 
easily were considered. 
Materials identified which are available in the desired density and size range include: 
polystyrene, silica or PMMA plain polymeric particles, streptavidin coated polymeric 
particles (Bangs Laboratories Inc. USA), metal coated polymeric beads 
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(Microparticles GmbH, Berlin, Germany), PLGA or chitosan polymeric micro-
capsules with a dextran liquid core (Nanomi BV, Oldenzaal, Netherlands), 
Aggregates (of various compositions, such as glycerol-water and polystyrene-NaCl 
or chalk), agarose particles (Agarose Bead Technologies, Madrid, Spain), uni and 
multi-lamellar liposomes (Encapsula, Brentwood, USA) and yeast cell walls 
(Lesaffre, Marcq-en-Baroeul, France). 
Types of micro-capsules mentioned by Mercade-Prieto and Zhang (2012) include 
polyelectrolyte multilayer systems to form microcapsules, which are potentially 
interesting as they ‘self-assemble’ in layers, melamine formaldehyde, yeast cells 
(and other microbial cells), proteoglycan gel, collagen fibrils, chromatographic 
particles (such as agarose), excipient powders, embolic agents etc.   Caruso (2001), 
Ariga et al. (2012) and Chaudhuri and Paria (2012) give a number of potential 
materials which can be used in constructing micro-capsules and Goldberg et al. 
(2007) lists material used for polymeric micelles.    
The first possible mimic identified for the cell was a polymeric micro-capsule, made 
from PLGA, chitosan, or both.  Their key advantages are that their density, size and 
shell thickness can be controlled and that they are commercially available, although 
this appears to be chiefly through companies which offer research and development 
and custom products.  There are a large number of possible customisations which 
can be applied including use of fluorescent materials in the shell or encapsulated 
material to ease the measurement of rupture.  Goldberg et al. (2007) state that 
particles smaller than 100nm can be encapsulated, which may also be a useful 
feature of this technology.   It is also possible to give them densities and diameters of 
the right order of magnitude.  According to the supplier (Nanomi B.V.) they can 
produce micro-capsules with a density of approximately 0.9 g/ml, a diameter of 10m 
and a shell thickness of 0.5m with fluorescent material incorporated into the shell 
for ease of visualisation. 
However, there are a number of issues in their construction in the size range of 
interest.  Blaiszik (2012) stated that there are more issues forming capsules between 
5 and 10m in size and with a tight size distribution.  Clumping is more of an issue at 
these small sizes.  To generate the micro-capsules would require both mechanical 
mixing and homogenisation and a considerable amount of time and to gain an even 
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shell thickness might require another method altogether such as co-axial jetting.  It 
can be noted that Lu et al. (1992) used a cell mimic system for which the size 
distribution was between approximately 20 and 300m, lending credence to the 
difficulties of working below 20 m suggested by Blaiszik (2012).  Furthermore 
although Mercade-Prieto et al. (2011) were able to separate their microcapsules into 
the ranges 8-20m, less than 8m and greater than 20m, by using nucleo-pore 
track etched membranes from Whatman, the equipment for making the 
microparticles included a fusion turbine, heater, homogenizer and the time required 
was approximately 9 hours, excluding the filtration steps. 
Possibly as a result of these technical difficulties the cost is considerable, with a 
quote, for example of €3000 (Euro) for 1 gram.  The information currently available in 
the literature and from manufacturers does not appear to include the micro-capsules 
response to shear, neither is the sensitivity of this parameter to and likely variability 
in the shell thickness known.  It cannot therefore be said for sure whether the micro-
capsules would respond to shear at the right order of magnitude for this application. 
Ariga et al. (2012) state that the layer-by-layer method can be used to construct a 
hollow microcapsule by using a chemically or thermally destructible central core.  If 
this core is porous this can also be used to introduce dye to the microcapsule core 
(e.g. CaCO3).  Chaudhuri and Paria (2012) further describe how the layer-by-layer 
method can be used to produce micro-capsules with multiple core shapes, multiple 
small cores and moveable cores within a hollow shell material.  Moveable cores are 
formed by coating the core in two types of layers the inner of which can be destroyed 
either chemically or thermally.   
Liposomes are available from a company called Encapsula Nano Sciences in a 
multi-lamellar form, with an onion-like structure.  These multi-lamellar liposomes are 
of a range of diameters from 60nm up to approximately 4m, so a fraction of these 
are in the right size range.  The density of these micro-capsules remains to be 
confirmed and is likely to vary depending on the size and number of layers of 
capsule inside, but for the moment is assumed likely to be approximately the same 
density as water.  The shell chemistry and strength can be altered by the 
incorporation of a number of chemicals including fluorescent molecules, which can 
be either encapsulated or added to the bi-layer, and it is also possible to attach anti-
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bodies to the surface. According to Goldberg et al. (2007) lipid stability is affected by 
temperature and osmolarity amongst other environmental factors and lipid polymer 
conjugate nanocapsules are more stable than lipid only.  
Emptied yeast cell walls can also be used as capsule material, but were excluded in 
this case due to the risk of introducing biological material to the process. 
Agarose micro-particles are available from ABT Beads with a reasonably narrow size 
range around 10m, with a maximum size of less than 20m and a minimum size of 
approximately 0.6m.  Again both the density and response to shear were unknown.  
Aluminium hydroxide and aluminium phosphate are available from Brenntag, with a 
minimum size of 0.3 m and 0.7 m respectively and a maximum size of 7 m and 6 
m respectively.  Response to shear rate had not been quantified. 
On discussion with a commercial vaccine manufacturer it was decided that the 
project would focus on chromatographic beads, as materials which are already 
safely used within the context of the biopharmaceutical industry.  A range of particles 
available at UCL were selected (see section 2.2.2), and assayed for their 
susceptibility to shear as described in section 2.2.1.1.  None of these showed any 
response to shear, as illustrated in Figure 4.2-2.  Further treatments gave the 
following results: acid treatment either completely destroyed or dissolved the beads, 
or did not result in any changes which made the beads more susceptible to shear. 
Homogenisation gave a substantial change in particle size distribution, implying that 
(i) the analytical methods selected should be capable of detecting any changes due 
to shear if they had occurred, (ii) the material itself is susceptible to breakage such 
as can be measured, but not under the shear conditions assayed.  Further work with 
this material range was therefore discontinued.  
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Figure 4.2-2.   Particle size distributions (PSDs) of a range of chromatographic material. 
Unsheared material (unbroken line) was compared to sheared material (dashed line) in a 
rotating shear device at a speed equivalent to a high shear centrifuge (12krpm, 417kW/kg). 
Results include PSDs for all chromatographic materials (A), PSDs for P6XL (B), PSDs for 
Sepharose Fast Flow (C), PSDs for Iber Agar (D), PSDs for 10um Agarose beads (E),  and PSDs 
for Sepharose CL4B (F). 
Work by Kolade et al. (2015) showed an effect of shear on an aluminium phosphate 
adjuvant, which suggested that it would show a measurable impact from shear in the 
range of interest.  Adju-Phos and Al-Hydrogel are used as adjuvants in injectable 
vaccination, and were therefore considered acceptable candidates in terms of 
biosafety profile, i.e. minimal risk from contamination.  Initial examination of the 
samples indicated that the particle size was approximately the same as mammalian 
cells, but that the sample appeared to settle marginally quicker than mammalian 
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cells, implying a greater density.  Al-Hydrogel showed no measureable response to 
shear, however Adju-Phos showed promising results, as described below. 
Figure 4.2-3 compares side-by-side the particle size distributions of cells and Adju-
Phos at no shear, low shear and high shear.  The Particle Size Distributions (PSDs) 
for Adju-Phos and this representative mammalian cell follow a similar pattern in their 
response to shear in that the size distribution includes two peaks (located at 4 and 
15μm diameters in Figure 4.2-3 A and 15 and 20μm diameters in Figure 4.2-3B), the 
relative size of which change with increasing shear.  For rotating shear device 
speeds between 6krpm and 12krpm both cells and Adju-Phos show a decrease in 
the ratio of large particles to small particles with increasing shear, approximately 
linear for Adju-Phos. Whilst there is a similarity in the shapes of the PSDs, in that two 
peaks are present, there are also substantial differences.  From the figure it may be 
observed that cells break down into very small constituent debris in response to 
shear, implying perhaps that cells are destroyed completely by shear, whilst Adju-
Phos is ‘chipped’. In addition it is clear, particularly at higher shears, that cells are 
more sensitive to shear. However, it is not necessary or expected that the shear 
mimic should give an identical response to shear, Adju-Phos and cells being very 
different materials.  Equally the degree of the response being less than possible 
inter-culture or inter cell-line variability should not be of concern.  The intention of the 
shear mimic is as a tool for measurement of shear in the same range as that which 
affects cells, not as a substitute for experimentation on mammalian cells, but with the 
aim of characterising the industrial system sufficiently to allow experiments on 
process material to be conducted at small scale, and/or at conditions representing a 
range of industrial process operating conditions.  What is key in this result is that 
both cells and Adju-Phos respond to shear in the same range. Mastersizer 
measurements (Figure 4.2-4, Figure 4.2-5) corroborated these results: showing a 
shift in particle size distribution towards the left and a decrease in the particle size 
measured.   
Before examining results further some discussion of different particle size distribution 
presentations is useful.  The Casy Counter works by measuring the size of individual 
particles and counting the number which fall in to each size range.  In the ‘frequency 
(% Number)’ distribution (e.g. Figure 4.2-3) the percentage of particles by number in 
each size bracket is plotted.  The Mastersizer by contrast measures the degree of 
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scatter generated by particles passing through a laser beam, which is a direct 
function of the volume occupied by the particle.  The Mastersizer therefore records 
the percentage of the total volume occupied by particles in each size bracket, 
referred to as ‘frequency (%volume)’ (Figure 4.2-6 B).  The Mastersizer software, 
however, has the capacity to estimate to the number based distribution (e.g. Figure 
4.2-4) using a number of assumptions.  These particle size distributions can further 
be represented by a number of parameters, including (i) percentiles, giving the 
diameter below which a given percentage of the particles can be found, and (ii) the 
peak or median diameter at which the largest number of particles can be found, 
either of which may be derived from a particle size distribution on a number or 
volume basis. 
The ease of measuring Adju-Phos on the Mastersizer and the greater reproducibility 
and flexibility of results analysis when compared to Casy Counter measurements, 
meant that this methodology was the preferred approach for later work on the shear 
mimic development.  Figure 4.2-5 shows the peak diameter derived from the volume 
based particle size distribution.  Error bars on this data indicate that the rotational 
shear device speed could be estimated using this mimic to within approximately 
1000rpm.  The breakage of Adju-Phos in response to shear is measurable and 
consistent, and falls within the same range as that for mammalian cells.   
Preliminary experiments were conducted to explore the impact of Adju-Phos 
concentration (5%, 10% and 15%), shear period (at 10, 20 and 30 seconds) and 
shear rate (at 0krpm, 6krpm and 12krpm).  The 90%ile (number basis) was a weak 
function of concentration and shear period (see supplementary data in Appendix D), 
but a strong function of the shear rate, whilst the peak (volume basis) was a strong 
function of shear rate only (see supplementary data in Appendix D).   Previous work 
has shown that for shear periods greater than 5 seconds, cell response remains 
unchanged, indicating maximum damage has already been achieved for a given 
shear rate (Hutchinson et al., 2006).  The Adju-phos cell mimic is therefore broadly 
in-line with this result. 
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Figure 4.2-3.  Effect of shear on the particle size distribution for a mammalian cell suspension (A) and 
Adju-Phos (B) by a USD rotational shear device at no shear ( ), low shear of 6krpm (- - -) and high 
shear of 12krpm (······), based on particle count (% number) using a Casy Counter. The particle size 
distribution and count for the debris is shown, with the full particle size distribution in inset.   N.b. the 
diameter values and units for Adju-Phos will not be correct, as the Casy counter is calibrated for cell 
types, but not for this material. 
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Figure 4.2-4. Effect of shear on the particle size distribution for 1%v/v Adju-Phos suspension by a 
USD rotational shear device at no shear ( ), low shear at 6krpm (- - -) and high shear at 12krpm (······) 
measured using the Mastersizer 2000. 
 
Figure 4.2-5.  Effect of shear on a 1%v/v Adju-Phos suspension using the USD rotational shear device at 
varying shear rates, based on Mastersizer 2000 data.   Error bars represent 95% confidence intervals 
using student t-test (n=4).  Open diamonds (◇) represent Adju-phos runs on the rotating disc shear 
device, filled triangles (▲) are Adju-phos runs on the pilot scale disc stack centrifuge (CSA-1) with solids 
manually removed from the solids collection chamber within the centrifuge bowl.  Filled square (■) is an 
Adju-phos run on a pilot scale tubular bowl centrifuge (CARR) with solids removed manually. 
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4.2.3. Evaluation of Adju-Phos in a low shear disc stack centrifuge (CSA-
1 and PSC-1) 
Adju-Phos had been shown to respond to shear in the same range as cells, and was 
of approximately the same size.  However, the density of Adju-Phos is somewhat 
greater than that of cells, approximately 1.01-1.25 and 1.05–1.14 kg/m3 respectively, 
and debris formed by Adju-Phos may not be as small.  It was therefore necessary to 
validate robustly the use of Adju-Phos in centrifuge systems, and to develop a 
methodology to account for the extraction of accumulated cell mimic material from 
the solids collection areas of the centrifuge, and confirm whether this compaction 
adversely affected the measurability of impact from the feedzone shear.  
Example particle size distributions are shown in Figure 4.2-6, as measured on the 
Mastersizer.  Figure 4.2-6 shows that following exposure to the conditions in the 
CSA-1 the size distribution has shifted to the left; showing a measurable impact from 
the exposure to the process conditions. The difference between the bowl and 
discharge particle size distributions demonstrates the degree of additional damage 
caused by the solids discharge processing step in this pilot scale disc stack 
centrifuge. 
The aim of running the shear mimic through the pilot scale CSA-1, which has 
previously been extensively characterised in work by UCL (Lau et al., 2013), was to 
confirm whether the shear mimic would return an accurate ‘prediction’ of the rotating 
shear device speed required to replicate this centrifuge.   Figure 4.2-5 therefore 
shows where the samples from the CSA-1 sit on the curves measured at USD.  As 
with previous work (Boychyn et al., 2004) it is assumed here that the main cause of 
damage to particles entering the disc stack centrifuge is shearing in the feed zone. 
For a contrast it is worth observing the consistency of the two measurements made 
with Adju-Phos in the CSA-1 centrifuge (Figure 4.2-5), to that made using 
mammalian cells (Figure 3.3-1), although of course these are two different cells 
types, grown in different culture conditions.    
Initially the count ratio measured on the Casy counter and the equivalent (number 
based) Mastersizer 90%ile parameter were used (see supplementary data in 
Appendix D).  This gave a higher than expected prediction of shear; 8.3 to 9.5krpm 
instead of the expected 6krpm.  It was speculated that this high prediction of shear 
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was due to the CSA-1 being run directly following a discharge, with air in the feed 
zone, potentially increasing the shear to which the material was exposed 
(Hutchinson et al., 2006).  The run was therefore repeated with the feed to the CSA-
1 switched directly from PBS to Adju-Phos suspended in PBS, ensuring that the feed 
zone was flooded from the beginning.  The result from this run was not, however, 
substantially different from that obtained previously. This implies that the CSA-1 
quickly becomes fully primed again following a discharge, and that another 
explanation was required for the disparity between expected and observed prediction 
of shear. 
It was observed that the particle size distribution following shearing in the rotating 
shear device was much narrower than that measured following processing through 
the feed zone of the CSA-1 (compare Figure 4.2-4 and Figure 4.2-6).  It is 
speculated that this may be due to differences in the exact mechanism of damage, 
or the relative importance of different mechanisms of damage, in the rotating disc 
shear device and in the pilot scale centrifuge.  It may also be associated with re-
aggregation of the sample between shearing and sample measurement, or 
phenomena in the solids collection chamber, such as particle-particle collisions.  
However, when the parameter against which the Adju-Phos damage measured was 
changed to the peak of the volume based particle size distribution curve (Figure 
4.2-5) the estimated rotating shear device speed was approximately 6krpm (6.1 and 
6.3krpm), which corresponds well to the expected value.  The discrepancy between 
the conclusions drawn based on the number or volume based distributions may be 
due to the measurement method employed.  The Mastersizer instrument measures 
more accurately the size of larger particles.  As discussed below this is particularly 
true for the older instrument used in this earlier work, which did not detect fine debris 
which was evident on the particle size distribution as measured on the newer 
instrument.  It is likely therefore that any differences in the particle size distribution, 
as discussed above, will show disproportionately in the number based distribution, 
whilst being less evident in the volume based distribution. 
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Figure 4.2-6.  PSD by %number (A) and %volume (B) for a 1%v/v Adju-Phos suspension processed by a 
pilot scale disc stack centrifugation (CSA-1), including the feed ( ) and solids discharge (- - -), and a 
bowl sample (······), which was collected manually without a solids discharge. Samples were measured 
using a Mastersizer 2000.  
B 
A 
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4.2.4. Following manual solids discharge 
The PSC-1 centrifuge, which the shear mimic was intended to characterise for the 
first time, presents the additional complication of automatically discharging when in 
use, or when the machine is stopped.  As a result the quantity of solids available for 
evaluation is significantly reduced, and could not therefore be measured using the 
Mastersizer 2000 as previously. 
Measurements for the runs on the PSC-1 were therefore conducted using the 
Mastersizer 3000 and the small volume dispersion unit.  The resulting PSD can be 
seen in Figure 4.2-7.  There is a clear difference in the appearance of the PSD in 
Figure 4.2-7 when compared to Figure 4.2-6.  It may be anticipated that the newer 
model, and indeed newer Mastersizer instrument, would detect finer debris which the 
Mastersizer 2000 did not. There was also concern, however, that the nature of this 
solid might be fundamentally different, and no longer representative of the solids 
which had accumulated in the bowl prior to discharge.  To mitigate these concerns 
the calibration curve was recreated by shearing Adju-Phos in the rotating shear 
device and measuring on the Mastersizer 3000; and the CSA-1 run was repeated, 
but with the solids manually discharged prior to stopping the centrifuge, in order to 
recreate the conditions which would be seen in the PSC-1 run.   
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Figure 4.2-7.  (A). PSD of a 1%v/v Adju-Phos suspension processed by CSA-1 centrifugation from the 
centrifuge bowl ( ). Solids discharge (- - -) and bowl samples (······) of 1% Adju-Phos suspension 
processed by PSC-1 centrifugation. (B). PSDs from the rotating shear device at low shear, 6krpm ( ) and 
high shear, 12krpm (- - -) . Samples measured using Mastersizer 3000.   
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It was found for the CSA-1, using the Malvern 3000, that the volume based PSD 
peak no longer gave a prediction that fell within the expected range.  However, 
switching to a number based PSD peak gave a good prediction using the low shear 
correlation of the USD shear device, shown in Figure 4.2-8.  Although it cannot be 
said for sure that the fine debris may not present a correlation, either in size or 
relative quantity, to the degree of shear, the fine debris, shown in Figure 4.2-7 in the 
size range 0.5-1.2μm, were discounted, for a number of reasons.  Firstly the larger 
particles are more directly comparable to those previous measured on the 
Mastersizer 2000, and should be detectable by a range of equipment types capable 
of detecting whole Adju-Phos particles.  Secondly the Mastersizer is weighted 
towards accurate measurement of larger particles, and therefore the size distribution 
of the debris is likely to be far more sensitive to any changes in quantities of whole 
Adju-Phos particles, and/or aggregates resulting, in the case of the centrifuge, from 
the compaction following shear or the presence of contaminant particles.  Finally, 
within the context of a centrifuge where the solids are discharged just before the 
machine stops, a significant amount of fine debris may be washed away by the rush 
of liquid leaving the bowl.  This is likely to explain the substantial difference in 
amount of debris seen in the CSA-1 and PSC-1 (Figure 4.2-7 (A)).   
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Figure 4.2-8.  PSD of a 1%v/v Adju-Phos suspension processed by a USD rotational disc shear device 
over a range of shear rates.  The number based peak diameter (μm) is generated using a single main 
peak identified from Figure 4.2-6 using the Mastersizer 3000 SV.  Open diamonds (◇ ) represent  Adju-
phos sheared in the rotating shear device. Filed triangle (▲) is solids from the bowl from runs on the 
CSA-1 centrifuge where a solids discharge has been performed just before stopping. The open circle ( ) 
is a run at maximum rotational speed and minimum flow, and the cross (✕ ) a run at minimum rotational 
speed and maximum flow on the PSC-1, with solids removed manually.  Error bars represent 95% 
confidence intervals using student t-test (n=3). 
4.2.5. Evaluation of Adju-Phos in a high shear tubular bowl centrifuge 
(CARR) 
Adju-Phos was also centrifuged in the CARR tubular bowl centrifuge.  This was done 
in order to confirm the utility of the above described method of correlating shear at 
pilot scale against shear in the rotating shear device at USD scale, by using the peak 
of the volume based particle size distribution curve as measured on the Mastersizer 
2000.  As with the CSA-1 disc stack, the CARR bowl centrifuge has been 
substantially characterised and is expected to require a high rotating shear device 
speed of 12krpm to imitate the effects of the centrifuge feed zone (Lau et al., 2013, 
Boychyn et al., 2004). 
Figure 4.2-5 shows where the samples from the CARR sit on the curves measured 
at USD.  The predicted equivalent rotating shear device speed of approximately 
12.5krpm corresponds very well with previously characterisation of this centrifuge. 
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4.2.6. Covering the operating range 
The PSC-1 centrifuge is hermetically sealed, and is therefore expected to be a low 
shear centrifuge (Hutchinson et al., 2006).  Beyond this no detailed characterisation 
of this centrifuge has previously been published.    
Figure 4.2-8 also shows the results from two runs on the PSC-1 designed to indicate 
the range of shears over the operating range of this centrifuge, which showed an 
equivalent rotating shear device speed of between 4.5krpm and 6.5krpm as the 
machine moves from minimum speed and maximum flow rate to maximum rotating 
speed and minimum flowrate.  In fact, using the volume based peak diameter for the 
PSC-1 runs gave the same equivalent rotational shear device speed as using the 
number based peak (see supplementary data in Appendix D).  This result is 
consistent with previous studies, which have noted an impact of centrifuge speed on 
shear rate for other centrifuge models (Westoby et al., 2011, Zaman et al., 2009).  
The shear mimic appears therefore to be sensitive enough to detect relatively small 
variations in shear across the operating range of a hermetically sealed continuous 
disc stack centrifuge. 
Results from the PSC-5 Computational Fluid Dynamics (CFD) model (Chapter 3), 
adjusted using the sensitivity analysis, gives a minimum of 4300rpm and maximum 
of 5500rpm for the same range of conditions.  As expected this confirms the 
expectation that the PSC is a low shear centrifuge, that the CFD predictions are the 
right order of magnitude, and shows a good match across the range for the CFD 
model.  The poorer match at the higher centrifuge speed may be due to the 
increasing importance of other shear/impact factors, or may imply a need for greater 
refinement in the CFD and / or breakage model. 
The implication which may be drawn is that care is needed in selecting appropriate 
parameters to correlate shear using the shear mimic.  But that even in a complicated 
process unit such as the continuous centrifuge good predictions of shear levels may 
be achieved.   Although not able to imitate the full complexity of the biological 
process stream the cell shear mimic may produce useful initial information on the 
conditions in a process unit operation, is substantially cheaper than biological 
material to produce and working with it does not require the same level of forward 
planning, time, safety precautions or cleaning.   
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4.3. General Discussion 
By combining Adju-Phos measurements and the Ultra Scale-Down (USD) protocol, it 
may be possible to predict the clarification for any given set of operating conditions, 
based on rotating speed and flow; or potentially for visualisation of windows of 
operation (Salte et al., 2006).   
For example, for the two extremes of operation measured on the PSC-1 centrifuge 
(Figure 4.2.7), using the rotating shear device at the Adju-Phos derived predicted 
speed followed by clarification in a laboratory scale centrifuge, yields clarification 
predictions between 98.8 and 98.9% for the uninfected CHO cells, and 94.4 and 
99.2% for the uninfected HEK cells (for which the measurements were presented in 
section 3.3.1).  These results are derived based on the standard method of scaling 
for settling conditions between laboratory and industrial scale centrifuges (see 
section 1.1.3.1). Similar information can be derived for the virus production 
processes presented in chapter 6.  These values may be derived using either 
Computational Fluid Dynamics (CFD) or Adju-Phos based measurements, but the 
costs in terms of time for the trials with Adju-Phos should be substantially less than 
those associated with CFD modelling; so that, long term, replacing CFD 
characterisation of equipment may be an attractive option presented by this 
technology. 
Some work of this nature has previously been done in upstream processing (Lu et 
al., 1992), (Poncelet and Neufeld, 1989), (Henzler, 2000).   However, the different 
conditions in downstream processing, in particular the higher shears over a shorter 
period, makes identifying a suitable mimic more challenging.  There is also arguably 
a longer potential time frame between passing the mimic through the unit operation 
and measuring the resultant particle size distribution (Henzler, 2000).   The proposed 
mammalian cell shear mimic, though slightly smaller, has a similar size to that of the 
mammalian cell, is of a similar density and responds to shear in the same range.  
However, the viscosity following breakdown is unlikely to be the same as that of a 
cell based process fluid, and it is possible that the relative susceptibility of the 
particle to hydrodynamic shear and the related interfacial phenomena (wall 
collisions/ air-liquid interfaces) may differ from that of actual cells; these factors may 
be significant in some cases.  In addition the mimic does not micronize in the same 
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way as the mammalian cell, which forms submicron particles when sheared; it is not 
therefore suggested that the mimic can be used to replace mammalian cells 
experimentally, or that the solids or supernatant from the centrifuge be used further 
in interaction studies with USD models or subsequent processing steps.  Until the 
model particle has been more fully characterised and its response to shear is more 
fully understood it is proposed to use it to verify CFD predictions of shear across 
single unit operations. 
Given that one of the chief justifications for use of this material is reduced cost it is 
worth drawing a comparison between the costs involved in the large scale 
experiments with this material and the alternatives of using a range of process 
materials or CFD simulation.  The cost of a 250ml bottle of Adju-Phos was 85Euros 
as of April 2014.  A single large scale experiment requires approximately 60ml, to 
which may be added the cost of approximately 6 litres of PBS, which can be 
purchased at 10x concentration for 45.9GBP for 1 litre.  More substantial are the 
costs associated with a day’s use of an expert user or centrifuge manufacturer’s 
engineer, in order that the centrifuge may be operated, dismantled and re-assembled 
safely, for which the cost is an estimated 1500GBP.   Clearly a single cell culture will 
be substantially more expensive, with media alone for example likely to cost of the 
order 5000GBP for a pilot scale run, and with a greater risk of failure, substantial 
time and expertise required, and a longer lead time. 
For adjuphos the centrifuge needs to be taken apart in order to extract the sheared 
and settled beads.  For some centrifuges, such as the CARR Powerfuge, bowl 
centrifuge this is simple, and part of the standard operating procedure.  For disc 
stack centrifuges such as the PSC-1 or PSC-5 this is more complicated, and would 
require a day of time from an expert user or GE engineer to be completed safely.  
This will also decrease the flexibility of using adjuphos, i.e. there will be a certain 
lead time associated with confirming availability of an engineer or expert user to 
coincide with equipment availability. 
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4.4. Summary 
The aim was to develop or find a material which could be used in place of biological 
material, which would be cheap to produce, safe to use, not introduce a problematic 
contaminant, and provide greater consistency than the biological equivalent.  This 
material, dubbed a ‘shear mimic’ could then be used to validate the Computational 
Fluid Dynamics (CFD) predictions, or provide a better prediction of shear in the 
centrifuge under a given set of operating conditions. 
A shear mimic, Adju-Phos, was identified which has a number of similarities to 
mammalian cells: 
i. It is sensitive to shear in the same range. 
ii. It has a particle size distribution with two peaks.    
iii. In response to shear the number of larger particles decreases and the number 
of smaller particles increases. Large particles clustered around a certain size 
range break down in to smaller particles also predominately of a certain size 
range.    
However Adju-Phos is far from perfect, in that it differs from mammalian cells as 
follows: 
i. It exhibits overlapping peaks, with a smaller difference between the particle 
size at the large and small particle peaks.   
ii. The predominant size is smaller than the typical mammalian cell. 
iii. Its density is slightly greater than that of mammalian cells. 
The fact that Adju-Phos responds to shear in the same range as mammalian cells, 
however, was considered of predominant importance.  
As the shear mimic is a novel concept use of the shear mimic for this application 
needed to be validated first.  This was done by running the shear mimic through low 
and high shear centrifuge models which have already been well validated (see 
sections 4.2.3 to 4.2.5).   Thus having demonstrated that the shear mimic provides a 
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good prediction of shear levels in the centrifuge, the same procedure was followed in 
the PSC-1 centrifuge (section 4.2.6).   
The predicted shear levels derived for the PSC-1 match well those that the CFD 
predicts, presented in the previous chapter, and serve to validate the modelling 
methodology used and predictions made for the PSC-5 centrifuge. 
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5. Development of a Shear Mimic for 
virus particles 
Contradicting views exist on the likely impact of shear on viral products, such as 
vaccines or gene therapy vectors. On the one hand, they are small relative to cells, 
and thus unlikely to be caught in velocity gradients from shear vortices. However, 
they are relatively large (compared to, for example, therapeutic proteins), 
enormously complicated biopharmaceutical products, whose exact mechanism of 
action, and thus critical quality attributes, are rarely understood. Moreover, they are 
evolved to disassemble or lose elements of their structure to deliver genetic material.  
In this chapter a technique is presented for measuring the impact of shear on 
particulates of a similar scale to viruses, which demonstrates that an impact from 
shear can indeed be seen.  The streptavidin coated nanobeads used here are 
available off-the-shelf, and are considerably easier and cheaper to measure and 
quantify than viral particles.  The virus shear mimic has been successfully used to 
predict levels of shear in the continuous feed pilot scale density gradient centrifuge, 
a common and powerful technique in viral purification.  This chapter can be read with 
reference to results in Chapter 6, where corresponding results are presented for the 
impact of shear on two virus types: influenza for viral vaccines and adenovirus for 
gene therapy. 
5.1. Objectives 
The objective of this phase of work was to identify a material which could be used as 
a virus shear mimic.  A single candidate, a streptavidin coated 100nm bead, has 
been investigated. 
As with the shear mimic for mammalian cells one of the key arguments for its use is 
the reduced costs associated.  Streptavidin coated nanobeads cost 894 Ultra Scale-
Down (USD) for a 10ml container in October 2014.  A single USD run requires 
approximately 250μl and a single large scale run requires approximately 6ml.  The 
beads were suspended in PBS, which can be purchased at a cost of 45.9GBP for 1L 
at 10x concentration.  This would be more than sufficient for a USD and a large scale 
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run. For a virus production, culture media costs alone, for a total of approximately 
60L of media, would be approximately 4740 USD, based on purchasing 3 x 20L bags 
of liquid media HyCloneTM CDM4Avian Media, which is produced by GE healthcare 
specifically for viral production using EB66 cells (excl. tax and shipping).  For 
experiments with the virus shear mimic preparation is extremely simple, involving as 
it does simply suspension and dispersion of the beads in the appropriate volume of 
PBS, as described in section 2.2.3.1.  This compares to the complexity, long lead 
time, and facility requirements to meet biosafety concerns, associated with viral 
vaccine production.   
The impact of shear on viral products, such as attenuated viral vaccines and gene 
therapies, and the processes producing them has not previously been explored.  For 
this reason the impact of shear on virus infected cells is explored further in sections 
6.2.4 to 6.2.6, and the impact on virus in section 6.3.  Measuring the impact of shear 
on a viral particle is particularly challenging (section 5.2.1.2), whilst both the 
measurement and production of viral material is costly, time consuming and requires 
specialist skills.  For this reason it was deemed desirable to develop a virus shear 
mimic. The results and process for this development are discussed in the following 
chapter, along with the application of the technology to verification of shear level in a 
PKII ultracentrifuge, where the challenges are similar to those already discussed for 
pilot scale centrifugation (section 4.1). 
5.2. Development methodology of the virus shear mimic  
5.2.1. Setting criteria 
5.2.1.1. General  
As with the cell shear mimic (section 4.1) virus production involves a long, 
complicated and failure prone process. Additional biosafety requirements can make 
experimentation and process characterisation of virus infected material very difficult.  
In addition the measurement of the impact of shear on a virus particle is particularly 
challenging.  Thus the objective of producing a virus shear mimic is as with the cell 
shear mimic, but with additional emphasis being placed on the ease with which the 
impact of shear might be measured. 
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5.2.1.2. Measuring the response of virus to shear 
Viruses are incredibly complicated biopharmaceutical products, the assays for which 
show a wide range of variance and limited sensitivity.  Standard approaches to 
measuring the quality of a viral product might include cell based infectivity assays, 
particle size measurement, intrinsic fluorescence, morphological assays such as 
transmission electron microscopy (TEM), gels, blots and proteomics all of which 
attempt to be surrogates to predict interaction with the end user. (Jawetz et al., 2013) 
Results from the work on the impact of shear on virus particles is presented in 
section 6.3 and relies on infectivity assays, TEM and particle size distributions.  
Assays were selected based on cost, time and availability.   
The virus shear mimic presented in this chapter successfully uses simple and 
quantifiable assay techniques. 
5.2.2. Identification of potential virus mimic candidates 
Fewer candidates were identified for the virus shear mimic than for the cell shear 
mimic, with fewer off the shelf materials available within the size and density range of 
interest.  A number of methods of production are listed by Goldberg et al. (2007) for 
construction of nano-particles including sonication and vortexing. 
As a first stage in the development of the shear mimic the criteria were set that the 
material should have the properties of being of a similar size to typical viruses and 
similar density. The mimic should have a measurable response to shear within the 
range of shears likely to be encountered in downstream processing units, and up to 
the shears, which show an impact on the virus product themselves.  However, as 
discussed above, measuring the impact of shear on viruses is itself extremely 
challenging. The material was therefore subjected to disruption in a rotating shear 
device at varying speeds, over the range previously shown to match shears in a low 
and high shear continuous centrifuge: i.e. at speeds of between 6 and 12krpm.  As it 
was anticipated that a particle as small as these nanobeads (~100nm) is unlikely to 
be impacted by shear in this range, a higher shear of 18krpm was also used.   The 
rule of thumb (section 1.1.4) commonly applied in bioprocessing is that a particle 
(cell, virus, biomolecule) will not be impacted by shear if it is smaller than the 
Kolmogorov’s microscale of turbulence. Computational Fluid Dynamics (CFD) 
simulations put this at approximately 1μm even for the highest shear device speed 
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used in these experiments (18krpm).    However, Vo and Papavassiliou (2016) show 
an impact on adsorbed molecules around nanoparticles at much lower shear rates, 
giving rise to the possibility of rearrangement and detachment of molecules 
associated with structures as small as a nanobead or virus. 
5.2.3. Analytics development: Measuring the response of the shear 
mimic  
Initial work with the virus shear mimic candidate was done with material which had 
been diluted in PBS and sheared. On which assays were then conducted to try to 
identify any impact from the shear (section 5.2.3.1).  As the aim was to use the virus 
shear mimic in density gradient ultracentrifugation to verify the level of shear in this 
industrial process, an additional step of laboratory scale density gradient 
fractionation was applied (section 5.2.3.2) after the initial work had been conducted 
showing an indication of the material responding to shear.   
5.2.3.1. Without ultracentrifugation 
The virus shear mimic candidate consists of a 100nm polystyrene bead, with a 
coating of streptavidin molecules.  The initial hypothesis was that the impact of shear 
might be visible in damage to this streptavidin layer, in a manner analogous to 
damage to virus proteins on a capsid or membrane layer.  What can be seen in 
Figure 5.2-1, however, is that the nanobeads were never mono-dispersed, but 
clumped, mostly in groups of 2 or 3, giving a peak nanobead size of approximately 
200nm.  This particle size distribution was not significantly effected by sonication or 
use of Tween-20.  However, by exposing the sample to high shear rates, the 
nanobead clumps began to break up and gave rise to a changing particle size 
distribution. This changing particle size distribution could be characterised by a 
number of simple parameters, expressing a general trend for decreased aggregate 
size, and increased count, as some nanobead aggregates break down.  The change 
in size is particularly noticeable in the upper size ranges of the particle size 
distribution and in the 95%ile diameter (Figure 5.2-2).  The 5%ile diameter changes 
very little if at all, perhaps due to the limitation at the lower size range dictated by the 
size of a single nanobead.  Comparing the decrease in the 50%ile diameter to that in 
the 95%ile diameter shows that the latter begins to fall at a lower shear rate, with a 
greater overall decrease.  This is consistent with shear having a greater impact on 
larger molecules and with larger aggregates being weaker on average. 
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Figure 5.2-1.  PSDs for nanobeads subjected to disruption by a rotating shear device at varying shear 
rates.  No shear (solid line), low shear at 6krpm (long dashes), medium shear at 12krpm (dots) and high 
shear at 18krpm (dot-dash) are measured using Nanosight. 
 
Figure 5.2-2.  PSD parameters for sheared nanobeads.  The 50%ile (A), 5%ile (B) and 95%ile (C) 
diameters, and total count (D) of nanobeads subjected to disruption by a rotating disc shear device at 
varying shear rates.  Each symbol represents repeat data sets. Lines are plotted through average of the 
repeats shown.  Error bars represent 95% confidence interval using student t-test (n=5) 
To test the original hypothesis that the streptavidin layer would be damaged by shear 
a biotinylated fluorescein was used in a dilution assay. Binding to undamaged 
streptavidin quenches the fluorescence observed.  As shown in Figure 5.2-3 A, there 
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is perhaps a slight increase in fluorescence assay corrected count at the highest 
shear compared to the previous shear levels, representing a very slightly lower 
dilution at which the fluorescence begins to increase.  The minimum fluorescence 
reached, and which it might be expected would show an increase in fluorescence, 
indicating a poorer bond between biotin and streptavidin, if the streptavidin were 
damaged, shows no consistent increase for the highest shear level (results not 
shown).   
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Figure 5.2-3. Fluorescence assay results of sheared nanobeads. Nanobeads have been subjected to 
disruption by a rotating shear device at varying shear rates. Samples were then serially diluted in a 96-
well plate and a fixed volume of fluorescein added to each well.  The curve of increasing fluorescence 
with decreasing nanobead concentration was fitted to a 4 parameter logistic fit curve, and the 
concentration, is plotted in figures A and B.  Where (A) represents counts using unsheared nanobeads 
as the 100% value, and (B) where the Nanosight count for each shear level is used to set the 100% 
nanobead concentration in the fluorescence assay.  The line is plotted through the average of duplicate 
measurements.  Error bars represent standard deviation of the sample (n=2). 
A further assay was therefore conducted to confirm whether the streptavidin was 
affected by shear. Sheared nanobeads were incubated with anti-biotinylated gold 
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tags, which will bind to streptavidin, and the number of tags per nanobead recorded 
using TEM.  The results (Figure 5.2-4) showed a wide variability and, an apparent 
difference between unsheared and sheared nanobeads which is not significant due 
to the large error on the sheared nanobead measurements. There is no indication of 
a difference between shear levels.  It might be hypothesised that any difference 
between sheared and unsheared nanobeads is due to the removal of adsorbed 
particles (Vo and Papavassiliou, 2016), which, when present, might hinder the 
binding of large particles such as the gold-tags, but not the biotinylated fluorescein. 
 
Figure 5.2-4.  Transmission electron microscope (TEM) measurements for sheared nanobeads.  
Nanobeads have been subjected to disruption by a rotating shear device at varying shear rates, then 
incubated with anti-biotin gold-tags, before imaging on TEM.  Some sample TEM images are shown (A), 
along with a bar chart (B) of the average number of gold tags per nanobead. Error bars represent 95% 
confidence intervals using student t-test, where the number of individual nanobeads identified ranged 
from 550 to 1288. 
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Taken together the above assays indicate that there is probably no substantial 
damage to the streptavidin layer in this virus shear mimic, and that measurement of 
the particle size distribution may give a stronger tool for tracking shear levels.  The 
particle size distribution, however, does not always give a very clean, repeatable 
measurement.  In addition, as will be discussed later, a good measure of particle 
size distribution is not always possible.  An alternative measure was therefore 
developed by combining the two assays (Figure 5.2-3B) (for calculation see 
supplementary data in Appendix E).  This should also show any damage to the 
streptavidin layer as an increase in the ‘count’ parameter potentially extending the 
range of the shear mimic, although this remains to be demonstrated.  This parameter 
showed an impact of shear on the nanobeads at shear device speeds greater than 
6krpm, therefore within the range likely to be experienced in industrial equipment. 
The result, although surprising given the small size of the nanobeads, raises the 
possibility of shear having an impact on smaller particles, such as viruses. This will 
be examined in more detail in section 6.3. 
5.2.3.2. Assessment of the nanobeads in density gradient centrifugation 
One of the most effective methods of concentrating and purifying viruses, which 
allows them to be separated from particles of a similar size or mass is density 
gradient centrifugation (Reimer et al. (1967), Duffy et al. (2005)).  Although generally 
considered a low impact technique the industrial scale continuous feed version has 
the potential to introduce shear, particularly in the feed zone (Figure 3.4-1), in a 
manner analogous to that demonstrated with continuous centrifugation for cell 
harvest (Boychyn et al., 2001).  The PKII was selected therefore as a large scale 
application for this shear measurement technique.  First, the effect on the nanobeads 
during concentration in a density gradient needed to be assessed, which was done 
at laboratory scale, in batch density gradient centrifugation. 
The measurement of particle size distribution following density gradient fractionation 
became considerable poorer, with variability in average density and nanobead 
concentration in the density gradient layers probably responsible.  There is still a 
general trend for increasing nanobead count with shear, although this will be 
dependent on which fraction is measured, and the degree to which the nanobeads 
have concentrated within the gradient, or been disrupted during harvesting of the 
fractions.  It may be possible to infer from the general trends in Figure 5.2-5 that 
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diameter at a given concentration is still lower for nanobeads that have been 
subjected to a higher level of shear, but this can only be seen on a number of 
repeated measurements over a range of concentrations.  Measurement of the 
particle size distribution on the nanosight is no longer therefore a reliable assay for 
the impact of shear on the nanobeads. 
 
Figure 5.2-5.  PSDs for nanobeads which have been subjected to disruption by a rotating shear device at 
varying shear rates prior to fractionation in a laboratory density gradient centrifuge. Geometric average 
of 5%ile, 50%ile and 95%ile diameters, with rotating shear device speeds of 6krpm (△), 12krpm ( ◇ ) and 
18krpm ( ✳ ), plotted against concentration of nanobeads.  The particle size distribution was measured 
and averaged over the three highest concentration fractions (selected based on minimum fluorescence). 
The method adopted therefore was that described in Figure 5.2-3B, of combining 
particle count and fluorescence assay, giving a clear trend with shear for the density 
gradient purified sample (Figure 5.2-6).  Indeed the level of change seen with shear 
is greater following purification in the density gradient than before (compare Figure 
5.2-3B and Figure 5.2-6), showing a difference between unsheared and low shear 
levels.  This is likely to be due to removal of loose streptavidin, and therefore a 
cleaner reading of the nanobead associated streptavidin concentration.   
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Figure 5.2-6.  Fluorescence assay results for sheared nanobeads which have been subjected to 
disruption by a rotating shear device at varying shear rates prior to fractionation in a laboratory density 
gradient centrifuge. The nanosight-fluorescence assay derived concentration for duplicate runs ( □, ∆ ) is 
plotted against the shear device speed to which the sample was subjected.  Error bars represent 
standard deviation of the duplicate sample.  The two large red circles ( ) are duplicate runs for 
nanobeads separated using the PKII continuous feed ultracentrifuge. 
5.2.4. Understanding the impact of density gradient and shear level on 
nanobead particles 
Sensitivities were conducted on shear level and duration, and on the density gradient 
used to fractionate the nanobeads.  Although increasing shear time showed a small 
increase in particle count, the more substantial impact was seen from changes in the 
density gradient (Figure 5.2-7).  Count changes with steeper and shallower density 
gradient, particularly at higher shear levels.  The density gradient for the data points 
shown in Figure 5.2-6 are equivalent to that used in the PKII centrifuge (detailed in 
section 5.2.5), where the measurement of density was based on a curve fitted to 
multiple points along the density gradient. It is further suggested that, although the 
density of the layer itself appears to show a clearer correlation against count, both 
the density and the integral of the density up to that point be taken, as co-correlates 
to improve precision.  Although this adds complexity to the use of this shear mimic 
for the prediction of shear at large scale, it does present an interesting finding in 
terms of the combined effect of pre-shearing and fractionation in a density gradient 
on nanoscale particulates. 
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It seems unlikely that this is due to shear from the density gradient itself, or anything 
similar.  Although it is conceivable that loosely held together aggregates disintegrate 
further, or that binding of biotinylated fluorescein to damaged streptavidin is inhibited 
in the presence of a more viscous solution. It may also possibly be a measurement 
artefact.   Further investigation is required to better understand this phenomenon.  
 
Figure 5.2-7. Combined nanosight and Fluorescence assay results for sheared nanobeads which 
have been subjected to disruption by a rotating shear device at varying shear rates prior to fractionation 
in a laboratory density gradient centrifuge.  The data points are for rotating shear device speeds of 0 ( ), 
6 ( ∆ ), 12 ( □ ), and 18 ( ◇ ) krpm, in different sucrose density gradients as measured by the density at the 
layers selected (A) and the integral of the density up to that layer (B).   
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5.2.5. Shear and density gradient: Applying the lessons to a real process 
Having established the technique for laboratory scale batch density gradient 
centrifugation, the pilot scale continuous feed density gradient PKII centrifuge was 
used to fractionate nanobeads.  The resulting change in count is plotted on Figure 
5.2-6 (open circles), where the density gradient is comparable to that used at 
laboratory scale.  The rotating speed and spin-down time at laboratory scale were 
chosen to match the 2t at large scale, and the density gradient modified to give 
approximately the same head at the expected position of the nanobeads, i.e. to 
account for the fact that the PKII density gradient only starts at 110mm from the 
centre of rotation, with PBS or process fluid filling the inlet feed zone and passing 
close to the central rotor to the centrifuge outlet.  It can be seen in Figure 5.2-8 that 
the nanobeads settle at the same position in both pilot and laboratory scale 
centrifuges.  The measure of fluorescence for each layer is a quick and easy way to 
identify the layer containing the nanobeads at both scales (Figure 5.2-8 A).  The 
reduced fluorescence at low density for laboratory scale, is not seen in the pilot scale 
centrifuges.  This is likely to be due to loose streptavidin, which in the continuous 
feed (pilot) centrifuge will be washed through in the flow-through.  This interpretation 
is further supported by the particle count measurement in Figure 5.2-8 B, which 
shows no detectible particulates in the low density fractions for the laboratory 
centrifuges. 
The predicted level of shear for the PKII continuous feed density gradient centrifuge 
corresponds to a rotating disc shear device speed of approximately 5krpm. This is 
the level of shear seen in a low shear industrial disc stack centrifuge such as might 
be used during the harvest stage of a cell culture process.  Although industrial 
density gradient centrifuges are generally assumed to be low shear processes, it is 
not altogether surprising that the level of shear should be comparable to that in a 
disc stack centrifuge, given the substantially higher rotational speeds mitigated by 
smaller feed diameter.  The results therefore indicate that the virus shear mimic is 
capable of giving a good prediction of shear at large scale conditions.  The 
implications of these levels of shear for viruses are explored more fully in section 6.3. 
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Figure 5.2-8.  Fractionation of the nanobeads in the laboratory density gradient centrifuge and in the PKII 
centrifuge over a sucrose gradient, (calculated in BRIX), as measured by (A) fluorescence quenching at 
lab scale and pilot scale density gradient centrifugation and (B) particle count using Nanosight.  Squares 
( □ ) are average of measurements from the laboratory density gradient centrifuge, and diamonds ( ◆ ) 
are average of measurements from the PKII continuous feed centrifuge. 
5.3. Computational Fluid Dynamics (CFD) Validation 
The predicted rotating disc shear device disc speed required to imitate the level of 
shear in the PKII based on the shear mimic is approximately 5krpm (section 5.2.5), 
which is the same order of magnitude of that from the CFD derived prediction of 
approximately 8.5krpm (Section 3.4.1). 
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5.4. Summary 
Streptavidin coated nanobeads are proposed as a shear mimic for viral products, in 
order to quantify shear levels in process units which may be relevant to the 
downstream purification of viral vaccines or vectors.   
A fluorescence assay was developed using a biotinylated fluorescein that quenches 
on binding to the streptavidin coat on the nanobeads.   However, results indicate that 
the shear does not substantially damage the streptavidin layer. Therefore the 
fluorescence assay could not be used to measure the impact of shear. 
Nanosight measurements of the nanobead particle size distribution revealed that the 
nanobeads clump, forming aggregates of multiple nanobeads.  These aggregates 
are broken down by shear, showing a decrease in particle diameter, and a 
corresponding increase in particle count. 
Sheared beads were applied to both lab and pilot scale density gradient 
centrifugation.  By combining the fluorescence assay and nanosight count 
measurement for the most concentrated layers the correlation between pre-shearing 
of the nanobeads and particle count was still in evidence. 
The methodology is further complicated, however, by the apparent dependence of 
this measurement on the density gradient conditions - the steepness of the gradient, 
head, 2t – which needed to be accounted for. 
The virus shear mimic has been used to measure the shear in the PKII density 
gradient centrifuge, more or less confirming the predictions made using CFD (section 
3.4.1). 
This shear level can be used in combination with measurements of the impact of 
shear on viral products in chapter 6, to infer the likely impact of process conditions. 
Despite the complexity of the analytical methods derived to measure the impact of 
shear for this viral shear mimic it may still be simpler and more consistent than 
measurements made on viral products themselves.  This question will also be 
explored in more depth in chapter 6. 
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6. Use of Ultra-Scale Down tool for 
Continuous Centrifugation Harvest 
of virus process materials 
6.1. Objective & Summary 
The centrifuge ultra scale-down (USD) model has previously been used successfully 
to predict the performance of various centrifuges for mammalian cell cultures 
(Hutchinson et al. (2006), Zaman et al. (2009)), protein precipitates (Boychyn et al., 
2004) and flocculants (Berrill et al., 2008), including comparison to large scale of 
clarification (Boychyn et al., 2004), solids remaining, fragment antibody recovery and 
process impurity concentrations (Lau et al., 2013), and impact on subsequent 
filtration performance (Zaman et al., 2009).  No literature has been published, 
however, on the use of the ultra scale-down mimic in predicting the performance on 
virus infected cell harvests.  Nor is the author aware of any literature on the effects of 
shear on virus infected cells or on the virus product itself.  This chapter therefore 
aims to redress this and gain insights into the performance of these important 
processes using this well characterised and already successfully demonstrated 
laboratory mimic. 
It may be assumed that the time frame is more or less equal for both large and small 
scale, on the basis that a comparable experiment would require the cells to be 
passaged an equal number of times.  Assuming 5 passages before bioreactor, this 
equates to a total lead time of approximately 4 weeks for both large and small scale.  
However, the effort and time working at a smaller scale may not be as significant, 
and a single failure at large scale is far more costly than at small scale.  Small scale 
experiments with cell culture would also be constrained by the required stage of cell 
culture, in terms of timing the experiment, but availability of equipment and operators 
should be less of a constraint (e.g. no requirement for pilot scale centrifuge and 
operator to be made available).  For viral vaccine production the complexity and 
costs are increased by biosafety concerns.  So therefore are the benefits of using 
USD technologies. 
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Studies were conducted on the impact of shear on HEK and EB66 cells before and 
after infection with adenovirus and influenza respectively.  The interest of these 
studies was in the implications for the harvest and subsequent processing of 
adenovirus and influenza for therapeutic and prophylactic viral vaccines. These are 
both areas of major importance, in which continuous cell line production of a viral 
product is involved and where scale plays a major role in cost and availability of 
sufficient product.    
The starting hypothesis was that virus infection would make cells more “fragile” and 
prone to damage by shear.  This was assessed by measuring clarification, protein 
release and cell count following shearing in the rotating disc shear device for both 
virus infected and uninfected cells.  Although it cannot be said definitively from the 
data that virus infected cells are not more sensitive to shear at some point in the 
infection process, the evidence strongly suggests that cells used to propagate 
enveloped influenza virus in cell culture may be more shear sensitive and more 
difficult to clarify in comparison to non-enveloped adenovirus.  The clarification may 
be worse for cells where the virus produces a significant amount of lysis debris, and 
unchanged, or even improved, for cells where the virus leaves the cell structure 
largely intact.  Further work is required before any definite patterns can be drawn for 
clarification and shear sensitivity for different cell types, virus types and culture 
conditions.   
With respect to the impact of shear on viral products the starting premise was that 
the viral particle’s small size would reduce the chances of its being caught in a vortex 
of small enough size for hydrodynamic shear alone to cause damage.  However, 
initial experimental work with streptavidin coated nanobeads (Chapter 5), indicated 
that even particles in the 100 nanometer size range may show a measurable change 
within a relatively low shear environment.  Indeed, although infectivity assays show 
no significant impact on the viruses from shear, there does appear to be some 
measureable changes in the virus particles with respect to the average particle size 
distribution and proteomic make-up.  The significance of these changes, if any, 
remains to be fully explored.   There is the possibility based on these results that, 
whilst the impact of shear appears subtle and the whole particle count may not be 
effected, other aspects of product quality may be influenced. 
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6.2. Impact of Virus Infection on Cells 
6.2.1. Impact of shear on HEK cells used to produce Adenovirus 
With increasing time post-infection HEK cells show no decrease in clarification, with 
clarification of sheared cells improving with later harvests (section 6.2.4.1).  This 
contrasts with the hypothesis.  It is interesting that the cell lysis by this virus does not 
appear to significantly decrease the clarification.   Cell count combined with the 
trypan blue viability assay appear to suggest that the explanation is related to cell 
death under this mechanism of virus lysis which leaves the cell structure largely 
intact (section 6.2.5.1).   
This has implications for the best approach to harvesting of adenovirus at large 
scale, because so much of the virus is inside the cell. Thus, a detergent lysis step or 
homogenisation is conducted to release the adenovirus from the cell mass.  Bench 
scale processes, which rely on low shear pelleting followed by freeze-thaw to lyse 
cells and release the virus product will not accurately reflect what happens in large 
scale processes, and therefore will give limited insight into the challenges and 
opportunities.  In particular, the addition of a higher-shear disc stack centrifugation 
step prior to lysis will clearly have implications for the product location and yield, and 
potentially for the relative importance placed on the processing of the supernatant.  
This is further complicated by the uncertainty respecting the relative quality of viral 
particles in the supernatant and in the cells which would also need to be investigated 
and taken into account (Altaras et al., 2005). 
Although these results would need to be confirmed for suspension cultures they 
potentially provide some valuable insights for the numerous large scale production 
processes being developed, particularly with respect to harvest windows and 
decisions regarding harvesting product from the supernatant, cell mass, or both. 
6.2.2. Impact of shear on EB66 cells used to produce Influenza virus 
EB66 cells infected with influenza show a distinctly different clarification to uninfected 
EB66 cells. In contrast to the above result, with HEK cells infected with adenovirus 
the clarification of influenza infected EB66 cells decreases with increasing time post 
infection (section 6.2.4.2).  
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Again, as for HEK cells and adenovirus, the cell count was measured for different 
shear levels, for both influenza virus infected and uninfected EB66 cells.  And as with 
HEK cells it was shown that after infection the cell count decreased less noticeably 
with shear than for uninfected cells (section 6.2.5.2). Application of the same 
explanation, of a greater number of dead cells, is supported by the decrease in 
viability. 
The laboratory scale and pilot scale results were compared in terms of clarification 
(section 6.2.4.3) and protein release (section 6.2.6.2), where a good comparability 
was found at the expected level of shear. 
6.2.3. Summary of cultures 
6.2.3.1. Adenovirus 
Cell culture and virus replication conditions for adenovirus in HEK cells are 
summarised in Table 2.2, and described in section 2.2.5.1. 
6.2.3.2. Influenza 
Cell culture and virus replication conditions for influenza virus in EB66 cells are 
summarised in section 2.2.5.2, and are as per the GSK pilot scale process in 
development. 
6.2.4. Clarification of virus infected cell material via centrifugation 
6.2.4.1. Adenovirus: The impact of infection period 
HEK cells grown in an adherent culture were sheared either four to six days following 
infection, two to three following infection, or without being infected with adenovirus, 
and clarification measured at lab scale.  It was anticipated that the cells might show 
increased sensitivity to shear following infection that could lead to the generation of 
fine debris which might impact on clarification (Silva et al., 2010), but as can be seen 
in Figure 6.2-1 this was not the case.  No significant decrease in clarification was 
seen in the first 3 days following infection, and following longer infection periods the 
clarification improved significantly. In fact, cells that had been infected by virus for 
longer periods of time became less shear sensitive by this measure.  
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Figure 6.2-1.  Clarification of  (A) uninfected HEK cells,  (B) infected HEK cells with adenovirus for less 
than 3 days, and  (C) infected HEK cells with adenovirus for between 4 and 6 days.  Cells have been 
subjected to disruption by a rotating shear device at varying shear rates prior to clarification in a 
laboratory centrifuge, with rotating shear device speeds of 0krpm ( □ ), 6krpm ( ∆ ), 8krpm ( x ), 10krpm ( ○) 
and 12krpm ( ◇ ) respectively.  Error bars represent 95% confidence intervals using student t-test (n=6).   
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6.2.4.2. Influenza: The impact of infection period 
Figure 6.2-2 shows that the clarification efficiency for influenza virus infected cells is 
significantly lower than that of non-virus infected cells based on a 95% confidence 
interval (n=3).  It also appears to show an increase in the impact of shear. As shear 
increases, the clarification efficiency decreases and is worsened with increased viral 
infection duration. 
It may be noted that whilst the slope of the curves in Figure 6.2-2 increase with virus 
infection, the distance between the slopes, representing different shear levels, only 
shows a clear visible increase after 5 days of infection.  This may represent a 
combined effect of the impact of virus infection on the cells and the subsequent 
increasing sensitivity of the clarification to shear. 
 
Figure 6.2-2.  Clarification of EB66 cells, (A) uninfected with influenza virus, (B,C) infected with influenza 
virus for 4 days (n.b. strains used in B and C were not identical) and (D) infected with influenza virus for 5 
days (same strain as in B).  Cells have been subjected to disruption by a rotating shear device at varying 
shear rates prior to clarification in a laboratory centrifuge, with rotating shear device speeds of 0krpm ( □ 
), 6krpm ( ∆ ), 8krpm ( x ), 10krpm ( ) and 12krpm ( ◇ ) respectively.    Measurements shown are for a 
single representative run with the exception of (A), where n=3. 
6.2.4.3. Influenza: Small versus large laboratory centrifuges 
The influenza virus was cultured at pilot scale (50litres), and clarified using a disc 
stack centrifuge (PSC-5).  Prior to these influenza based studies this disc stack 
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centrifuge was run with both HEK and CHO cells at the same flow rate and rotational 
speed as used for the clarification of the influenza harvest.  The clarification of these 
HEK and CHO cell cultures were measured both for the disc stack centrifuge and 
using the ultra scale-down mimic (consisting of rotating disc and laboratory 
centrifuge), which has been used extensively for the prediction of clarification in 
mammalian cell cultures.  This work (see section 3.3.1) confirmed that the centrifuge 
in question is a low shear centrifuge, with rotating shear device speeds of the order 
of 4.6 krpm and 6 krpm for HEK and CHO respectively giving a good prediction of 
clarification and protein release levels (Melinek et al., 2017).  As this scale-down 
mimic has not yet been validated for use with virus infected continuous cell line 
harvest it was deemed important to include validation at scale, in discussing the 
implications of the presented results.   
Figure 6.2-3 therefore includes the clarification as measured for the disc stack 
supernatant.  The equivalent rotating shear device speed required to accurately 
match the disc stack centrifuge clarification, overall protein release and relative 
concentration for a number of host cell proteins (Figure 6.2-9 and Figure 6.2-10) is 
approximately 4.5krpm.  This result is therefore consistent with expectations. 
It was noted that there was an unexpected discrepancy between the small and large 
lab scale centrifuges (compare Figure 6.2-2D and Figure 6.2-3).  Clarification from 
the larger lab scale centrifuge was consistently below that of the smaller lab scale 
centrifuge.  Given the costs and industrial setting of this work it was not possible to 
complete sufficient repeats to verify the significance of this difference.  However, it 
was noted that this effect was less visible in the non-infected EB66 cells.  It has been 
hypothesised that this difference may be due to differences in the g-forces or head 
present in these different systems, but again it was not possible to fully verify this 
hypothesis.  It may also be observed that the infected EBB66 cells give a less 
consistent measure of clarification.  This may be due to (i) differences in the way the 
debris or cells pellet, or (ii) difference in the supernatant make up, such that there is 
a tendency to form solid impurities, which manifest as a floating ‘scum-film layer’ 
following virus infection, or (iii) differences in methodology, as noted in the materials 
and methods, clarification section. 
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Figure 6.2-3.  Clarification of EB66 cells, infected with influenza virus for 5 days.  Cells have been 
subjected to disruption by a rotating shear device at varying shear rates prior to clarification in a 
Beckmann laboratory centrifuge, using 15ml falcon tubes, with rotating shear device speeds of 0krpm 
(□), 6krpm ( ∆ ), 8krpm  ( x ), 10krpm ( ) and 12krpm ( ◇ ) respectively.  Measurements shown are for two 
separate runs, each using a different viral strain of influenza.  In addition red circles ( ) give the 
clarification measured on the PSC-5 centrifuge. 
6.2.5. Cell count 
6.2.5.1. Adenovirus: The impact of infection period 
Figure 6.2-4 shows no difference in the decrease in cell count relative to initial cell 
numbers for the first 3 days following infection, and no impact of shear on cell count 
following a longer period of infection. In fact, cells became less shear sensitive as 
infection time increased. Trypan blue was used to demonstrate that this change is 
likely to be due to cell death which occurs somewhere between the 3rd and 4th day 
of infection.  
It has been shown elsewhere (Tait et al., 2009) that older or dead cells in non-virus 
infected cultures may be less shear sensitive, possibly due to the flaccid and 
weakened cell structure of the dead cell in the shear velocity gradients.  This 
hypothesis is supported by cell count and viability assays and clarification (section 
6.2.4.1) which show (i) that cell counts for sheared infected cells follow the same 
trend as for uninfected cells during the first 2 days of infection, whilst after longer 
infection periods the cell count no longer decreases with shear, and (ii) there is a 
decrease in viability of cells after 3 days of infection.  As the cells die and become 
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more flexible they have less tendency to break-down or form the micro-debris 
(Figure 6.2-5) which decreases clarification efficiency.   
For biosafety reasons, adenovirus infected cells could not be removed from the virus 
lab, and particle size distributions could not therefore be measured on a particle 
analyser such as the Mastersizer or Casy, for comparison to similar work with the 
continuous centrifuge ultra-scale down system.  A combination of Nanosight and 
haemocytometer were therefore used, to measure the impact of shear in terms of the 
break down of whole cells into debris, as illustrated in Figure 6.2-5. 
Visually the cells appear to remain largely whole and intact, with the population 
increasing substantially over the post-infection period.  The debris count, as 
measured in the size range ~60 to 600nm, does not appear to increase substantially, 
reinforcing the impression given by visual inspection.  The virus induced lysis takes 
the form of an increased permeable cell membrane, as oppose to the absolute 
destruction of the cell, under these culture conditions.  It may be that the fact that 
these are adherent cell cultures plays to the morphology of the cells and their shear 
sensitivity, i.e. if these cells were grown as a HEK suspension the result would be 
different.  This remains to be confirmed. 
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Figure 6.2-4.  Normalised cell counts for HEK cells, not infected with adenovirus ( ◆ ), infected with 
adenovirus for less than 3 days ( □ ) and infected with adenovirus for between 4 and 6 days ( x ).  Cells 
have been subjected to disruption by a rotating shear device at varying shear rates, and then counted 
using a haemocytometer.  Cell count has been normalised against unsheared cell count.  Error bars 
represent 95% confidence intervals using student t-test (n=4).   
 
 
Figure 6.2-5.  Ratio of debris to whole cells as measured by Nanosight (debris) and haemocytometer 
(cells).  The ratio has been normalised to give a value of 1 for unsheared cells.  Nanosight measurements 
were completed for the supernatant.  Measurements shown are for uninfected HEK cell, cells, infected 
with adenovirus for less than 3 days and cells infected with adenovirus for more than 3 days. 
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6.2.5.2. Influenza: The impact of infection period 
Figure 6.2-6 , shows a similar pattern to that seen in adenovirus infected HEK: the 
proportion of cells destroyed by shear in influenza infected cells decreases following 
infection, particularly for the highest shear level.   
It was noted that the following infection the proportion of remaining cells which are 
viable increased with shear, whilst for uninfected cells it decreased. This may imply 
that cells deemed to be non-viable are marginally more likely to be destroyed by 
shear, possibly including infected cells.  This could not be confirmed by infectivity 
assays, as with adenovirus, because influenza virus released by shear would not be 
enveloped, and therefore not mature, viable or infective. 
The viability of sheared cells is marginally, but consistently, greater than for 
unsheared cells in the virus infected cells, whilst in the non-virus infected cells it is 
less.  For unsheared cells  the viability was 96+/-4.5% (95% CI, student t-test, n=3), 
to 73+/-9.2% and 77+/-10.8% (95% CI, student t-tests, n=2) for uninfected EB66 
cells, and 4 and 5 days post infection respectively.   For cells subjected to shear in 
the rotating shear device at a speed of 12krpm, for example, the viabilities of the 
uninfected EB66 cells was 92%, and cell viabilities of influenza infected cell at 4 and 
5 days post infection were 78% and 81% respectively.  As a percentage of the 
original number in the sample therefore the non-viable cell count decreased more 
than the viable cell count.   
Taken together the decrease in clarification between uninfected and virus infected 
cells (Figure 6.2-2), and the increasing shear insensibility indicated by the cell count 
(Figure 6.2-6), implies that clarification is being impacted by the debris formed by 
virus induced cell lysis during or following viral egress from the cell. The Vi-Cell 
images certainly show a noisier background after a number of days of infection 
which may be membrane components which form during virus egress from the cell. 
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Figure 6.2-6.  Cell counts for EB66 cells, not infected with influenza virus ( ∆, ▲, ▲ ), infected with 
influenza virus for 4 days ( ■, ■ ) and infected with influenza virus for 5 days ( ◊, ◆, ◆ ).  Cell have been 
subjected to disruption by a rotating shear device at varying shear rates, and then counted using a Vi-
Cell.  In (A) measurements shown are for three separate runs each using various influenza A viral strains.  
In (B) average normalised measurements are shown for pre-infection and the two post-infection time 
points  
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6.2.6. Proteins 
6.2.6.1. Adenovirus: Protein release 
Within the first 3 days following infection there is evidence that shear may cause 
release of virus from cells.  Immunoblots (see supplementary data in Appendix F) 
were conducted showing that the viral protein concentrations in the supernatant 
increase with increasing shear, as shown in Figure 6.2-7.  Although the proteins 
selected are nominally identified, it should be noted that these identifications are 
designed for illustrative purposes only.  Overall measures of protein concentration in 
the supernatant show an increase with increasing shear, with each lane on the 
Western blots run at equal protein concentration. From which it appears that viral 
proteins are released at a greater rate than host cell proteins.  This is supported by 
an increase of more than a log in infective units in the supernatant (Figure 6.3-2), 
based on a duplicate measurement using a blue forming units assay for 
quantification of virus by counting transfected cells.   
From section 6.2.4.1 and 6.2.5.1 infected cells appear no more likely to be destroyed 
by shear than uninfected cells. This implies that the virus production processes are 
efficient, with cells producing more protein as virus production factories than they do 
for normal metabolic activities.  Indeed this agrees well with evidence that 
adenovirus production is highly metabolically demanding (Silva et al., 2010), and 
with the high burst volumes shown for adenovirus in HEK (Xu et al., 2015a), and also 
with evidence that adenoviruses may induce autophagy (Balvers et al., 2011). 
It may also be noted that the evidence gathered to date does not preclude the 
possibility that the additional virus release is due to detachment of virus which was 
bound to the external cell membrane, or disaggregation of virus aggregates (Slater, 
2018), as oppose to destruction of virus infected cells.  Further work is required to 
verify the source of the additional virus in the supernatant following shear. 
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Figure 6.2-7.  Graphs show relative concentrations for selected viral proteins (identified on the 
immunoblot in Appendix F supplementary data).  Graphs on the top are of lysate concentrations, and on 
the bottom are of concentration in the supernatant.  Striped is unsheared, dotted has been subjected to 
an intermediate level of shear (12krpm in the rotating shear device) and filled has been subjected to a 
high level of shear (18krpm in the rotating shear device).  In the lysate plot results from three replicate 
runs are shown, and in the supernatant plots two replicate runs (1, 3) harvested 2 to 3 days post infection 
and one run (7) harvested approximately 5 days post infection.  The concentrations for all runs have 
been normalised against the same reference sample. 
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6.2.6.2. Influenza: Protein release 
With increasing shear more proteins are released from EB66 cells, as shown in 
Figure 6.2-8, with an immunoblot against EB66 host cell proteins shown in Figure 
6.2-9 and with a number of individual protein levels quantified in Figure 6.2-10, 
showing significant increases in the concentration of various proteins with shear. 
It would be valuable to future similar work to complete (see supplementary data, 
Appendix F) an immunoblot of the influenza virus proteins, as it is potentially 
informative with respect to demonstrating the relative shear induced release of viral 
protein from cells as compared to host cell proteins.   It may be for example that viral 
protein release would be more problematic than that of host cell proteins for 
downstream purification, in particular chromatography. 
 
Figure 6.2-8.  Total protein concentration for EB66 cells infected with influenza virus for 5 days.  Cells 
have been subjected to disruption by rotating disc shear device at varying shear rates prior to 
clarification in a Beckmann laboratory centrifuge, using 15ml falcon tubes.  Measured using modified 
Lowry method.   Two measurements shown at laboratory scale ( □, ◊ ), using influenza A strains. In 
addition the red circle ( ) gives the clarification measured on the PSC-5 centrifuge 
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Figure 6.2-9.   Sample Immunoblot, tagged with antibodies against EB66 host cell proteins.  Lanes are 
supernatant of influenza virus infected EB66 cells subjected to rotating shear device speeds of 6 and 
12krpm respectively, supernatant of EB66 cells not infected with virus subjected to a rotating shear 
device speed of 6krpm, supernatant of influenza virus infected EB66 cells subjected to rotating shear 
device speeds of 6, 12, 6, 0 and 0krpm, the supernatant from PSC-5 and the same virus run as in the 
other lanes, lysate from influenza virus infected EB66 cells subjected to rotating shear device speeds of 
0, 6 and 12krpm and a reference virus infected supernatant sample (the supernatant from the PSC-5 on 
the first virus run). Equal volume of sample was loaded in each lane.   
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Figure 6.2-10.  Graphs show relative concentrations for selected host cell proteins (identified on the 
immunoblot in Figure 6.2-9).  Graphs show average concentrations for two separate run (with different 
viral strains) and from the day before harvest for the second run.  Cells have been subjected to 
disruption by a rotating shear device at varying shear rates prior to clarification in a Beckmann 
laboratory centrifuge, using 15ml falcon tubes.  The protein concentrations for each run have been 
normalised such that the concentration for the PSC-5 centrifuge supernatant for that run is 100. In the 
bar charts striped is unsheared, dotted has been subjected to a low level of shear (6krpm in the rotating 
shear device) and filled has been subjected to a high level of shear (12krpm in the rotating shear device).  
Error bars are sample standard deviation of duplicate measurement (n.b. ‘run 1 – 1 day’ has duplicates 
for the mid shear level only).   
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6.3. Impact of Shear on Viruses 
A virus is an extremely complicated and heterogeneous biological agent, large on a 
molecular scale, with multiple component and structural levels involved in the many 
stages of its life cycle and interaction with its host.  As a result there remain many 
questions regarding that life cycle, the role of the different structural components of 
the virus, and how the virus interacts with the cell and the wider host organism.  In 
bioengineering terms, the critical quality attributes remain to be fully elucidated 
(Rathore and Winkle (2009), Vandercammen et al. (2012), Metz et al. (2009)).  For 
cost, time and resource reasons only a limited number of carefully selected assays 
could be performed.  
Cell based infectivity assays are of primary importance, demonstrating a likely 
subsistence of the basic functional features of the virus structure.  Results based on 
infectivity assays alone support the original hypothesis that virus will be too small to 
be significantly effected by shear at the levels tested, i.e. within the range likely to be 
seen in industrial equipment.    
However, previous stress experiments on viruses, focused on the impact of 
temperature and pH, showed substantial changes in other measures, before any 
change in infectivity was evident (Rexroad et al., 2003).  This may be partly due to 
the high variability or low accuracy in infectivity outputs, such as TCID50 assays.  
However, it may also reflect a certain robustness in the virus, that it retains the ability 
to transfect and infect even after undergoing a number of morphological changes.  
Evidence for such morphological changes, in measurement of particulate size and 
protein composition of isolated, post sheared virus, was therefore sought, to confirm 
the degree of impact from shear, if any. 
6.3.1. Impact of shear on adenovirus infectivity 
Figure 6.3-1 shows the TCID50 infectivity assay results for adenovirus at a range of 
shear levels.  Even at the highest shear level assayed no significant change in the 
infectivity of the virus is seen.  The largest difference between the minimum and 
maximum infective titre based on this assay, for a given run, was 0.4 log10/ml, not an 
unacceptable range for this assay type.  This result was confirmed by use of a 
plaque assay quantified using Blue Forming Units (BFU), which showed no 
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significant change in the number of cells transfected by the sheared adenovirus 
(Figure 6.3-2).  The BFU assay did, however, show an increase in the number of 
infective units in the supernatant with shear, showing infective virus being released 
from virus infected cells.  For the whole cell lysate the largest difference between the 
minimum and maximum infective titre based on the plaque assay was 0.2 log10/ml, 
again indicating a reasonable level of accuracy, and with no outliers.  The maximum 
increase in the number of infective virus in the supernatant by contrast was 1.7 
log10/ml.   The number of infective units per ml was in good agreement between the 
TCID50 and BFU assays. 
It may be noted that the results graphed in Figure 6.3-1 to Figure 6.3-4 are 
normalised, in order to improve the presentation, given the large differences in virus 
titres seen between replicate runs.  The measurements were normalised separately 
for each replicate run by dividing by the average titre across all shear levels. 
 
Figure 6.3-1.   TCID50 infectivity assay for adenovirus subjected to varying shear rates.  The virus count is 
plotted as a percentage of the average virus count across all shears for each run.   Five replicate results 
are shown (each represented by a different symbol- ◊, , ∆, □).  Error bars represent 95% confidence 
intervals using student t-test (n=5).  Samples were subjected to shear at 0 and 12krpm for 20 seconds, 
and 18krpm for 1 minute. 
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Figure 6.3-2. Infectivity assay for adenovirus subjected to varying shear rates.  The virus count is plotted 
as a percentage of the average virus count across all shears.  Three replicate results are shown (each 
represented by a different symbol- ∆, ○, ▫).  Error bars represent 95% confidence intervals using student 
t-test (n=3).  Samples were subjected to shear at 0 and 12krpm for 20 seconds, and 18krpm for 1 minute.  
In addition duplicate results ( ■, ◆ ) are shown for samples which were subjected to disruption by a 
rotating shear device at varying speeds, as above, and then centrifuged.  Following spin-down the 
supernatant was removed, frozen, thawed and the infectivity measured using the BFU assay. 
6.3.2. Influenza: Infectivity 
Influenza virus, being enveloped, and forming at the cell cytosolic membrane, is not 
released in its infective form by shear induced lysis of the infected cells.  This is 
demonstrated by the results in Figure 6.3-3.  As seen above for adenovirus no 
significant change in the number of infective units is seen with shear.  The largest 
difference between the minimum and maximum infective titre based on this assay, 
for a given run, was 0.75 log10/ml. 
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Figure 6.3-3.   TCID50 infectivity assay for influenza virus subjected to varying shear rates.  The virus 
count is plotted as a percentage of the average virus count across all shears.  Samples were subjected to 
shear at 0, 6 and 12krpm for 20 seconds, and 18krpm for 1 minute. Four replicate results (each 
represented by a different symbol- , ∆, □, ◊) are shown for supernatant from spin-down of the sample 
after shearing, with one assay result shown for the unspun cell lysate following shear (x).  Error bars 
represent 95% confidence intervals using student t-test (n=5).   
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6.3.3. Fractionated Adenovirus: Particle Size 
To confirm that no increase could be seen in the number of obviously damaged 
adenoviruses with shear Transmission Electron Microscope (TEM) was used.  
Although involving only a very limited sample size, there was no sign of any increase 
in the number of obviously damaged particles, or morphological changes which 
could be detected by TEM.  Further the number of particles which could be identified 
as adenovirus did not change significantly (Figure 6.3-4).  It may be noted that the 
count from TEM is an order of magnitude greater than that measured using infectivity 
assay techniques.  This may reflect a large number of non-infective virus, indicating 
a very high P:I (particle to infectivity) ratio of the sample. It may be noted, however, 
that TEM measurements were performed on supernatant from spun-down samples, 
not whole cell lysate.  And therefore an increase in count might have been expected.  
The absence of this increase may reflect a substantial number of non-infective virus 
already in the supernatant before shearing of the cells.  If so this non-infective virus 
shows no more propensity to be destroyed by shear than infective virus.  Despite the 
large error bars on the normalised count the largest difference between the minimum 
and maximum count, for a given run, using TEM was 0.5 log10/ml. This is not 
substantially greater than that seen above for adenovirus infectivity assays. TEM, 
however, is clearly not a very accurate or easily quantifiable measure of virus 
morphology.  
Particle size distribution is one measure that  can change significantly in response to 
certain stresses before any impact is seen on the virus infectivity (Rexroad et al. 
(2003)).  Figure 6.3-5A shows the particle size distribution of adenovirus, which has 
been fractionated in a CsCl density gradient following shear, where measurements 
were conducted on the fractions that had been identified as containing adenovirus 
and showed the highest concentration of virus.  The shift in the position of the peak 
is shown in Figure 6.3-5B.  The change in modal diameter, although small, is 
significant for this substantial level of shear.  The shear level used here is likely to be 
far higher than any shear seen in industrial process equipment, but the duration of 
shear may also be shorter.   The presence of adenovirus in the particle size 
distribution samples, was confirmed by both silver staining and western blot against 
Ad5 coat proteins (data not shown).  
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Figure 6.3-4.  TEM adenovirus particle count following disruption using a rotating shear device at varying 
shear rates, prior to centrifugation.  Supernatant following spin down was frozen, and later thawed, 
mixed with a known nanobead concentration and counted using TEM.  Images show examples of virions 
as seen on TEM, and nanobeads, based on whose concentration the virus count was determined (see 
section 2.2.7.5).  An average of 243+/-59 (95% confidence interval, student t-test, n= 13) nanobeads was 
counted for each replicate at each shear rate.  The virus count is plotted as a percentage of the average 
virus count across all shears.  Results are shown for four replicate runs (each represented by a different 
symbol- , ◊, □, ▫).  Error bars represent 95% confidence intervals using student t-test (n=4).  Samples 
were subjected to shear at 0 and 12krpm for 20 seconds, and 18krpm for 1 minute. 
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Figure 6.3-5.  (A) Sample PSD for adenovirus fractionated using CsCl density gradient centrifugation, 
measured on the Nanosight.  Lines are labelled with the relevant rotating shear device speeds in krpm.  
(B)  Changing peak diameter as measured on the Nanosight for adenovirus subjected to varying shear 
rates.  Samples were subjected to disruption by shear in a rotating shear device at 0 and 12krpm for 20 
seconds, and 18krpm for 1 minute.  Triplicate results are shown, for each of which a different symbol ( ∆, 
◊, x ) is used.  Errors bars represent 95% confidence intervals using student t-test (n=3).  
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6.3.4. Fractionated Influenza: Particle Size 
Similarly, Figure 6.3-6 shows the particle size distribution for influenza virus, showing 
what may be an increased range of diameters at the peak of the particle size 
distribution.  The repeat measurements of the 0krpm sample indicate that the peak 
(modal value) and width of the curve at the peak remain consistent for this 
measurement technique.  Further repeats would be required to confirm the 
significance of this results, but the change appears, visually, to be more substantial 
than that seen for adenovirus at a similar shear level.  This would support the notion 
that enveloped viruses may be more shear sensitive than unenveloped viruses.  The 
presence of influenza virus in these samples was confirmed by Western blot against 
Haemagglutinin (HA) antigens (see Appendix F). 
 
Figure 6.3-6.   Sample PSD for influenza virus supernatant fractionated using sucrose density gradient 
centrifugation, measured on the CPS Disc Centrifuge.  Samples were subjected to disruption by shear in 
a rotating shear device at 0 and 12krpm for 20 seconds.  A single run was completed, with replicate 
measurements at 0krpm, to indicate the repeatability of the measurement method.  Lines are labelled 
with the relevant rotating shear device speeds in krpm. 
6.3.5. Fractionated Influenza: SDS-Page & Western blot 
Sypro Ruby staining was used to assess the isolated influenza virus samples for any 
change in overall protein levels, which might be caused by loss of envelope proteins, 
or a greater propensity to aggregation or destruction of viruses with a given protein 
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makeup.  An attempt was also made to use a Western blot against HA proteins 
(Supplementary data, Appendix F), but the quality was poor.  This immunoblot does 
however, serve to demonstrate definitively that the sucrose fractionated samples do 
contain influenza virus.  Figure 6.3-7 shows a stained gel from a single virus run, 
with protein composition for each shear level measured in triplicate.  Some protein 
levels can clearly be seen to be changing consistently across the triplicate 
measurements.  Proteins at molecular weights of 218, 122, 66, and 58kDa appear to 
show a decrease between low shear (0 and 6krpm) and high shear levels (12 and 
18krpm).  Of these 122 and 66kDa are not readily identifiable as viral proteins, and 
122kDa may be an identified EB66 protein.  By contrast the relative concentration of 
proteins in the range 30 to 50kDa, which may be identified as trypsinised 
Polymerase Acidic (PA) protein (an influenza core protein), appear to increase.  The 
overall impression is that influenza virus may encounter a tipping point somewhere 
between 6 and 12krpm in the rotating shear device, above which changes in the 
prevalence of some proteins changes.  The significance of these changes would 
need to be confirmed by further replicates, but it does indicate that the virus may be 
impacted by shear even in the range encountered in the process environment.  An 
additional possible explanation for these changes is that cellular proteins from 
destroyed or damaged cells become associated with the virus particle or that 
proteases are released by sheared cells.  The PSC-5 clarified sample gives some 
indication of the impact that these proteases might have, as this sample was left 
overnight unfrozen and could have been exposed to proteases for a longer period of 
time.  The protein make-up of this sample appears roughly in line with a sample 
exposed to a low shear level, as would be expected for a low shear centrifuge such 
as the PSC-5. 
The impact of shear on viruses has been very little investigated to date, due possibly 
to the relatively small size of the virus particles, putting them below the range which 
hydrodynamic shear might be anticipated to impact, and the complicated nature of 
the particles and substantial uncertainty in the assays required to monitor that 
impact.  Despite shear showing no significant impact on infectivity for both 
adenovirus and influenza, evidence has been found of a slight change in average 
particle size, and, for influenza, a modification in the proteomic make-up.  Further 
work is required to confirm these initial findings and elucidate their significance. 
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Figure 6.3-7.   Sypro Ruby Gel for influenza virus.  Supernatant of samples subjected to disruption by 
shear in a rotating shear device at 0, 6 and 12krpm for 20 seconds and 18krpm for 1 minute.  The sample 
clarified in the PSC-5 centrifuge was left overnight without freezing.  Influenza viruses in all the samples 
have been isolated by fractionation using a sucrose density gradient.  A single run was completed, with 
triplicate measurements on a single sypro ruby gel.  The OD of the samples for all wells is identical, at 
the peak absorbance wavelength of 290nm.   
   
Page 213 of 308 
 
 
Figure 6.3-8  Graphs indicating the relative quantity of protein, for no shear at 0krpm (unfilled), low shear 
at  6krpm (light dotted), intermediate shear at 12krpm (dense dotted), high shear at 18krpm (filled) and 
PSC-5 clarified (stripped), as measured on a protein gel (Figure 6.3-7), for influenza which has been 
sheared, frozen overnight, and fractionated by sucrose density gradient.  Error bars are standard 
deviation of triplicate measurements. 
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6.4. Operating windows for Influenza production in EB66 cells  
As discussed in the introduction (section 1.1.3) the aim of USD modelling is to 
produce usable results, which should therefore be presented in a form that can 
quickly be translated to process changes.  Figure 6.4-1 is therefore included to 
illustrate how such an operating window might look for the PSC-5 centrifuge in the 
influenza process under investigation.  The data in Figure 6.4-1 is derived from the 
curves in Figure 6.2-2A and Figure 6.2-3 for uninfected EB66 cells and harvest 
respectively.  The shear imposed by the continuous centrifuge at a given set of 
operating conditions was derived from the formula in section 3.2.2.3.  Results imply 
that considerable improvements in clarification could be achieved, from the current 
value of approximately 75% to approximately 92%, by altering centrifuge speed and 
flow rate.  However, the best possible clarifications are only achieved at the highest 
rotating speeds and lowest flowrates in a very narrow window which could result in 
greater variability.  On this basis it is suggested that the current operating conditions 
be retained, or that flowrate be increased by about 100l/hr, which may allow an 
improvement of order 4% in clarification without substantially increasing variability.   
This result would need to be confirmed experimentally.  Clearly selection of an 
alternative operating condition is open to interpretation and better clarification might 
well be possible.  The operating windows allow these possibilities to be explored. 
Figure 6.4-1 also illustrates the differences between uninfected and influenza 
producing cell cultures at harvest.  The pre-infection culture clarifies far better for the 
majority of the operating space.  Although it may be noted that according to this 
predicted operating window the influenza producing culture will clarify better than the 
pre-infection culture at the lowest rotational speed-highest flow.  The change of 
clarification across the operating window for the influenza producing culture is also 
more complicated.  For the pre-infection culture, as we move towards the top right 
corner the decrease in shear as the machine is operated more slowly appears to be 
offset by the decrease in clarification efficiency. For the influenza producing culture 
by contrast the effects of rotational speed and flow rate on shear and settling 
efficiency appear to compete across the operating window, resulting in minimum 
clarification towards the middle of the operating window. 
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Figure 6.4-1. Operating windows for clarification in the PSC-5 disc stack centrifuge for EB66 cells 
pre-infection and 5 days post infection with influenza virus (i.e. the standard day of harvest).  The range 
of PSC-5 centrifuge operating parameters of speed and inlet flow rate are covered, with predicted 
clarification based on CFD predictions of equivalent rotating shear device speed, and clarification based 
on the experimental outputs from the large laboratory scale centrifuge.  The current operating conditions 
are marked with an x, and possible adjusted operating conditions are marked with a . 
6.5. Summary of main findings  
Little has previously been published regarding the impact of shear on virus producing 
processes.  It is assumed that virus infection increases the fragility of cells, and thus 
their susceptibility to shear.  It is further assumed that the virus products themselves 
are two small to be damaged by shear.  The aim of this section of work was to begin 
examining these hypotheses. 
Contrary to expectations the clarification for adenovirus infected HEK cells, grown as 
an adherent culture, improved following infection, and showed less susceptibility to 
shear.  This result was consistent with evidence showing a less pronounced 
decrease in cell count with shear in cells which have been infected with adenovirus.  
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The implication being that virus infection results in cells which are less susceptible to 
damage by shear. 
For adenovirus the infectivity may not change with increasing shear – although this is 
hard to establish, as the infectivity assay may not have sufficient resolution. 
However, the particle size distribution does change – and becomes increasingly 
noisy at higher shear levels. This may indicate that some shear effect is occurring, 
possible clipping of hexon proteins, – but nothing that significantly effects its overall 
biological activity.  
The impact of shear on EB66 cells, grown as a suspension culture, before and after 
infection with influenza virus was also examined.  Contrary to adenovirus infection of 
HEK cells, the influenza infected EB66 cells showed a significant decrease in 
clarification.  However, it is not clear that virus infected cells are more susceptible to 
shear.  Evidence from cell count changes with shear pre and post infection with 
influenza appear to support this result.  The decrease in clarification seems to be 
due to the debris formed by viral egress.  This indicates that budding virus types may 
have a substantial negative impact on downstream processing when compared to 
lytic virus types, which may give rise to improved clarification. 
As for adenovirus the infectivity assays do not show any indication of a negative 
impact from shear on the influenza virus itself.  However, particle size distribution 
does appear to be impacted more substantially than in adenovirus.  This result would 
need to be confirmed, but might be indicative of greater shear sensitivity in 
enveloped viruses. 
Further it has been demonstrated that the ultra scale-down laboratory mimic 
previously developed for use with mammalian cells gives a good prediction on a 
range of parameters for the harvest by continuous centrifugation of EB66 cells 
producing influenza virus.  Particularly with respect to viral vectors, where substantial 
expense, expertise and biosafety issues may also play a role, this represents 
demonstration of a highly promising tool for timely and robust process development. 
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7. Summary & Future Works 
The subject of this thesis was ultra-scale down tools for viral vaccine harvest and 
early purification steps.  The focus of the work has been on two centrifuge unit 
operations:  harvest by continuous centrifugation, and virus purification and 
concentration by density gradient ultra centrifugation.  To this end the Computational 
Fluid Dynamics (CFD) modelling was extended to include a simulation in 3 
dimensions and population balance modelling to gain further insight in to the shear 
environments in both centrifuge types, with a novel validation approach using 
synthetic shear mimics.  Further the existing ultra-scale down method was applied 
for the first time to the centrifugal harvest of a viral vaccine production process, to 
investigate the impact of various viral production process parameters on cell shear 
sensitivity, and to investigate the impact of shear on virus particles themselves.   
Previous CFD work modelling the shear in continuous centrifuges and in the rotating 
shear device, which was designed to replicate the effects of shear in the feedzone of 
the centrifuge, appears to draw a comparison between the two based on peak shear 
and a 2D axi-symmetric assumption.  This work sought to increase the 
understanding of the centrifuge and rotating shear device shear environments by 
comparing them in three additional ways: in terms of the nature of the shear (normal 
versus extensional), the volumetric distribution of shear levels, and by applying a 
simple population model to account for the level of shear and the time of exposure to 
that shear. The hypothesis being that the two environments would be comparable, 
adding weight to the existing evidence from scale-down studies on cell culture 
harvests.   The results show comparability not in terms of maximum shear but with 
the magnitude of shear over the majority of the modelled volumes.  The extensional 
shear in both modelled volumes was similar, including in or near the highest shear 
zones. Most of the shear in the modelled volumes was simple shear.  A reasonable 
prediction of shear was achieved by the population balance analysis method as 
validated against shear mimic and cell samples.  Interestingly, this work identified 
that ultracentrifugation introduced a small amount of shear, which has not been 
previously identified.  However, work remains to be completed on debugging the 
methodology and increasing accuracy for which I would propose the first step would 
be to analyse the sensitivity of outputs to the assumptions made. 
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It is a recognised requirement of CFD modelling to validate experimentally.   
However, the typical experimental validation methods are not applicable to a pilot 
scale centrifuge processing virus infected materials.  It was therefore proposed to 
develop a shear mimic for mammalian cells.  This approach has a number of clear 
advantages over use of mammalian cells: it avoids the cost, time and resources to 
grow sufficient volumes of mammalian cell culture, the biosafety and cleaning 
burdens are considerably reduced, and it broadens the evidence base for 
comparability between the scale-down model and industrial unit operation.  The 
rotating shear device was used to test the susceptibility of microparticle material to 
shear, and Adju-Phos was identified, which showed a measurable response to shear 
over the same range as mammalian cells. The hypothesis was that a material of 
approximately the same size and density of a mammalian cell, and which responds 
to shear in the same range, when subjected to shear by the rotating shear device, 
will also respond to shear in the pilot / industrial scale continuous centrifuge in an 
equivalent manner.  Centrifuges which have already been well characterised using 
both CFD and the ultra-scale down approaches were used first to test this 
hypothesis.  Good ‘predictions’ of equivalent Ultra Scale-Down (USD) rotating shear 
device speed were demonstrated for Adju-Phos in both a high and low shear 
centrifuge. 
However, the slightly greater density of Adju-Phos when compared to mammalian 
cells, and the larger size of the debris formed by shear induced break-down, meant 
that the material settled very well in the centrifuge, with negligible particulates in the 
supernatant.  It was therefore necessary to take the centrifuge apart to extract 
sample, which had been subjected to shear in the centrifuge feed zone.   This was 
not possible with the centrifuge of interest located at a GMP research facility owned 
by GSK.  UCL had recently purchased a PSC-1 centrifuge, which is, according to the 
manufacturer, comparable to the PSC-5, however opening up the centrifuge 
revealed a substantial difference in geometric layout in the feed zone, the 
significance of which could not be determined based on existing knowledge.  The 
CFD modelling approach was therefore expanded to incorporate geometric as well 
as operating condition sensitivities, and the PSC-1 run with Adju-Phos at two 
extreme operating conditions to add confidence to the validation of the CFD 
modelling approach, and by extension the predictions made for the PSC-5 
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centrifuge.  Two mammalian cell cultures were also used giving an order of 
magnitude shear level for the PSC-5 centrifuge. 
The existing ultra-scale down tool was used to compare the clarification, protein 
release and impurity profile for the influenza viral vaccine production process to that 
from the PSC-5 disc stack centrifuge harvest.  It was also used to investigate the 
impact of virus infection on the shear sensitivity of HEK293 and EB66 by adenovirus 
and influenza respectively.  It was hypothesised that the USD tools would give good 
predictions for viral vaccine production processes, and that infection with virus would 
have a negative impact on the clarification and shear sensitivity of the cells.  Results 
of the experiments appear to demonstrate that the USD tool does indeed give a 
good prediction of the centrifuge harvest, but that virus infection does not necessarily 
increase the shear sensitivity of cells, or indeed decrease the clarification in all 
cases, with stark differences observed between enveloped and non-enveloped viral 
propagation.  The latter may depend more strongly on the virus release mechanism 
and the amount of debris resulting, than on the process conditions. 
It was speculated that an ultra-scale down system could be developed for the 
KII/PKII semi-continuous density gradient ultra centrifuges, which is analogous to the 
existing ultra-scale down method for centrifugal harvest: subjecting the sample to 
representative shear using the rotating shear device, followed by fractionation in a 
laboratory-scale ultra centrifuge with the scaling factor being related to the ω2t.  Work 
presented in this thesis, including CFD combined with population balance modelling, 
and use of a synthetic virus shear mimic, may provide insights that are valuable to 
the development of such a scale down model, including the apparent importance of 
hydrodynamic head or the profile of the density gradient.  However, it was not 
possible to complete the requested assays on the viral vaccine process material and 
future work requires further experimentation.  These experiments could take some 
post filtration process material, shear it in the rotating shear device and fractionate it 
using the laboratory scale density gradient ultracentrifuge, with the idea of 
identifying, (i) whether the results would be comparable to those in the PKII and (ii) 
whether any comparable semi-solid impurity might form at laboratory scale. 
Some initial work was completed on the impact of shear on the viral product, but 
further work is needed to allow more definite interpretation of these results and 
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further repeats, and development of the proteomic approaches for measuring the 
impact of shear on viruses.  It was initially hypothesised, given that the CFD analysis 
showed a Kolmogorov scale of 1μm even at a high rotational speed of 18krpm (in the 
rotating disc shear device), that neither nanobeads nor viruses would be impacted at 
all by this level of shear.  The streptavidin coated nanobeads did in fact show an 
impact from shear at much lower shear rates.  For the both influenza virus and 
adenovirus the infectivity showed negligible impact from shear, whilst the 
measurement of the particle size distribution and virus protein make-up showed an 
apparent relationship to shear, but one which is much harder to interpret definitively.  
It does, however, indicate an effect which warrants greater investigation, starting with 
additional replicate runs on influenza to confirm the significance of the differences 
seen, and optimisation of the Western blot work for adenovirus to confirm the extent 
of any proteomic changes which may be seen for this virus type. 
There is also room for significant additional work on interaction studies at ultra-scale 
down for a continuous cell-line viral production process and to further develop the 
windows of operation and experimentally validate the models generated.    
The original project proposal included interaction studies for the downstream harvest 
and purification steps up to and including the ultracentrifuge.  It is speculated that 
including the filtration steps might reveal more about the original motivation for the 
project: the formation of semi-solid impurities.  The work completed here has shown 
no evidence of these as a result of shear alone.  It is therefore speculated that 
cumulative shear across the steps of harvest centrifugation, filtration and 
ultracentrifugation gives rise to the phenomenon.  The work in this thesis provides 
evidence that the existing USD system could be a good representation of the disc 
stack centrifuge for virus producing processes, although further measurements, for 
example particle size distributions and concentration of lipids and other host cell 
components, might add to this.  With respect to filtration there are a number of 
options for scale down.  For microfiltration this includes chiefly laboratory scale using 
of the order 10-100s of ml of material and well plate based filtration systems which 
use Tecan robots and vacuum to create a transmembrane pressure drop.  For 
tangential flow ultrafiltration there is a USD device which aims to mimic the shear in 
the filtration system using a rotating disc, and laboratory scale systems for which the 
shear-time multiple could potentially be used as a scaling factor.  Filter and piping 
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material would need to be kept consistent between scales, though pump type would 
almost certain be different for practical reasons.  Other relevant scaling factors are 
likely to include the concentration gradient at the filter surface, as it may be that this 
too has relevance to the solid impurity formation.  Future interaction studies might 
look for any indication of the relative importance of shear and concentration, and any 
indication of whether shear at a given stage is of more or less importance, for a 
given process stream.   
Finally it was suggested by Sandrine Dessoy that a larger version of the shear 
device would be valuable, allowing greater quantities of material for further scale 
down work up to and including chromatography optimisation, based on the quantities 
of material that in house GSK scale down models require.  This might take the form 
of a reactor like vessel with a stirring / shearing impeller, or a continuous circulation, 
flow through or automated batch flow through version of the existing USD shear 
device. 
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8. Validation 
My sponsoring company (GSK Vaccines) produces a vaccine for seasonal flu based 
on an inactivated virus.  This is a relatively high volume market with a large (and 
growing) number of suppliers and a recognised demand based on national health 
authority policies for provision of flu vaccine to at risk sections of society.  As with 
many vaccine products there is pressure from these large-volume purchasers to 
lower Cost Of Goods (CoGs).  There is, however, also a recognised need for 
influenza vaccines, particularly rapid production, in case of a pandemic. (VWP, 2013) 
The seasonal nature of flu, and the evolution of different strains, means that each 
year process development, troubleshooting and clinical safety trails must be 
completed, all within very tight timeframes.  This is also likely to limit the amount of 
material, expert personnel and resources available for any new or alternative 
process developments which may be occurring in parallel with annual production.  
(Proctor, 2012) 
Any new process developed would need to go through full regulatory approval.  
Knowledge may be gleaned from previous work with the flu vaccine produced using 
legacy processes, though there is likely to have been limited characterisation 
conducted during this preceding period of production.  It is likely that any radical 
change in the flu vaccine production process may require submission for approval 
following the tenets of the modern regulatory procedures, i.e. Quality by Design 
(QbD), though regulators do recognize the need to maintain elements of the previous 
regime in order to handle legacy products.  The company would therefore need to be 
in discussion with regulators from a very early stage to understand the requirements 
for their submission. (Rathore and Winkle, 2009) 
In order to make use of a Ultra Scale-Down (USD) model in a regulatory submission 
the user needs to be able to demonstrate that USD is ‘qualified’ and/or the 
performance (in terms of Critical Quality Attributes, Key Process Parameters etc.) 
scales correctly and predictably throughout the design space.  (Rathore and Winkle, 
2009) 
In the case of a viral vaccine (or indeed any vaccine) identification of the Critical 
Quality Attributes (CQAs) is in itself challenging: these are complex, often 
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heterogeneous and often legacy products whose mechanism of action may not be 
understood.  In terms of high level characteristics efficacy and safety are the priority 
for a vaccine, but these cannot always be linked directly to an easily measurable 
physicochemical characteristic.   Cell based assays and animal models are 
available, though time consuming, of limited accuracy in transfer to humans and 
costly, while product variability at clinical trial will obviously be limited by safety 
concerns.  Ideally critical quality parameters should be selected, based on a risk 
based approach, but the uncertainties make it difficult to narrow down.  This may 
therefore require measurement of a very broad range of parameters in order to 
identify acceptable performance surrogates; which would make high throughput 
testing and large numbers of scale down runs usefully feasible.  (Rathore and 
Winkle, 2009, Vandercammen et al., 2012, Metz et al., 2009)     
Selection and validation of assays and product attributes to be measured is therefore 
likely to be a major challenge in characterising and qualifying the USD model.  
Multivariate analysis and centre point repeats will be needed to characterise likely 
complex interactions and variability in the process outcomes.   
VWP (2013) do provide guidelines for measuring flu vaccine quality including the 
following: 
- Hemagglutinin (HA) antigen identification against a central calibration strain, 
for which an immunodiffusion assay is suggested; 
- HA physicochemical properties; 
- Neuraminidase (NA) antigen identification (measured enzymatically); 
- NA levels, where the ratio of NA to HA is required to remain consistent for any 
given strain; 
- Purity: removal of exogenous agents, ratio Hemagglutinin to total proteins, 
concentration of cellular DNA, detergents, organic solvents, inactivating 
agents, ovalbumin, endotoxin etc. 
- Aggregates’ size, make-up and dissolution kinetics;  
Other process parameters to be monitored might include yield, stability, adsorption to 
adjuvant etc. 
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Typically on and off-line process testing is used for continuous process validation at 
the large scale, which can then be used for continued validation of USD models and 
design spaces derived from them (Phillips et al., 2009).  The nature of historic data 
already collected for the disk stack and Density Gradient-Ultra Centrifugation (DG-
UCF) may also therefore impact upon which parameters / qualities are selected to 
compare between the scales. 
Parameters useful for linking to up/downstream processes may also need to be 
considered, for example nature and degree of solids in a centrifuge supernatant 
stream which may cause clogging of downstream filters (Chhatre et al., 2011).  
Challenge studies are also suggested as a way to understand the relationship 
between consecutive stages; taking conditions to extremes at one stage and 
evaluating the outcome from the subsequent processing stage (Banerjee et al., 
2010).   The purpose of a particular stage should also be considered in selecting 
parameters to monitor / prioritise.  DG-UCF for example could be expected to have a 
significant impact on impurity levels, whilst equally the degree of shear, time 
exposed to shear and final degree of concentration might have detrimental effects on 
the product. (Aldington, 2014) 
Alfa Wassermann have previously developed a laboratory scale version of their DG-
UCF, the patent for which claims comparable performance based upon the gradient 
and distribution of virus versus impurities (Meriño, 2013). 
Whatever the final set of qualities selected for monitoring and USD validation 
subsequent process stream preparation and assays should be identical at both 
scales for optimal comparability.  These will therefore need to be planned carefully.  
(Tsang et al., 2014)   
 A USD model should also ideally have the same control capacities as its large scale 
equivalent and take into account constraints in large scale manufacturing, such as 
increased hold times or mixing scale (Tsang et al., 2014).   
In the case of disc stack centrifugation process parameters which may vary include 
bowl speed and flow-rate which are scaled using Q/Sigma (Maybury et al., 2000, 
Boychyn et al., 2004) and centrifuge model which will impact upon the degree of 
shear encountered in the feed zone.  However, the USD model is still being adjusted 
   
Page 225 of 308 
 
to account for factors such as solids sedimentation and enhanced settling which may 
vary with solids concentration or character.  (Tustian et al., 2007) 
For DG-UCF variables to be examined might include the density gradient media and 
centrifuge model (impact on shear), rotor type, sample load, density gradient media 
concentration and preparation, bowl speed, residence time, feed flow rate etc. 
(Merino et al., 2003)  The aim would be to create a USD which allowed for 
adjustments to match the range of conditions which might occur at large scale.  The 
existing disk stack centrifuge USD exemplifies the possibilities and difficulties this 
may involve. 
Shear is frequently cited as a key concern in scale-up (Garcia et al., 2012).  It is thus 
hoped that using the shear mimic and CFD modelling can allow sufficient verification 
of the range of shear expected at large scale and the comparability of shear at the 
different scales and under different conditions.   Ideally the range of shears will thus 
be explored at reduced cost and with a more easily controlled variability in the input 
material and assays.  In the spirit of QbD both the CFD and shear mimic 
development were themselves systematised: As a first approach to confirm the 
repeatability of results with the shear mimic the response to variations in 
concentration, shear rate and shear period were explored using a Design of 
Experiments (DoE) factorial model; The CFD models for the disk stack centrifuge 
was benchmarked against previous models, input data, and  modelling approach 
(including explicit and implicit assumptions) fully documented (although checking 
remains to be completed) and meshing sweeps were performed to confirm that the 
model has been sufficiently discretized.
   
Page 226 of 308 
 
9. Bibliography 
British pharmacopoeia, London : Published for the General Medical Council by 
Constable & Co. 
NF Official Compendia of Standards, Rockville, Md., United States Pharmacopeial 
Convention. 
ALDINGTON, S. Quality by Design (QbD) Applied to purification Process 
Development, Characterisation, Qualitification and Validation.  MBI Quality by 
Design for Effective Bioprocess Design and Validation, 2014 UCL. Lonza. 
ALTARAS, N. E., AUNINS, J. G., EVANS, R. K., KAMEN, A., KONZ, J. O. & WOLF, 
J. J. 2005. Production and formulation of adenovirus vectors. Gene Therapy 
and Gene Delivery Systems, 99, 193-260. 
ANDERSON, E. C., PETERSEN, D. F. & TOBEY, R. A. 1970. Density Invariance of 
Cultured Chinese Hamster Cells with Stage of Mitotic Cycle. Biophysical 
Journal, 10, 630-645. 
ANDREADIS, S. T., ROTH, C. M., LE DOUX, J. M., MORGAN, J. R. & YARMUSH, 
M. L. 1999. Large-scale processing of recombinant retroviruses for gene 
therapy. Biotechnol Prog, 15, 1-11. 
ARIGA, K., JI, Q., RICHARDS, G. J. & HILL, J. P. 2012. Soft Capsules, Hard 
Capsules, and Hybrid Capsules. Soft Materials, 10, 387-412. 
ASSELBORN, T., SUPER, A. & N, J. 2015. Manual for software allowing non 
invasive quantification of cell density in adherent cell cultures. Department of 
Biochemical Engineering, University College London. 
BALVERS, R., JIANG, H., PIYA, S., GOMEZ-MANZANO, C. & FUEYO, J. 2011. 
Adenovirus, autophagy and lysis: ecstasies and agonies. Future Virology, 6, 
1161-1164. 
BANERJEE, A., MA, N. N. & RAMASUBRAMANYAN, N. 2010. Designing in Quality: 
Approaches to Defining the Design Space for a Monoclonal Antibody Process. 
Biopharm International, 23, 26-40. 
BEKARD, I. B., ASIMAKIS, P., BERTOLINI, J. & DUNSTAN, D. E. 2011. The Effects 
of Shear Flow on Protein Structure and Function. Biopolymers, 95, 733-745. 
BERRILL, A., HO, S. V. & BRACEWELL, D. G. 2008. Ultra scale-down to define and 
improve the relationship between Flocculation and disc-stack centrifugation. 
Biotechnology Progress, 24, 426-431. 
BIDDLECOMBE, J. G., CRAIG, A. V., ZHANG, H., UDDIN, S., MULOT, S., FISH, B. 
C. & BRACEWELL, D. G. 2007. Determining antibody stability: Creation of 
solid-liquid interfacial effects within a high shear environment. Biotechnology 
Progress, 23, 1218-1222. 
BIO-RAD(A) CriterionXT Precast Gel Instruction Guide. Rev F ed. 
BIO-RAD(B) Criterion Blotter Instruction Manual. Rev B ed. 
BLAISZIK. 20/11/2012 2012. RE: email: micro-capsules. 
BOULDING, N., YIM, S. S. S., KESHAVARZ-MOORE, E., SHAMLOU, P. A. & 
BERRY, M. 2002. Ultra scaledown to predict filtering centrifugation of 
secreted antibody fragments from fungal broth. Biotechnology and 
Bioengineering, 79, 381-388. 
BOYCHYN, M., DOYLE, W., BULMER, M., MORE, J. & HOARE, M. 2000. 
Laboratory scaledown of protein purification processes involving fractional 
precipitation and centrifugal recovery. Biotechnology and Bioengineering, 69, 
1-10. 
   
Page 227 of 308 
 
BOYCHYN, M., YIM, S. S. S., BULMER, M., MORE, J., BRACEWELL, D. G. & 
HOARE, M. 2004. Performance prediction of industrial centrifuges using 
scale-down models. Bioprocess and Biosystems Engineering, 26, 385-391. 
BOYCHYN, M., YIM, S. S. S., SHAMLOU, P. A., BULMER, M., MORE, J. & HOARE, 
A. 2001. Characterization of flow intensity in continuous centrifuges for the 
development of laboratory mimics. Chemical Engineering Science, 56, 4759-
4770. 
BRYAN, A. K., GORANOV, A., AMON, A. & MANALIS, S. R. 2010. Measurement of 
mass, density, and volume during the cell cycle of yeast. Proceedings of the 
National Academy of Sciences of the United States of America, 107, 999-
1004. 
CAMPOS, S. K. & BARRY, M. A. 2006. Comparison of adenovirus fiber, protein IX, 
and hexon capsomeres as scaffolds for vector purification and cell targeting. 
Virology, 349, 453-462. 
CARR, D. R. & BRADSHAW, S. E. 2016. Gene therapies: the challenge of super-
high-cost treatments and how to pay for them. Regenerative Medicine, 11, 
381-393. 
CARUSO, F. 2001. Nanoengineering of particle surfaces. Advanced Materials, 13, 
11-74. 
CASTELLANOS, M., PEREZ, R., CARRILLO, P. J., DE PABLO, P. J. & MATEU, M. 
G. 2012. Mechanical disassembly of single virus particles reveals kinetic 
intermediates predicted by theory. Biophysical Journal, 102, 2615-24. 
CELL_BIOLABS_INC 2004a. Product Manual:  QuickTiter Adenovirus Titer 
Immunoassay Kit. Catalog Number VPK-109. 
CELL_BIOLABS_INC 2004b. Product Manual: B-Galactosidase Staining Kit. Catalog 
Number AKR-100. 
CHAN, G., BOOTH, A. J., MANNWEILER, K. & HOARE, M. 2006. Ultra scale-down 
studies of the effect of flow and impact conditions during E-coli cell 
processing. Biotechnology and Bioengineering, 95, 671-683. 
CHANG, S. H., SUN, D. P., LIANG, H. H., WANG, J., LI, J., GUO, L., WANG, X. L., 
GUAN, C. C., BORUAH, B. M., YUAN, L. M., FENG, F., YANG, M. R., 
WANG, L. L., WANG, Y., WOJDYLA, J., LI, L. J., WANG, J. W., WANG, M. 
T., CHENG, G. H., WANG, H. W. & LIU, Y. F. 2015. Cryo-EM Structure of 
Influenza Virus RNA Polymerase Complex at 4.3 angstrom Resolution. 
Molecular Cell, 57, 925-935. 
CHAUDHURI, R. G. & PARIA, S. 2012. Core/Shell Nanoparticles: Classes, 
Properties, Synthesis Mechanisms, Characterization, and Applications. 
Chemical Reviews, 112, 2373-2433. 
CHHATRE, S., PAMPEL, L. & TITCHENER-HOOKER, N. J. 2011. Integrated Use of 
Ultra Scale-Down and Financial Modeling to Identify Optimal Conditions for 
the Precipitation and Centrifugal Recovery of Milk Proteins. Biotechnology 
Progress, 27, 998-1008. 
CHRISTENSEN, J. B., BYRD, S. A., WALKER, A. K., STRAHLER, J. R., 
ANDREWS, P. C. & IMPERIALE, M. J. 2008. Presence of the adenovirus 
IVa2 protein at a single vertex of the mature virion. J Virol, 82, 9086-9093. 
CHUA, J. V. & CHEN, W. H. 2010. Bench-to-bedside review: vaccine protection 
strategies during pandemic flu outbreaks. Crit Care, 14, 218. 
DE NEVERS, N. 1991. Fluid mechanics for chemical engineers, McGraw-Hill. 
DIMITROV, D. S. 2004. Virus entry: Molecular mechanisms and biomedical 
applications. Nature Reviews Microbiology, 2, 109-122. 
   
Page 228 of 308 
 
DORAN, P. M. 2013. Bioprocess engineering principles, Waltham, MA, Focal Press. 
DOSHI, N., ZAHR, A. S., BHASKAR, S., LAHANN, J. & MITRAGOTRI, S. 2009. Red 
blood cell-mimicking synthetic biomaterial particles. Proceedings of the 
National Academy of Sciences of the United States of America, 106, 21495-
21499. 
DUFFY, A. M., O'DOHERTY, A. M., O'BRIEN, T. & STRAPPE, P. M. 2005. 
Purification of adenovirus and adeno-associated virus: comparison of novel 
membrane-based technology to conventional techniques. Gene Therapy, 12 
Suppl 1, S62-72. 
EDELSTEIN 2016. Vectors Used in Gene Therapy Clinical Trials. Journal of Gene 
Medicine. February 2016 ed. 
ENCAPSULA. Available: http://www.encapsula.com/products_01.html. 
FENG, S. Z., JIAO, P. R., QI, W. B., FAN, H. Y. & LIAO, M. 2011. Development and 
strategies of cell-culture technology for influenza vaccine. Appl Microbiol 
Biotechnol, 89, 893-902. 
FISCHER, H., POLIKARPOV, I. & CRAIEVICH, A. F. 2004. Average protein density 
is a molecular-weight-dependent function. Protein Science, 13, 2825-2828. 
FLICKINGER, M. C. & DREW, S. W. 1999. The encyclopedia of bioprocess 
technology : fermentation, biocatalysis, and bioseparation, New York, Wiley. 
FREI, M. 2011. Centrifugation Separations - Differential Centrifugation. BioFiles 
[Online], 6. Available: http://www.sigmaaldrich.com/content/dam/sigma-
aldrich/articles/biofiles/biofiles-pdf/biofiles_v6_n5.pdf. 
GARCIA, T., MCCURDY, V., WATSON, T. N. J., ENDE, M. A., BUTTERELL, P., 
VUKOVINSKY, K., CHUEH, A., COFFMAN, J., COOPER, S. & 
SCHUEMMELFEDER, B. 2012. Verification of Design Spaces Developed at 
Subscale. Journal of Pharmaceutical Innovation, 7, 13-18. 
GAROFF, H., HEWSON, R. & OPSTELTEN, D. J. 1998. Virus maturation by 
budding. Microbiol Mol Biol Rev, 62, 1171-90. 
GENZEL, Y. 2015. Designing cell lines for viral vaccine production: Where do we 
stand? Biotechnology Journal, 10, 728-U115. 
GENZEL, Y. & REICHL, U. 2009. Continuous cell lines as a production system for 
influenza vaccines. Expert Review of Vaccines, 8, 1681-1692. 
GOLDBERG, M., LANGER, R. & JIA, X. Q. 2007. Nanostructured materials for 
applications in drug delivery and tissue engineering. Journal of Biomaterials 
Science-Polymer Edition, 18, 241-268. 
GROS, A. & GUEDAN, S. 2010. Adenovirus Release from the Infected Cell as a Key 
Factor for Adenovirus Oncolysis. The Open Gene Therapy Journal, 3, 24-30. 
GÜRTLER, L. 2006. Influenza Report 2006. In: KAMPS, S., HOFFMANN, C. & 
PREISER, W. (eds.) Influenza Report 2006. Flying Publisher. 
GUU, T. S. Y., DONG, L. P., WITTUNG-STAFSHEDE, P. & TAO, Y. J. Z. 2008. 
Mapping the domain structure of the influenza A virus polymerase acidic 
protein (PA) and its interaction with the basic protein 1 (PB1) subunit. 
Virology, 379, 135-142. 
HANDEL, A., AKIN, V., PILYUGIN, S. S., ZARNITSYNA, V. & ANTIA, R. 2014. How 
sticky should a virus be? The impact of virus binding and release on 
transmission fitness using influenza as an example. Journal of the Royal 
Society Interface, 11. 
HARRISON, S. C. 2010. Virology. Looking inside adenovirus. Science, 329, 1026-7. 
   
Page 229 of 308 
 
HARSHE, Y. M., LATTUADA, M. & SOOS, M. 2011. Experimental and Modeling 
Study of Breakage and Restructuring of Open and Dense Colloidal 
Aggregates. Langmuir, 27, 5739-5752. 
HARUKI, H., GYURCSIK, B., OKUWAKI, M. & NAGATA, K. 2003. Ternary complex 
formation between DNA-adenovirus core protein VII and TAF-I beta/SET, an 
acidic molecular chaperone. Febs Letters, 555, 521-527. 
HEDLUND, M., LARSON, J. L. & FANG, F. 2010. Antiviral Strategies for Pandemic 
and Seasonal Influenza. Viruses-Basel, 2, 1766-1781. 
HENNING, P., LUNDGREN, E., CARLSSON, M., FRYKHOLM, K., JOHANNISSON, 
J., MAGNUSSON, M. K., TANG, E., FRANQUEVILLE, L., HONG, S. S., 
LINDHOLM, L. & BOULANGER, P. 2006. Adenovirus type 5 fiber knob 
domain has a critical role in fiber protein synthesis and encapsidation. Journal 
of General Virology, 87, 3151-3160. 
HENZLER, H. J. 2000. Particle stress in bioreactors. Adv Biochem Eng Biotechnol, 
67, 35-82. 
HSU, H.-W. & PERRY, E. S. 1981. Separations by centrifugal phenomena, New 
York ; Chichester, Wiley. 
HU, W. W., BERDUGO, C. & CHALMERS, J. J. 2011. The potential of hydrodynamic 
damage to animal cells of industrial relevance: current understanding. 
Cytotechnology, 63, 445-460. 
HULO, CASTRO, D., MASSON, BOUGUELERET, BARIOCH, XENARIOS & 
MERCIER, L. 2011. Cell lysis [Online]. Available: 
http://viralzone.expasy.org/all_by_species/1077.html 2016]. 
HUTCHINSON, N., BINGHAM, N., MURRELL, N., FARID, S. & HOARE, M. 2006. 
Shear stress analysis of mammalian cell suspensions for prediction of 
industrial centrifugation and its verification. Biotechnology and Bioengineering, 
95, 483-491. 
J. MAYBURY, M. H., P. DUNNILL 1999. The use of laborartory Centrifugation 
Studies to Predict Performance of Industrial Machines: Studies of Shear-
Insensitive and Shear-Sensitive Materials. Biotechnology & Bioengineering, 
67, 265-273. 
JAWETZ, E., MELNICK, J. L. & ADELBERG, E. A. 2013. Review of medical 
microbiology. Norwalk, Conn.: Appleton & Lange. 
JOSEFSBERG, J. O. & BUCKLAND, B. 2012. Vaccine process technology. 
Biotechnology and Bioengineering, 109, 1443-1460. 
KADA, FALK & GRUBER 1999. Accurate measurement of avidin and streptavidin in 
crude biofluids with a new, optimized biotin fluorescein conjugate. Biochimica 
et Biophysica Acta 1427. 
KAMPS, HOFFMANN & PREISER 2006. Influenza Report 2006. Flying Publisher. 
KASALA, D., YOON, A. R., HONG, J., KIM, S. W. & YUN, C. O. 2016. Evolving 
lessons on nanomaterial-coated viral vectors for local and systemic gene 
therapy. Nanomedicine, 11, 1689-1713. 
KOLADE, O. O., JIN, W. B., TENGROTH, C., GREEN, K. D. & BRACEWELL, D. G. 
2015. Shear Effects on Aluminum Phosphate Adjuvant Particle Properties in 
Vaccine Drug Products. Journal of Pharmaceutical Sciences, 104, 378-387. 
KOLEWE, M. E., HENSON, M. A. & ROBERTS, S. C. 2010. Characterization of 
aggregate size in Taxus suspension cell culture. Plant Cell Reports, 29, 485-
494. 
   
Page 230 of 308 
 
KOTTERMAN, M. A., CHALBERG, T. W. & SCHAFFER, D. V. 2015. Viral Vectors 
for Gene Therapy: Translational and Clinical Outlook. Annual Review of 
Biomedical Engineering, Vol 17, 17, 63-89. 
KUMAR, G. B. S., GANAPATHI, T. R., REVATHI, C. J., PRASAD, K. S. N. & 
BAPAT, V. A. 2003. Expression of hepatitis B surface antigen in tobacco cell 
suspension cultures. Protein Expression and Purification, 32, 10-17. 
LACKIE, J. M. & BLACKSHAW, S. E. 2007. The dictionary of cell and molecular 
biology, Amsterdam ; Boston, Academic Press. 
LAMB, R. A., HOLSINGER, L. J. & PINTO, L. H. 1994. The Influenza-a Virus M2 Ion 
Channel Protein and Its Role in the Influenza Virus Life Cycle. Cellular 
Receptors for Animal Viruses, 303-321. 
LAU, E. C., KONG, S., MCNULTY, S., ENTWISLE, C., MCILGORM, A., DALTON, K. 
A. & HOARE, M. 2013. An ultra scale-down characterization of low shear 
stress primary recovery stages to enhance selectivity of fusion protein 
recovery from its molecular variants. Biotechnology and Bioengineering, 110, 
1973-1983. 
LEUNG, W. W.-F. 1998. Industrial centrifugation technology, New York, McGraw-
Hill. 
LEVY, M. S., COLLINS, I. J., YIM, S. S., WARD, J. M., TITCHENER-HOOKER, N., 
SHAMLOU, P. A. & DUNNILL, P. 1999. Effect of shear on plasmid DNA in 
solution. Bioprocess Engineering, 20, 7-13. 
LI, M. & QIU, Y. X. 2013. A review on current downstream bio-processing technology 
of vaccine products. Vaccine, 31, 1264-1267. 
LIFESCIENCES 2014. User Guide: Mini Gel Tank. For protein electrophoresis of 
Novex, NuPAGE, and Bolt Mini Gels. A.0 ed. 
LIU, H., JIN, L., KOH, S. B., ATANASOV, I., SCHEIN, S., WU, L. & ZHOU, Z. H. 
2010. Atomic structure of human adenovirus by cryo-EM reveals interactions 
among protein networks. Science, 329, 1038-43. 
LOPES & KESHAVARZ-MOORE, E. 2012. Prediction and Verification of Centrifugal 
Dewatering of P. pastoris Fermentation Cultures Using An Ultra Scale-Down 
Approach. Biotechology and Bioengineering, 109, 2039-2047. 
LOTFIAN, P., LEVY, M. S., COFFIN, R., WARD, J. & SHAMLOU, P. A. 2003a. 
Shear-induced release of disabled herpes simplex virus from baby-hamster 
kidney cells. Biotechnology and Applied Biochemistry, 38, 271-281. 
LOTFIAN, P., LEVY, M. S., COFFIN, R. S., FEARN, T. & AYAZI-SHAMLOU, P. 
2003b. Impact of process conditions on the centrifugal recovery of a disabled 
herpes simplex virus. Biotechnology Progress, 19, 209-215. 
LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. & RANDALL, R. J. 1951. Protein 
measurement with the Folin phenol reagent. Journal of Biological Chemistry, 
193, 265-75. 
LU, G. Z., THOMPSON, B. G. & GRAY, M. R. 1992. Physical Modeling of Animal-
Cell Damage by Hydrodynamic-Forces in Suspension-Cultures. 
Biotechnology and Bioengineering, 40, 1277-1281. 
LUISI, P. L. & STANO, P. 2011. Synthetic biology: minimal cell mimicry. Nat Chem, 
3, 755-6. 
LYNCH, J. P., FISHBEIN, M. & ECHAVARRIA, M. 2011. Adenovirus. Seminars in 
Respiratory and Critical Care Medicine, 32, 494-511. 
MALVERN_WEBSITE. Static Light Scattering (SLS) [Online]. Available: 
http://www.malvern.com/en/products/technology/static-light-scattering/. 
   
Page 231 of 308 
 
MANNWEILER, K. & HOARE, M. 1992. The Scale-down of an Industrial Disk Stack 
Centrifuge. Bioprocess Engineering, 8, 19-25. 
MAYBURY, J. P., HOARE, M. & DUNNILL, P. 2000. The use of laboratory 
centrifugation studies to predict performance of industrial machines: Studies 
of shear-insensitive and shear-sensitive materials. Biotechnology and 
Bioengineering, 67, 265-273. 
MCCOY, R., HOARE, M. & WARD, S. 2009. Ultra Scale-Down Studies of the Effect 
of Shear on Cell Quality; Processing of a Human Cell Line for Cancer Vaccine 
Therapy. Biotechnology Progress, 25, 1448-1458. 
MCCREATH, G. & SHIVHARE, M. 2011. Drawn to Scale. European 
Biopharmaceutical Review, 62-28. 
MCLEAN, J. E., RUCK, A., SHIRAZIAN, A., POOYAEI-MEHR, F. & ZAKERI, Z. F. 
2008. Viral manipulation of cell death. Current Pharmaceutical Design, 14, 
198-220. 
MELINEK, B. 2013. MRes Submission:  Development of Synthetic Shear Tracer 
Particles for Scale-Down Models of Continuous Centrifugation and Density 
Gradient Ultra-Centrifugation as a Mimic of Various Vaccine Candidates. 
UCL. 
MELINEK, B., DESSOY, S., MANNALL, G., BRACEWELL, D. G. & 
MUKHOPADHYAY, T. 2017. The Creation and Investigation of a Synthetic 
Shear Mimic for Mammalian Cells in Industrial Processes Under review before 
submission to Biotechnolgy Progress. 
MERCADE-PRIETO, R., NGUYEN, B., ALLEN, R., YORK, D., PREECE, J. A., 
GOODWIN, T. E. & ZHANG, Z. B. 2011. Determination of the elastic 
properties of single microcapsules using micromanipulation and finite element 
modeling. Chemical Engineering Science, 66, 2042-2049. 
MERCADE-PRIETO, R. & ZHANG, Z. B. 2012. Mechanical characterization of 
microspheres - capsules, cells and beads: a review. Journal of 
Microencapsulation, 29, 277-285. 
MERIÑO, S. 15/03/2013 10:27 2013. RE: Alfa Wassermann Ultracentrifuge. Type to 
MELINEK, B. 
MERINO, S. P., WOERDEN, DALESSIO, S. J., HOPATCONG, OTTEN, R. R. L. R. 
& MONTFOORT. 2003. Centrifuge with removable core for scalable 
centrifugation. US 2003/0114289 A1. 
METZ, B., VAN DEN DOBBELSTEEN, G., VAN ELS, C., VAN DER GUN, J., 
LEVELS, L., VAN DER POL, L., ROTS, N. & KERSTEN, G. 2009. Quality-
control issues and approaches in vaccine development. Expert Review of 
Vaccines, 8, 227-238. 
MICHALSKY, R., PFROMM, P. H., CZERMAK, P., SORENSEN, C. M. & 
PASSARELLI, A. L. 2008. Effects of temperature and shear force on 
infectivity of the baculovirus Autographa californica M nucleopolyhedrovirus. 
Journal of Virological Methods, 153, 90-6. 
MILO, R., JORGENSEN, P., MORAN, U., WEBER, G. & SPRINGER, M. 2010. 
BioNumbers - the database of key numbers in molecular and cell biology 
[Online]. Nucleic Acids Red. (D750-D753). Available: 
http://kirschner.med.harvard.edu/files/bionumbers/fundamentalBioNumbersHa
ndout.pdf. 
MITTEREDER, N., MARCH, K. L. & TRAPNELL, B. C. 1996. Evaluation of the 
concentration and bioactivity of adenovirus vectors for gene therapy. J Virol, 
70, 7498-7509. 
   
Page 232 of 308 
 
MOLECULAR_PROBES_INC 2007. Sypro Ruby Protein Gel Stain. 
MORENWEISER, R. 2005. Downstream processing of viral vectors and vaccines. 
Gene Therapy, 12, S103-S110. 
MORSHED, K. N., BARK, D., JR., FORLEO, M. & DASI, L. P. 2014. Theory to 
predict shear stress on cells in turbulent blood flow. Plos One, 9, e105357. 
MOYER, C. L. & NEMEROW, G. R. 2012. Disulfide-bond formation by a single 
cysteine mutation in adenovirus protein VI impairs capsid release and 
membrane lysis. Virology, 428, 41-7. 
MUENNIG, P. A. & KHAN, K. 2001. Cost-effectiveness of vaccination versus 
treatment of influenza in healthy adolescents and adults. Clinical Infectious 
Diseases, 33, 1879-1885. 
MUKHOPADHYAY, T. Vaccines Future.  MBI Vaccine Development and 
Commercialisation, 2012 UCL. UCL. 
MYBIOSOURCE.COM. 2016. PV recombinant protein :: Minor core protein (PV) 
Recombinant Protein [Online]. Available: 
http://www.mybiosource.com/prods/Recombinant-Protein/Minor-core-protein-
PV/PV/datasheet.php?products_id=1083513. 
NESBETH, D. Cell Engineering to Ease Primary Recovery.  MBI Downstream 
Processing: From Cell to Column, 2012 UCL. UCL. 
OSTERHAUS, A., FOUCHIER, R. & RIMMELZWAAN, G. 2011. Towards universal 
influenza vaccines? Philos Trans R Soc Lond B Biol Sci, 366, 2766-73. 
PAMPEL, L. W., BOUSHABA, R. & TITCHENER-HOOKER, N. J. 2008. A 
methodical approach to ultra-scale-down of process sequences: Application to 
casein removal from the milk of transgenic animals. Biotechnology Progress, 
24, 192-201. 
PEIXOTO, C., SOUSA, M. F., SILVA, A. C., CARRONDO, M. J. & ALVES, P. M. 
2007. Downstream processing of triple layered rotavirus like particles. J 
Biotechnol, 127, 452-61. 
PEREZ-BERNA, A. J., MARABINI, R., SCHERES, S. H. W., MENENDEZ-
CONEJERO, R., DMITRIEV, I. P., CURIEL, D. T., MANGEL, W. F., FLINT, S. 
J. & MARTIN, C. S. 2009. Structure and Uncoating of Immature Adenovirus. 
Journal of Molecular Biology, 392, 547-557. 
PETTITT, D., SMITH, J., FUERSTENAU-SHARP, M., BURE, K., HOLLANDER, G., 
PEREDKI, P., SLADE, A., JONES, P., MITROPHANOUS, K. & DAVID, B. 
2016. Emerging Platform Bioprocesses for Viral Vectors and Gene Therapies. 
Bioprocess International. 
PFLUG, A., GUILLIGAY, D., REICH, S. & CUSACK, S. 2014. Structure of influenza 
A polymerase bound to the viral RNA promoter. Nature, 516, 355-360. 
PHEASEY, N., JOHN, J., LOVE, C., COFFIN, R., WARD, J. M., BOUSHABA, R., 
HOARE, M. & LEVY, M. S. 2006. A capillary cytometer method to quantitate 
viable virus particles based on early detection of viral antigens and cellular 
events within single cells. Journal of Virological Methods, 137, 213-218. 
PHILLIPS, J., ERICSON, L., KARUNATILAKE, C., KUHN, B., RATHORE, A., 
LUNDELL, E., KRAUSE, H., RINN, C., SIEDLER, M., SIMON, S., WEBER, 
C., WITHERS, B., VINCI, V., DEFELIPPIS, M., DOBBINS, J., HILTON, M., 
MEIKLEJOHN, B., MIROQUESADA, G., KRUMMEN, L., TATICEK, R., 
MARTIN-MOE, S., KELLEY, B., BLUMENTALS, I., ERICKSON, J., 
GARDNER, A., PAOLELLA, D., PATEL, P., RINELLA, J., STAWICKI, M., 
STOCKDALE, G., SCHENERMAN, M., WASSERMAN, G., OLIVER, C., RAM, 
K., KELLIHER, L., ROBBINS, D., ANDERSON, J., AHUJA, S., CRAIGHEAD, 
   
Page 233 of 308 
 
N., NIEDZIELSKI, A., SCHARF, O., BLOOM, L., BANERJEE, A., 
KIRCHHOFF, C., LAMBERT, W., SINGH, S., BERRIDGE, J., SEAMON, K. & 
VENUGOPAL, S. 2009. A-Mab: a Case Study in Bioprocess Development. 
CMC Biotech Working Group, 2. 
PIERCE_BIOTECHNOLOGY 2015. Instructions.  Pierce BCA Protein Assay Kit. In: 
SCIENTIFIC, T. (ed.). 
PLOTKIN, S. A. & PLOTKIN, S. L. 2011. The development of vaccines: how the past 
led to the future. Nat Rev Microbiol, 9, 889-93. 
PONCELET, D. & NEUFELD, R. J. 1989. Shear breakage of nylon membrane 
microcapsules in a turbine reactor. Biotechnology and Bioengineering, 33, 95-
103. 
PROCTOR, M. Vaccine Commercialisation and Project Management.  MBI Vaccine 
Development and Commercialisation, 2012 UCL. medImmune. 
RAPPUOLI 2006. Cell-Culture-Based Vaccine Production: Technological Options. 
The Bridge, 36, 25-31. 
RATHORE, A. S. & SOFER, G. K. 2005. Process validation in manufacturing of 
biopharmaceuticals : guidelines, current practices, and industrial case studies. 
Biotechnology and bioprocessing series. Boca Raton: Taylor & Francis. 
RATHORE, A. S. & WINKLE, H. 2009. Quality by design for biopharmaceuticals. 
Nature Biotechnology, 27, 26-34. 
REIMER, C. B., BAKER, R. S., VAN FRANK, R. M., NEWLIN, T. E., CLINE, G. B. & 
ANDERSON, N. G. 1967. Purification of large quantities of influenza virus by 
density gradient centrifugation. J Virol, 1, 1207-16. 
REITER, M., PORTSMOUTH, D. & BARRETT, P. N. 2014. Avian Suspension 
Culture Cell Lines for Production of Vaccines and Other Biologicals. In: 
MEYER, H.-P. & SCHMIDHALTER, D. R. (eds.) Industrial scale suspension 
culture of living cells. Wiley-VCH Verlag GmbH & Co. 
REXROAD, J., WIETHOFF, C. M., GREEN, A. P., KIERSTEAD, T. D., SCOTT, M. 
O. & MIDDAUGH, C. R. 2003. Structural stability of adenovirus type 5. J 
Pharm Sci, 92, 665-78. 
ROLDAO, A., MELLADO, M. C. M., CASTILHO, L. R., CARRONDO, M. J. T. & 
ALVES, P. M. 2010. Virus-like particles in vaccine development. Expert 
Review of Vaccines, 9, 1149-1176. 
RUSSELL, W. C. 2009. Adenoviruses: update on structure and function. Journal of 
General Virology, 90, 1-20. 
SALOMON, R. & WEBSTER, R. G. 2009. The Influenza Virus Enigma. Cell, 136, 
402-410. 
SALTE, KING, BAGANZ, HOARE & TITCHENER-HOOKER, N. 2006. A 
Methodology for Centrifuge Selection for the Separation of High Solids 
Density Cell Broths by Visualisation of Performance Using Windows of 
Operation. Wiley Periodicals. 
SAXENA, A., TRIPATHI, B. P., KUMAR, M. & SHAHI, V. K. 2009. Membrane-based 
techniques for the separation and purification of proteins: an overview. Adv 
Colloid Interface Sci, 145, 1-22. 
SCHAAP, I. A. T., EGHIAIAN, F., DES GEORGES, A. & VEIGEL, C. 2012. Effect of 
Envelope Proteins on the Mechanical Properties of Influenza Virus. Journal of 
Biological Chemistry, 287, 41078-41088. 
SCHERMAN, D. E. O. C. 2014. Advanced textbook on gene transfer, gene therapy 
and genetic pharmacology : principles, delivery and pharmacological and 
biomedical applications of nucleotide-based therapies. 
   
Page 234 of 308 
 
SHARMA, C., MALHOTRA, D. & RATHORE, A. S. 2011. Review of Computational 
fluid dynamics applications in biotechnology processes. Biotechnology 
Progress, 27, 1497-1510. 
SHAW, M. L., STONE, K. L., COLANGELO, C. M., GULCICEK, E. E. & PALESE, P. 
2008. Cellular proteins in influenza virus particles. Plos Pathogens, 4. 
SHIGEMATSU, S., DUBLINEAU, A., SAWOO, O., BATEJAT, C., MATSUYAMA, T., 
LECLERCQ, I. & MANUGUERRA, J. C. 2014. Influenza A virus survival in 
water is influenced by the origin species of the host cell. Influenza and Other 
Respiratory Viruses, 8, 123-130. 
SILVA, A. C., PEIXOTO, C., LUCAS, T., KUPPERS, C., CRUZ, P. E., ALVES, P. M. 
& KOCHANEK, S. 2010. Adenovirus vector production and purification. Curr 
Gene Ther, 10, 437-55. 
SILVESTRY, M., LINDERT, S., SMITH, J. G., MAIER, O., WIETHOFF, C. M., 
NEMEROW, G. R. & STEWART, P. L. 2009. Cryo-Electron Microscopy 
Structure of Adenovirus Type 2 Temperature-Sensitive Mutant 1 Reveals 
Insight into the Cell Entry Defect. J Virol, 83, 7375-7383. 
SINOBIOLOGICALINC Influenza A H1N1 Nucleoprotein / NP Protein (His Tag). Sino 
Biological Inc. 
SLATER, N. 2018. Viva Examination. 
SRIVASTAVA. Analytical Tools for Characterization of 21st Century Vaccines.  MBI 
Vaccine Development and Commercialisation, 2012 UCL. Protein Sciences 
Corporation. 
SVIBEN, D., FORCIC, D., KURTOVIC, T., HALASSY, B. & BRGLES, M. 2016. 
Stability, biophysical properties and effect of ultracentrifugation and 
diafiltration on measles virus and mumps virus. Archives of Virology, 161, 
1455-67. 
TAIT, AUCAMP & HOARE 2009. Ultra Scale-Down prediction using microwell 
technology of the industrial scale clarification characteristics by centrifugation 
of mammalian cell broths. biotechnology & Bioengineering, 104, 321-31. 
THE RAPID REFERENCE TO INFLUENZA RESOURCE CENTER TEAM. 
ADAPTED FROM WILSCHUT, M. A. P. 2006. The Influenza Virus: Structure 
and Replication [Online]. Elsevier. Available: 
http://www.rapidreferenceinfluenza.com/chapter/B978-0-7234-3433-7.50009-
8/aim/influenza-virus-structure. 
THERMO. 2006. Basics of Centrifugation [Online]. Cole Parmer Technical Library. 
Available: http://www.coleparmer.co.uk/TechLibraryArticle/30. 
THERMO_FISHER_SCIENTIFIC 2015. User guide: iBlot 2 Dry Blotting system. For 
dry, electroblotting of proteins from mini-, midi-, and E PAGE gels. C.0 ed. 
THOMAS, C. R. & GEER, D. 2011. Effects of shear on proteins in solution. 
Biotechnology Letters, 33, 443-456. 
TITCHENER-HOOKER, N. J., DUNNILL, P. & HOARE, M. 2008. Micro biochemical 
engineering to accelerate the design of industrial-scale downstream 
processes for biopharmaceutical proteins. Biotechnology and Bioengineering, 
100, 473-487. 
TSANG, V. L., WANG, A. X., YUSUF-MAKAGIANSAR, H. & RYLL, T. 2014. 
Development of a scale down cell culture model using multivariate analysis as 
a qualification tool. Biotechnol Prog, 30, 152-60. 
TUSTIAN, A. D., SALTE, H., WILLOUGHBY, N. A., HASSAN, I., ROSE, M. H., 
BAGANZ, F., HOARE, M. & TITCHENER-HOOKER, N. J. 2007. Adapted ultra 
   
Page 235 of 308 
 
scale-down approach for predicting the centrifugal separation behavior of high 
cell density cultures. Biotechnology Progress, 23, 1404-1410. 
UNIPROT. 2015. UniProtKB - Q2KS10 (COR10_ADE05) [Online]. Available: 
http://www.uniprot.org/uniprot/Q2KS10. 
UNIPROT. 2016a. UniProtKB - P0C0U1 (PB1F2_I34A1) [Online]. Available: 
http://www.uniprot.org/uniprot/P0C0U1. 
UNIPROT. 2016b. UniProtKB - P68951 (NP_ADE05) [Online]. Available: 
http://www.uniprot.org/uniprot/P68951. 
VANDERCAMMEN, A., PONSAR, C., MAINIL, R., VIGANO-WOLFF, C., 
CHAUBARD, J., LE-TALLEC, D., CALIARO, G., CHAMPLUVIER, B., 
KRAMER, L., PARKER, M., SCHWARTZ, M., CAUWENBERGHS, N., 
OUZAMA, N., DESSOY, S., SCHOFIELD, T., LA BRAS, V., FERRIS, B., 
YANG, H., FINKBOHNER, J., LIU, J., SCHENERMAN, M., THOMPSON, M., 
WASHABAUGH, M., RANJIT, D., JUNKER, B., MARALDO, D., ABRAHAM, 
D., BLUE, J., WARREN, J., SCHALLER, J., MIKOLA, M., RETZLAFF, M., 
KOSINSKI, M., NILESH, M., THORNTON, R., SITRIN, R., LORENZ, T., 
BANERJEE, A., GHOSH, B., STEENO, G., KHANDKE, L., BLOOM, L., 
PHELAN, L., RUPPEN, M., ROHLFING, P., REPETTO, R., RODRIGUEZ, R., 
NEMA, S., GHIGLIERI, C., KLOCK, C., JAIPERSAD, D., ZABLACKIS, E., 
ALBANESI, G., CHOUVENC, P., HALSTEAD, R., GEVIER, R., 
PUVANESARAJAH, V., AWAFO, V., GOMEZ, P., VENUGOPAL, S., 
DESHPANDE, S. & DURST, T. 2012. A-Vax: Applying Quality by Design to 
Vaccines. CMC-Vaccines Working Group. 
VANREIS, R., GADAM, S., FRAUTSCHY, L. N., ORLANDO, S., GOODRICH, E. M., 
SAKSENA, S., KURIYEL, R., SIMPSON, C. M., PEARL, S. & ZYDNEY, A. L. 
1997. High performance tangential flow filtration. Biotechnology and 
Bioengineering, 56, 71-82. 
VELLINGA, J., VAN DER HEIJDT, S. & HOEBEN, R. C. 2005. The adenovirus 
capsid: major progress in minor proteins. Journal of General Virology, 86, 
1581-1588. 
VO, M. & PAPAVASSILIOU, D. 2016. The effects of shear and particle shape on the 
physical adsorption of polyvinyl pyrrolidone on carbon nanoparticles. 
Nanotechnology, 27. 
VWP 2013. Guideline on Influenza Vaccines - Quality Module. In: AGENCY, E. M. 
(ed.). London: European Union. 
WAEHLER, R., RUSSELL, S. J. & CURIEL, D. T. 2007. Engineering targeted viral 
vectors for gene therapy. Nature Reviews Genetics, 8, 573-87. 
WESTOBY, M., ROGERS, J. K., HAVERSTOCK, R., ROMERO, J. & PIERACCI, J. 
2011. Modeling Industrial Centrifugation of Mammalian Cell Culture Using a 
Capillary Based Scale-Down System. Biotechnology and Bioengineering, 108, 
989-998. 
WHITFORD, W. & FAIRBANK, A. 2011. Considerations in Scale-up of Viral Vaccine 
Production. BioProcess International, 9, 16-28. 
WHO. 2014. Influenza (Seasonal).  Fact Sheet No. 211 [Online]. Available: 
http://www.who.int/mediacentre/factsheets/fs211/en/ [Accessed 17-10-2016 
2016]. 
WIETHOFF, C. M., WODRICH, H., GERACE, L. & NEMEROW, G. R. 2005. 
Adenovirus protein VI mediates membrane disruption following capsid 
disassembly. J Virol, 79, 1992-2000. 
   
Page 236 of 308 
 
WISNIEWSKI, J. R., HEIN, M. Y., COX, J. & MANN, M. 2014. A "Proteomic Ruler" 
for Protein Copy Number and Concentration Estimation without Spike-in 
Standards. Molecular & Cellular Proteomics, 13, 3497-3506. 
WOLFF, M. W. & REICHL, U. 2011. Downstream processing of cell culture-derived 
virus particles. Expert Review of Vaccines, 10, 1451-1475. 
XU, F., ZHAO, C., LI, Y. H., LI, J., DENG, Y. P. & SHI, T. L. 2011. Exploring virus 
relationships based on virus-host protein-protein interaction network. Bmc 
Systems Biology, 5. 
XU, W., NEILL, T., YANG, Y., HU, Z., CLEVELAND, E., WU, Y., HUTTEN, R., XIAO, 
X., STOCK, S. R., SHEVRIN, D., KAUL, K., BRENDLER, C., IOZZO, R. V. & 
SETH, P. 2015a. The systemic delivery of an oncolytic adenovirus expressing 
decorin inhibits bone metastasis in a mouse model of human prostate cancer. 
Gene Therapy, 22, 247-56. 
XU, Y., MILLEDGE, J., ABUBAKAR, A., SWAMY, R., BAILEY, D. & HARVEY, P. 
2015b. Effects of centrifugal stress on cell disruption and glycerol leakage 
from Dunaliella salina. De Gruyter Open, 1, 20-27. 
YARMUSH, M. L. 2003. Biotechnology for biomedical engineers, Boca Raton, Fla., 
CRC Press. 
YEOH, G. H., CHEUNG, C. P. & TU, J. 2014. Multiphase flow analysis using 
population balance modeling : bubbles, drops, and particles. 
YIM, S. S. & SHAMLOU, P. A. 2000. The engineering effects of fluids flow on freely 
suspended biological macro-materials and macromolecules. Adv Biochem 
Eng Biotechnol, 67, 83-122. 
ZAMAN, ALLAN & HO 2009. Ultra scale-down approaches for clarification of 
mammalian cell culture broths in disc-stack centrifuges. Biotechnology 
Progress, 25, 1709-16. 
ZHANG, H., KONG, S., BOOTH, A., BOUSHABA, R., LEVY, M. S. & HOARE, M. 
2007. Prediction of shear damage of plasmid DNA in pump and centrifuge 
operations using an ultra scale-down device. Biotechnology Progress, 23, 
858-865. 
ZHANG, X. & GODBEY, W. T. 2006. Viral vectors for gene delivery in tissue 
engineering. Adv Drug Deliv Rev, 58, 515-34. 
ZHIRNOV, O. P., IKIZLER, M. R. & WRIGHT, P. F. 2002. Cleavage of influenza A 
virus hemagglutinin in human respiratory epithelium is cell associated and 
sensitive to exogenous antiproteases. J Virol, 76, 8682-8689. 
 
 
   
Page 237 of 308 
 
 
Appendix A: PSC-5 Comsol model setup 
1. Global Definitions  
Date  Oct 6, 2014 10:29:25 AM  
Global settings  
Name  
PCS5 - 9 (fpt 2 Fixed Rotor moving wall) - MesH 2 (13500-6500RPM - 
200lph) solveV5 RB modified mesh.mph  
Path  
D:\Users\Beatrice\Documents\work\PSC-5\rotating equipment 
version\PCS5 - 9 (fpt 2 _ Fixed Rotor _ moving wall) - MesH 2 (13500-
6500RPM - 200lph)_solveV5_RB_modified mesh.mph  
COMSOL 
version  
COMSOL 5.0 (Build: 244)  
Unit 
system  
SI  
Used products  
COMSOL Multiphysics  
CFD Module  
Particle Tracing Module  
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1.1. Parameters 1  
Parameters  
Name  Expression  Value  Description  
omega  Speed*2*pi[rad]  1413.7 rad/s  angular velocity  
Speed  13500[rpm]*Para  225 1/s  rotational speed  
Mesh  0.85  0.85  mesh size ratioing  
partsize  15[um]  1.5E−5 m  size of particle  
partdens  1010[kg/m^3]  1010 kg/m³  density of particle  
TIME  0[s]  0 s  
 
visc  1  1  
multiplication factor for viscosity for initial 
solution  
Para  1  1  
 
 
2. Component 1  
Date  Oct 6, 2014 10:29:26 AM  
Component settings  
Unit system  SI  
Geometry shape order  automatic  
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2.1. Definitions  
2.1.1. Coordinate Systems  
Boundary System 1  
Coordinate system type  Boundary system  
Tag  sys1  
Coordinate names  
First  Second  Third  
t1  t2  n  
 
2.2. Geometry 1  
Units  
Length unit  m  
Angular unit  deg  
Geometry statistics  
Description  Value  
Space dimension  3  
Number of domains  8  
Number of boundaries  76  
Number of edges  155  
Number of vertices  100  
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2.2.1. Entry (Cyl1)  
Position  
Description  Value  
Position  {0, 0, 0}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  9.89[mm]/2  
Height  114[mm]  
 
2.2.2. Distributor 1 (Cyl2)  
Position  
Description  Value  
Position  {0, 0, -3.4[cm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  40.28[mm]/2  
Height  3.4[cm]  
   
Page 241 of 308 
 
 
2.2.3. Distributor 2 (Cone1)  
Position  
Description  Value  
Position  {0, 0, -5.9[cm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Bottom radius  24.7[mm]/2  
Height  2.5[cm]  
Specify top size using  Radius  
Top radius  40.28[mm]/2  
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2.2.4. Distributor 3 (Cyl3)  
Position  
Description  Value  
Position  {0, 0, -9.5[cm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  24.7[mm]/2  
Height  3.6[cm]  
 
2.2.5. Distributor - to Exclude 1 (Cyl4)  
Position  
Description  Value  
Position  {0, 0, -9.5[cm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  13.93[mm]/2  
Height  1.2[cm]  
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2.2.6. Distributor - to Exclude 2 (Cyl5)  
Position  
Description  Value  
Position  {0, 0, -8.3[cm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  10.29[mm]/2  
Height  0.5[cm]  
 
2.2.7. Distributor - to Exclude 3 (Cone2)  
Position  
Description  Value  
Position  {0, 0, -7.8[cm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
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Bottom radius  10.29[mm]/2  
Height  0.2[cm]  
Specify top size using  Radius  
Top radius  6.65[mm]/2  
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2.2.8. Distributor - to Exclude 4 (Blk1)  
Position  
Description  Value  
Position  {13.93[mm]/2, 0, -9.5[cm] + 1.2[cm] - 0.79[cm]}  
Rotation angle  
Description  Value  
Rotation  90  
Axis  
Description  Value  
Axis type  x - axis  
Size and shape  
Description  Value  
Width  0.2[cm]  
Depth  0.79[cm]  
Height  0.5[cm]  
 
2.2.9. Distributor Flow Area 1 (Dif1)  
Compose  
Description  Value  
Keep interior boundaries  Off  
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2.2.10. Entry to Channel 1-1 (Blk2)  
Position  
Description  Value  
Position  {-7.36[mm]/2, 12.3[mm] - 0.8[mm], -9.5[cm] - 3.68[mm]/2}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Width  7.36[mm]  
Depth  7.935[mm]*3/4  
Height  3.68[mm]/2  
 
2.2.11. Entry to Channel 1-2 (Cyl6)  
Position  
Description  Value  
Position  
{-7.36[mm]/2 + 7.36[mm]/2, 12.3[mm] - 0.8[mm], -9.5[cm] + 
3.68[mm]/2}  
Axis  
Description  Value  
Axis type  y - axis  
Size and shape  
Description  Value  
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Radius  7.36[mm]/2  
Height  44.99[mm] + 0.8[mm]  
 
2.2.12. Entry to Channel 1-4 (Cone4)  
Position  
Description  Value  
Position  
{-7.36[mm]/2 + 7.36[mm]/2, 12.3[mm] - 0.6[mm] + 44.99[mm] + 
0.6[mm], -9.5[cm] + 7.36[mm]/2 - 3.68[mm]/2}  
Axis  
Description  Value  
Axis type  y - axis  
Size and shape  
Description  Value  
Bottom radius  7.36[mm]/2  
Height  0.5[cm]  
Specify top size using  Radius  
Top radius  11.51[mm]/2  
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2.2.13. Block 3 (Blk3)  
Position  
Description  Value  
Position  
{-7.36[mm]/2 + 7.36[mm]/2 - 11.51[mm]/2, 12.3[mm] - 0.6[mm] + 
44.99[mm] + 0.6[mm], -9.5[cm] + 7.36[mm]/2 - 3.68[mm]/2 + 
11.51[mm]/3}  
Rotation angle  
Description  Value  
Rotation  40  
Axis  
Description  Value  
Axis type  x - axis  
Size and shape  
Description  Value  
Width  11.51[mm]  
Depth  11.51[mm]  
Height  11.51[mm]  
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2.2.14. Entry to Channel Union (Uni1)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.15. Entry to Channel Extrude 2 (Ext3)  
Settings  
Description  Value  
Extrude from  Faces  
Input object handling  Keep  
Distances  
Distances (m)  
1.983[mm]  
Distances  
Description  Value  
Keep cross-sectional faces  Off  
Scales  
Scales xw  Scales yw  
1  1  
Displacements  
Displacements xw (m)  Displacements yw (m)  
0  0  
Twist angles  
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Twist angles (deg)  
0  
 
2.2.16. Entry to Channel Extrude (Ext1)  
Settings  
Description  Value  
Extrude from  Faces  
Input object handling  Keep  
Distances  
Distances (m)  
1.983[mm]  
Distances  
Description  Value  
Keep cross-sectional faces  Off  
Scales  
Scales xw  Scales yw  
1  1  
Displacements  
Displacements xw (m)  Displacements yw (m)  
0  0  
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Twist angles  
Twist angles (deg)  
0  
 
2.2.17. Entry to Channel 1-3 (Cone3)  
Position  
Description  Value  
Position  
{-7.36[mm]/2 + 7.36[mm]/2, 12.3[mm] - 0.6[mm], -9.5[cm] + 
7.36[mm]/2}  
Axis  
Description  Value  
Axis type  y - axis  
Size and shape  
Description  Value  
Bottom radius  7.36[mm]*1.3  
Height  7.936[mm]  
Specify top size using  Radius  
Top radius  7.36[mm]/2  
 
2.2.18. Entry to Channel Intersection (Int1)  
Compose  
Description  Value  
Keep interior boundaries  Off  
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2.2.19. Entry to Channel 1-3.2 (Cone7)  
Position  
Description  Value  
Position  
{-7.36[mm]/2 + 7.36[mm]/2, 12.3[mm] - 0.6[mm], -9.5[cm] + 
7.36[mm]/2}  
Axis  
Description  Value  
Axis type  y - axis  
Size and shape  
Description  Value  
Bottom radius  7.36[mm]*1.3  
Height  7.936[mm]  
Specify top size using  Radius  
Top radius  7.36[mm]/2  
 
2.2.20. Entry to Channel Intersection 1 (Int2)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.21. Channel 2 (Rot1)  
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Settings  
Description  Value  
Keep input objects  On  
Rotation  45  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.22. Channel 3 (Rot2)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  90  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.23. Channel 4 (Rot3)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  135  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.24. Channel 5 (Rot4)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -90  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.25. Channel 6 (Rot5)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -45  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.26. Channel 7 (Rot6)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -135  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.27. Channel 8 (Rot7)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -180  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.28. Discs Stack 1-1 (Cone5)  
Position  
Description  Value  
Position  {-10[cm], -10[cm], 0}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Bottom radius  126.96[mm]/2  
Height  36.2[mm]  
Specify top size using  Radius  
Top radius  67.32[mm]/2  
 
2.2.29. Disc Stack 1-2 (Cyl7)  
Position  
Description  Value  
Position  {-10[cm], -10[cm], 36.2[mm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
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Radius  60.8[mm]/2  
Height  115[mm] - 36.2[mm]  
 
2.2.30. Disc Stack 1-3 (Cone6)  
Position  
Description  Value  
Position  {-10[cm], -10[cm], 115[mm] - 36.2[mm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Bottom radius  126.96[mm]/2  
Height  36.2[mm]  
Specify top size using  Radius  
Top radius  67.32[mm]/2  
 
2.2.31. Disc Stack 1-4 (Ext2)  
Settings  
Description  Value  
Extrude from  Faces  
Input object handling  Keep  
Distances  
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Distances (m)  
115[mm]-36.2[mm]  
Distances  
Description  Value  
Reverse direction  On  
Scales  
Scales xw  Scales yw  
1  1  
Displacements  
Displacements xw (m)  Displacements yw (m)  
0  0  
Twist angles  
Twist angles (deg)  
0  
 
2.2.32. Cut Through Discs 1 (Cyl8)  
Position  
Description  Value  
Position  {-10[cm] + 126.96[mm]/3, -10[cm] + 126.96[mm]/3, 0}  
Axis  
Description  Value  
Axis type  z - axis  
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Size and shape  
Description  Value  
Radius  11.51[mm]/2  
Height  115[mm]  
 
2.2.33. Cut Through Discs 2 (Rot8)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  180  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
 
2.2.34. Cut Through Discs 3 (Rot9)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  90  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
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2.2.35. Cut Through Discs 4 (Rot10)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -90  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
 
2.2.36. Cut Through Discs 5 (Rot11)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  45  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
 
2.2.37. Cut Through Discs 6 (Rot12)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -45  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
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2.2.38. Cut Through Discs 7 (Rot13)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  135  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
 
2.2.39. Cut Through Discs 8 (Rot14)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  225  
Point on axis of rotation  {-10[cm], -10[cm], 0}  
Axis type  z - axis  
 
2.2.40. Move 1 (Mov1)  
Settings  
Description  Value  
x  0.1  
y  0.1  
z  -0.095  
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2.2.41. Union 3 (Uni3)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.42. Work Plane 1 (Wp1)  
Settings  
Description  Value  
Plane  yz - plane  
Unite objects  
Description  Value  
Unite objects  On  
Visualization  
Description  Value  
Projection (light blue)  Off  
 
Plane Geometry (Sequence2D)  
2.3. Materials  
2.3.1. Water  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–8  
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Material parameters  
Name  Value  Unit  
Dynamic viscosity  visc*eta(T[1/K])[Pa*s]  Pa·s  
Density  rho(T[1/K])[kg/m^3]  kg/m³  
Basic Settings  
Description  Value  
Dynamic viscosity  visc*eta(T[1/K])[Pa*s]  
Ratio of specific heats  1.0  
Electrical conductivity  
{{5.5e-6[S/m], 0, 0}, {0, 5.5e-6[S/m], 0}, {0, 0, 5.5e-
6[S/m]}}  
Heat capacity at constant 
pressure  
Cp(T[1/K])[J/(kg*K)]  
Density  rho(T[1/K])[kg/m^3]  
Thermal conductivity  
{{k(T[1/K])[W/(m*K)], 0, 0}, {0, k(T[1/K])[W/(m*K)], 0}, {0, 
0, k(T[1/K])[W/(m*K)]}}  
Speed of sound  cs(T[1/K])[m/s]  
Functions  
Function name  Type  
eta  Piecewise  
Cp  Piecewise  
rho  Piecewise  
k  Piecewise  
cs  Interpolation  
 
2.7. Mesh 4  
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Mesh statistics  
Description  Value  
Minimum element quality  0.0  
Average element quality  0.0  
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2.7.1. Size (Size)  
Settings  
Description  Value  
Calibrate for  Fluid dynamics  
Maximum element size  0.0066  
Minimum element size  0.00125  
Curvature factor  0.5  
Resolution of narrow regions  0.8  
Maximum element growth rate  1.13  
Predefined size  Fine  
 
2.7.2. Size 1 (Size1)  
Selection  
Geometric entity 
level  
Boundary  
Selection  
Boundaries 1–4, 6, 8–11, 13–22, 24, 26–29, 32–36, 39–40, 42, 
44, 46–54, 56, 59–63, 65–73, 75  
Settings  
Description  Value  
Calibrate for  Fluid dynamics  
Maximum element size  0.00461*Mesh  
Minimum element size  4.98E-4*Mesh  
Curvature factor  0.4  
Curvature factor  Off  
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Resolution of narrow regions  0.9  
Resolution of narrow regions  Off  
Maximum element growth rate  Off  
Predefined size  Finer  
Custom element size  Custom  
 
2.7.3. Size 2 (Size2)  
Selection  
Geometric entity level  Edge  
Selection  Edges 4, 10, 12, 48, 51, 66, 116, 145, 147, 153  
Settings  
Description  Value  
Maximum element size  10[um]  
Minimum element size  1[um]  
Curvature factor  0.2  
Curvature factor  Off  
Resolution of narrow regions  Off  
Maximum element growth rate  1.3  
Maximum element growth rate  Off  
Predefined size  Extremely fine  
Custom element size  Custom  
 
2.7.4. Corner Refinement 1 (Cr1)  
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Selection  
Geometric entity level  Domain  
Selection  Domains 1–8  
 
2.7.5. Free Tetrahedral 1 (Ftet1)  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–8  
Settings  
Description  Value  
Method  Delaunay (legacy version)  
 
2.7.6. Boundary Layers 1 (Bl1)  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–8  
Settings  
Description  Value  
Handling of sharp edges  Trimming  
Maximum angle for trimming  20  
 
Boundary Layer Properties 1 (Blp1)  
Selection  
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Geometric entity 
level  
Boundary  
Selection  
Boundaries 3, 8–11, 13–18, 20–21, 26–29, 32–36, 40, 42, 44, 
46–49, 51–54, 56, 59–62, 65–70  
Settings  
Description  Value  
Number of boundary layers  5  
Thickness adjustment factor  2.5  
 
2.7.7. Free Tetrahedral 2 (Ftet2)  
Selection  
Geometric entity level  Remaining  
Settings  
Description  Value  
Method  Delaunay (legacy version)  
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Appendix B: PKII Comsol model setup 
1. Global Definitions  
Date  Jun 18, 2015 10:11:24 AM  
Global settings  
Name  
Pre-geometry details KII K3 v4 mod channelwidth v3 
geometrycorrection.mph  
Path  
D:\Users\Beatrice\Documents\work\ultracentrifuge\pre-geometry details 
KII_K3_v4_mod_channelwidth_v3_geometrycorrection.mph  
COMSOL 
version  
COMSOL 5.2a (Build: 262)  
Unit 
system  
SI  
Used products  
COMSOL Multiphysics  
CFD Module  
 
1.1. Parameters 1  
Parameters  
Name  Expression  Value  Description  
TIME  0[s]  0 s  
 
Param  1  1  ramp up the speed(stability)  
Mesh  1  1  to test the effects of the mesh fineness  
P2  1  1  ramping down the flow  
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2. Component 1  
Date  Apr 13, 2015 3:05:09 PM  
Component settings  
Unit system  SI  
Geometry shape order  automatic  
 
2.1. Definitions  
2.1.1. Selections  
Explicit 1  
Selection type  
Explicit  
Selection  
Boundary 19  
 
2.1.2. Coordinate Systems  
Boundary System 1  
Coordinate system type  Boundary system  
Tag  sys1  
Coordinate names  
First  Second  Third  
t1  t2  n  
 
2.2. Geometry 1  
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Units  
Length unit  m  
Angular unit  deg  
Geometry statistics  
Description  Value  
Space dimension  3  
Number of domains  2  
Number of boundaries  19  
Number of edges  43  
Number of vertices  27  
 
2.2.1. Cylinder 1 (Cyl1)  
Position  
Description  Value  
Position  {0, 0, 0}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  130[mm]/2  
Height  0.42[m]  
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2.2.2. Cylinder 2 (Cyl2)  
Position  
Description  Value  
Position  {0, 0, 0}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  110[mm]/2  
Height  0.42[m]  
 
 
 
2.2.3. Block 1 (Blk1)  
Position  
Description  Value  
Position  {109[mm]/2, 0, 0}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
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Width  21[mm]*2  
Depth  0.173[cm]  
Height  0.42[m]  
 
2.2.4. Block 4 (Blk4)  
Position  
Description  Value  
Position  {109[mm]*2, 0, 0}  
Rotation angle  
Description  Value  
Rotation  0.85  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Width  21[mm]*2  
Depth  0.173[cm]/2  
Height  0.42[m]  
 
2.2.5. Block 5 (Blk5)  
Position  
Description  Value  
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Position  {109[mm]*2, 0.173[cm]/2, 0}  
Rotation angle  
Description  Value  
Rotation  -0.85  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Width  21[mm]*2  
Depth  0.173[cm]/2  
Height  0.42[m]  
 
2.2.6. Rotate 1 (Rot1)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  60  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.7. Rotate 2 (Rot2)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  120  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.8. Rotate 3 (Rot3)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  180  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.9. Rotate 4 (Rot4)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  240  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.10. Rotate 5 (Rot5)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  300  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.11. Union 1 (Uni1)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.12. Difference 1 (Dif1)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.13. Cone 1 (Cone1)  
Position  
Description  Value  
Position  {0, 0, 0.42 - 1.5[mm]}  
Axis  
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Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Bottom radius  1[cm]  
Height  0.1[cm] + 1.5[mm]  
 
2.2.14. Block 2 (Blk2)  
Position  
Description  Value  
Position  {-1.5[mm]/2, 0, 0.42 - 1.5[mm]}  
Axis  
Size and shape  
Description  Value  
Width  1.5[mm]  
Depth  129[mm]/2 - 38[mm]/4  
Height  1.5[mm]  
Description  Value  
Axis type  z - axis  
2.2.15. Rotate 6 (Rot6)  
Settings  
Description  Value  
Keep input objects  On  
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Rotation  60  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.16. Rotate 7 (Rot7)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  120  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.17. Rotate 8 (Rot8)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  180  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.18. Rotate 9 (Rot9)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  240  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.19. Rotate 10 (Rot10)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  300  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
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2.2.20. Union 2 (Uni2)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.21. Mirror 1 (Mir1)  
Settings  
Description  Value  
Keep input objects  On  
Point on plane of reflection  
Description  Value  
Point in plane  {0, 0, 0}  
Normal vector to plane of reflection  
Description  Value  
Plane normal  {0, 0, 1}  
 
 
 
 
 
 
 
 
2.2.22. Move 1 (Mov1)  
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Settings  
Description  Value  
x  0  
y  0  
z  0.42  
 
2.2.23. Union 3 (Uni3)  
Compose  
Description  Value  
Keep interior boundaries  Off  
 
2.2.24. Block 3 (Blk3)  
Position  
Description  Value  
Position  {0, 0, -5[mm]}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Width  130[mm]/2  
Depth  130[mm]/2  
Height  0.42[m] + 10[mm]  
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2.2.25. Rotate 11 (Rot11)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  30  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.26. Rotate 12 (Rot12)  
Settings  
Description  Value  
Rotation  -60  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
 
 
 
2.2.27. Rotate 13 (Rot13)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -60  
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Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.28. Rotate 14 (Rot14)  
Settings  
Description  Value  
Keep input objects  On  
Rotation  -60  
Point on axis of rotation  {0, 0, 0}  
Axis type  z - axis  
 
2.2.29. Block 6 (Blk6)  
Position  
Description  Value  
Position  {-0.4, -0.1, -0.01}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Width  0.4  
Depth  0.4  
Height  0.3  
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2.2.30. Cylinder 3 (Cyl3)  
Position  
Description  Value  
Position  {0, 0, 0}  
Axis  
Description  Value  
Axis type  z - axis  
Size and shape  
Description  Value  
Radius  110[mm]/2 + 11[mm]/2  
Height  0.42[m] + 1[cm]  
 
2.2.31. Intersection 1 (Int1)  
Settings  
Description  Value  
Keep input objects  On  
 
2.3. Materials  
2.3.1. Water  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–2  
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Material parameters  
Name  Value  Unit  
Dynamic viscosity  eta(T[1/K])[Pa*s]  Pa·s  
Density  rho(T[1/K])[kg/m^3]  kg/m³  
Basic Settings  
Description  Value  
Dynamic viscosity  eta(T[1/K])[Pa*s]  
Ratio of specific heats  1.0  
Electrical conductivity  
{{5.5e-6[S/m], 0, 0}, {0, 5.5e-6[S/m], 0}, {0, 0, 5.5e-
6[S/m]}}  
Heat capacity at constant 
pressure  
Cp(T[1/K])[J/(kg*K)]  
Density  rho(T[1/K])[kg/m^3]  
Thermal conductivity  
{{k(T[1/K])[W/(m*K)], 0, 0}, {0, k(T[1/K])[W/(m*K)], 0}, {0, 
0, k(T[1/K])[W/(m*K)]}}  
Speed of sound  cs(T[1/K])[m/s]  
Functions  
Function name  Type  
eta  Piecewise  
Cp  Piecewise  
rho  Piecewise  
k  Piecewise  
cs  Interpolation  
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2.4. Rotating Machinery, Turbulent Flow, k-ε 
Used products  
COMSOL Multiphysics  
CFD Module  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–2  
 
2.5. Mesh 1  
Mesh statistics  
Description  Value  
Minimum element quality  0.002189  
Average element quality  0.381  
Tetrahedral elements  25016  
Pyramid elements  232  
Prism elements  21537  
Triangular elements  6124  
Quadrilateral elements  831  
Edge elements  557  
Vertex elements  27  
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2.5.1. Size (Size)  
Settings  
Description  Value  
Calibrate for  Fluid dynamics  
Maximum element size  0.00908*Mesh  
Minimum element size  0.00171  
Curvature factor  0.5  
Resolution of narrow regions  0.8  
Maximum element growth rate  1.13  
Predefined size  Fine  
Custom element size  Custom  
 
2.5.2. Size 1 (Size1)  
Selection  
Geometric entity level  Boundary  
Selection  Boundaries 1–2, 4–5, 8–16  
Settings  
Description  Value  
Calibrate for  Fluid dynamics  
Maximum element size  0.00394*Mesh  
Minimum element size  2.57E-4  
Minimum element size  Off  
Curvature factor  0.3  
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Curvature factor  Off  
Resolution of narrow regions  0.95  
Resolution of narrow regions  Off  
Maximum element growth rate  1.08  
Maximum element growth rate  Off  
Predefined size  Extra fine  
Custom element size  Custom  
 
2.5.3. Size 2 (Size2)  
Selection  
Geometric entity level  Edge  
Selection  Edges 16, 18, 21, 23  
Settings  
Description  Value  
Maximum element size  0.0052*Mesh  
Minimum element size  5.2E-5  
Minimum element size  Off  
Curvature factor  0.2  
Curvature factor  Off  
Resolution of narrow regions  Off  
Maximum element growth rate  1.3  
Maximum element growth rate  Off  
Predefined size  Extremely fine  
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Custom element size  Custom  
 
2.5.4. Corner Refinement 1 (Cr1)  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–2  
 
2.5.5. Free Tetrahedral 1 (Ftet1)  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–2  
Settings  
Description  Value  
Method  Delaunay (legacy version)  
 
2.5.6. Boundary Layers 1 (Bl1)  
Selection  
Geometric entity level  Domain  
Selection  Domains 1–2  
Settings  
Description  Value  
Handling of sharp edges  Trimming  
Maximum angle for trimming  20  
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Boundary Layer Properties 1 (Blp1)  
Selection  
Geometric entity level  Boundary  
Selection  Boundaries 1–2, 4–5, 8–16  
Settings  
Description  Value  
Number of boundary layers  5  
Thickness adjustment factor  2.5  
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Appendix C: Chapter 3 Supplementary 
Data 
Figure(C) 1 C to F shows the shear level in the rotating disc shear device on the 
same basis, for reference.  These results are based on raw data output from the 
CFD model, which doesn’t allow for a clear understanding of the spatial distribution 
of the shear, such as the relative sizes of high shear zones.  It may also be observed 
from Figure(C) 1 G and H that the level of shear in the ultracentrifuge is very much 
comparable to that seen in the PSC-5 centrifuge, suggesting that these two 
centrifuge types may cause a similar level of shear damage. 
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Figure(C) 1. Juxtaposed images showing the spatial distribution of shear rate values in the PSC-5, 
and PKII centrifuges and in the rotating disc shear device.  The data points shown are as per the mesh 
point outputs, i.e. areas of denser meshing will contribute disproportionately to the points shown.  A and 
B show shear rate for the PSC-5 centrifuge, modelled using the rotating machinery function, across the 
height of a cross-section at the radial point of highest shear (A) and with increasing radial distance (B).  
C and D show shear rates for the rotating disc shear device for a disc speed of 6000rpm with increasing 
radial distance, similarly E and F are for a disc speed of 12000rpm.  G and H show shear rate for the PKII 
ultracentrifuge, modelled using the rotating machinery function, across the height of a cross-section at 
the radial point of highest shear (G) and with increasing radial distance (H).   
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Key variables are introduced by the use of a breakage model, in the form of the 
parameters of the power law breakage kernel (Eqn. 11, section 2.1.1.4).  The impact 
of breakage kernel parameter selection is illustrated in Figure(C) 2 for the PSC-5 and 
Figure(C) 3 for the PKII.  The breakage kernel parameters selected for use at large 
scale were those in sensitivity run #4, on the basis of similarities to the shear impact 
seen for cells and AdjuPhos, where damage is seen at shears greater than 
approximately 6000rpm, and substantial particle destruction is evident at 12000rpm, 
where the difference between the damage after 5 seconds and that after 20 seconds 
is not substantial, and where the increasing shear damage follows a roughly linear 
route. It should be noted that the results presented in Figure 3.2-22 are dependent 
on the breakage kernel parameters used, and that further optimisation of these 
parameters to more closely approach the experimental observed breakage trend is 
possible.  The result presented here is the best that could be achieved within the 
time available. 
 
Figure(C) 2. Decrease in particle count in rotating shear device with different particle breakage 
parameters, and an assumed particle size of 5μm, after a shear period of 5 secs (■) and 20 secs (◆). 
Where the path by the disc is within 0.001m of the disc, and the number of passes depends on the speed 
of the disc.  The particle parameters for each run is shown in the table.  4A is a sensitivity run where the 
path of the particles closest to the disc tip have been shifted by a random distance, within 200μm, away. 
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Figure(C) 3. Predicted particle breakage for a selected set of particle breakage parameters in the 
rotating disc shear device, for a range of run times: 5seconds (■), 20seconds (◆) and 1 minute (▲).  
Particle diameters assumed uniform at 100nm.  Red circles ( ) are the predictions for the PKII 
centrifuge. 
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The impact of PSC-5 geometry sensitivities on outputs, as measured by rotating disc 
speed required to replicate particle breakage, is shown in Figure(C) 4.   
 
Figure(C) 4. Sensitivity run results for the geometric features of a PSC style centrifuge feed zone, 
including inner and outer radius and angle and diameter of inlet branches, over a range of speeds and 
flowrates.  The relative equivalent disc speed in the rotating disc shear device is based on particle 
breakage modelling as illustrated in Figure 3.2-22.  The dashed lines indicate the equivalent range for the 
PSC-5 measured-geometry used in the main PSC-5 simulation. Sensitivity run parameters are detailed in 
Table 2.2-1. 
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Appendix D: Chapter 4 Supplementary 
Data 
Initially the count ratio measured on the Casy counter (Figure(D) 2) and the 
equivalent (number based) Mastersizer 90%ile (Figure(D) 1) parameter were used.  
This gave a higher than expected prediction of shear; 8.3 to 9.5krpm instead of the 
expected 6krpm.   
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Figure(D) 1. Effect of shear on a 1%v/v Adju-Phos suspension using the USD rotational shear device 
at varying shear rates, based on Mastersizer 2000 data.   Error bars represent 95% confidence intervals 
using student t-test (n=4).  Open diamonds (◇) represent Adju-phos runs on the rotating disc shear 
device, filled triangles (▲) are Adju-phos runs on the pilot scale disc stack centrifuge (CSA-1) with solids 
manually removed from the solids collection chamber within the centrifuge bowl. 
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Figure(D) 2. Effect of shear on a 1%v/v Adju-Phos suspension using the USD rotational shear device 
at varying shear rates, based on Casy Counter data.   Error bars represent 95% confidence intervals 
using student t-test (n=4).  Open diamonds (◇) represent Adju-phos runs on the rotating disc shear 
device, filled triangles (▲) are Adju-phos runs on the pilot scale disc stack centrifuge (CSA-1) with solids 
manually removed from the solids collection chamber within the centrifuge bowl. 
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The figures below illustrate, in order, the steps taken to analyse the position of the 
peak for the raw mastersizer data. 
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33ul/ml, 10seconds shearing
33ul/ml, 30seconds shearing
100ul/ml, 30seconds shearing
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53ul/ml, 20seconds shearing
Volume Based Peak Diameter (um)
12krpm 6krpm 0 shear
 
Figure(D) 3. Sensitivity analysis on rotating shear device speed, Adju-Phos concentration and 
shearing period on the volume based peak diameter, as measured using the Mastersizer 2000MS. 
0 0.5 1 1.5 2
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33ul/ml, 30seconds shearing
100ul/ml, 30seconds shearing
100ul/ml, 10seconds shearing
53ul/ml, 20seconds shearing
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53ul/ml, 20seconds shearing
53ul/ml, 20seconds shearing
Number Based 90%ile Diameter (um)
12krpm 6krpm 0 shear
 
Figure(D) 4. Sensitivity analysis on rotating shear device speed, Adju-Phos concentration and 
shearing period on the number based 90%ile diameter, as measured using the Mastersizer 2000MS. 
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Figure(D) 5. Effect of disruption shear rate on the particle size distribution for 1%v/v Adju-Phos 
suspension by a USD rotational shear device over a range of shear rates.  The peak diameter on a 
volume basis is generated using a single peak based distribution on Mastersizer 3000 SV.  Open 
diamonds (◇) are the results from Adju-phos sheared in the rotating shear device.  Error bars represent 
95% confidence intervals using student t-test (n=3).  The open circle ( ) is a run at top speed and 
minimum flow, and the cross (x) a run at min speed and max flow, on the PSC-1 centrifuge (which 
automatically discharges before stopping), with solids removed manually.    
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Appendix E: Chapter 5 Supplementary 
Data 
 
 
Figure(E) 1. Derivation of the Fluorescence assay corrected concentration whereby the count from 
the nanosight is calibrated against the expected number of nanobeads based on the streptavidin 
concentration derived from the fluorescence assay.   
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Appendix F: Chapter 6 Supplementary 
Data 
 
Figure(F) 1. Sample immunoblot, tagged with polyclonal antibodies against adenovirus type 5 coat 
proteins.  Lanes, Ad5 reference, lysate of HEK cells infected with adenovirus and subjected to rotating 
shear device speeds of 0, 18 and 12krpm, a reference of adenovirus infected HEK cells, lysate of 
uninfected HEK cells, and supernatant of HEK cells infected with adenovirus and subjected to rotating 
shear device speeds of 0, 18 and 12krpm.  Equal mass of protein was loaded in each lane. 
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An attempt was made to produce a similar immunoblot against HA influenza proteins 
(Figure(F) 2) but the quality of the blot was too poor for analysis.  There was 
insufficient time to repeat this assay.   
 
Figure(F) 2. Sample immunoblot, tagged with antibodies against HA proteins.  Lanes are, in order, 
molecular weight markers, EB66 cells infected with influenza and clarified using the PSC-5 centrifuge, 
subjected to shear in the rotating shear device at speeds of 0, 6 and 12krpm before being clarified at 
laboratory scale, and repeat measurements of the large scale centrifuge supernatant (PSC-5) and 
shearing at rotational shear device speeds of 0 and 12krpm and clarification at laboratory scale.  N.B. 
equal volume of sample loaded in each lane.  Laboratory scale samples have been clarification at 
conditions equivalent to those used at large scale. 
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Figure(F) 3. Sample immunoblot, tagged with antibodies against HA proteins.  Lanes are, in order, 
molecular weight markers,  EB66 cells infected with influenza and subjected to rotating shear device 
speeds of 0, 6, 12 and 18krpm, large scale PSC-5 centrifuge processed influenza infected EB66 cells, a 
blank lane and repeat measurements for EB66 cells infected with influenza and subjected to rotating 
shear device speeds of 6, 12 and 18krpm.    N.B. Equal mass of protein in each lane as measured by peak 
absorption.  The laboratory scale samples have been clarified at conditions equivalent to those used at 
large scale, and all samples have been fractionated using a sucrose gradient. 
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Appendix G: Chapter 2 Buffer Recipes 
PBS 
PBS tablets (Sigma Aldrich) were dispersed in RO milliq water. The concentration 
was 1 x 1.95-9g tablet in approximately 200ml.  A magnetic stirrer was used to 
ensure the PBS was fully dissolved. 
PBS was used to suspend nanobeads, chromatographic beads, adju-phos, al-
hydrogel and sucrose. 
Tris HCl 
10xTris-HCl was made up as follows:  61g of Trizma Hydrochloride (T3253, Sigma, 
UK) was dissolved in 1000ml of milliq water, and NaOH (71692-1KG, Sigma) added 
drop-wise to adjust the pH to 8.1. 
10mM Tris-HCl was made by adding 10ml of 10xTris-HCl to 490ml of milliq water.  
10mM Tris-HCl was used to make up CsCl density gradients, and to suspend the 
virus sample before adding to the density gradient. 
Tris Base 
6g Tris base (SC-3715A, santa cruz) and 8.766g NaCl (746398-1kg, sigma-aldrich, 
UK) was added to 1litre of milliq water, and 1M HCl added drop-wise to adjust pH to 
7.6. 
NP40 buffer 
NP40 buffer was made-up by addition to 50ml of milliq water of the following, in the 
following order:  3.48g NaCl (746398-1kg, sigma-aldrich), 0.242g Tris (SC-3715A, 
Santa Cruz Biotechnology Inc), 0.292g EDTA (E6758-10G, Sigma), 1M HCl 
(258148-2.5L, Sigma) added drop-wise to adjust the pH to 7.3, 2ml NP40 (I3021-
100ML, Sigma).  The volume was made up to 100ml with milliq water.  NP40 was 
stored refrigerated. 
STB Sample buffer 
Non-reducing STB (Laemmli) buffer was made-up by addition to 50ml of milliq water 
of the following, in the following order: 0.605g Tris, HCl added drop-wise to adjust 
the pH to 6.8, milliq water to make up the volume of 100ml, of which 7ml was taken, 
and 0.4g SDS (L3771-25g, sigma), 2ml glycerol (G5516-100ML, Sigma) and a trace 
of bromophenol blue (114391-5g, sigma-aldrich) added.  For reducing STB an 
additional 1ml of 2-mercaptoethanol (M3148-25ml, sigma) was added along with the 
SDS. 
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Acids and Base 
10ml of 99% sulphuric acid, H2SO4 (BDH AnalaR) was diluted in 190ml milliq water 
to create a 1 molar stock solution. 
6ml of 37% HCl was diluted in 193ml milliq water to create a 1 molar stock solution. 
42g of sodium bicarbonate, NaHCO3, powder (Fluka Analytical) was dispersed in 
500ml milliq water to create a 1 molar stock solution. 
Both 1 molar and concentrated acids were used to treat Agarose and the streptavidin 
coated nanobeads as described in section 2.1.2.1 and NaHCO3 used to neutralise 
the acid following treatment. 
Acid treatment was used to stress test shear mimic candidates, with the aim of 
demonstrating that the assay techniques chosen/ developed were capable of 
measuring damage to the shear mimics.  It was also used as a simple, single step 
treatment, in an attempt to weaken chromatographic bead materials, and make them 
more susceptible to damage by shear. 
Silver stain solutions 
Fixing solution: 400ml methanol (M/3900/17, Fischer scientific), 100ml acetic acid 
(126040010, Acros Organics) and 500ml milliq water; 
Sensitising solution, prepared by addition, in order of: 
o 100ml milliq water 
o 10ml sodium thiosulphate (72049-250G, Sigma Aldrich) (5%w/v) 
o 17g sodium acetate (S5636-500G, Sigma Aldrich) 
o And, once the above was dissolved, 75ml ethanol and milliq water to 
250ml 
Silver stain solution: 
o 25ml milliq water 
o 2.5mg silver nitrate (209139-25G, Sigma Aldrich) 
o And, once the above was dissolved, milliq water to 250ml 
Developing solution: 
o 2.5g sodium carbonate (791768-500G, Sigma Aldrich) 
o 500ml milliq water 
o 200μl Formaldehyde (F8775-25ml, Sigma Aldrich) 
Stopping solution: 
o 3.65g EDTA-Na22H2O (E5134-100G, Sigma Aldrich); 
o Filled to 250ml with milliq water 
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Sypro Tangerine solutions 
Fixation solution consists of 250ml of 7.5% acetic acid with 50μl sypro tangerine 
added and mixed vigorously.  7.5% acetic acid. 
 
